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Main Findings 
The broad intention of this thesis was to understand which factors regulate the 
release of serotonin and noradrenaline throughout the brain. Multiple factors, 
such as ion channels, transporters and neurotransmitter receptors shape the 
release of serotonin and noradrenaline within strict spatial and temporal 
windows. I was interested in how fast inhibition mediated by GABAARs may 
influence LC and DRN neuronal excitability. Therefore, within this thesis I 
localised distinct GABAAR subunits to the cellular and sub-cellular 
compartments of neurochemically diverse cell types which comprise the 
networks of two major monoaminergic brain centres, the noradrenergic Locus 
Coeruleus (LC) and the serotonergic Dorsal Raphe Nucleus (DRN). The 
GABAAR alpha1 subunit was predominantly localised to the non-principal, 
putative interneurons of the LC and DRN, whereas the GABAAR alpha2 and 
alpha3 subunits were mainly localised to the principal monoaminergic cells. This 
apparent segregation suggests that the precise targeting of certain GABAAR 
subunits to different cellular and sub-cellular compartments is important for 
shaping LC and DRN neuronal excitability, and thus the release of 
noradrenaline and serotonin. 
As these monoaminergic systems are engaged by stressor exposure (Swinny et 
al., 2010, Kirby et al., 2000, Kirby et al., 2007), and as they have been shown to 
have an important role in shaping mood (Stockmeier et al., 1998, Baumann et 
al., 2002), I was also interested to understand whether stressors engaged the 
GABAergic system to influence the release of monoamines. Moreover, I have 
demonstrated that a mild repeated stressor influences GABAAR expression at 
the transcriptomic level, in a brain region and subunit specific manner and thus 
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provide evidence for an important role of the GABAAR alpha3 subunit in the 
processing of stressor related information via the DRN. The finding that the 
stress neuropeptide CRH, contacts putative inhibitory synapses of serotonergic 
and non-serotonergic neurons of the DRN provides further evidence for the 
potential role of GABAergic neurotransmission in shaping DRN neuronal 
excitability in response to stressors. Finally, through behavioural phenotyping I 
have been able to demonstrate that a stressor induced increase in GABAAR 
alpha3 subunit expression in the DRN, parallels adaptive-like behavioural 
changes in response to a novel environment.  
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1. Chapter 1: General Introduction 
 
The overall aim of my PhD project is to first elucidate the expression patterns of 
specific Gamma-Amino Butyric Acid-A receptor (GABAAR) subunits within the 
cellular networks of two brain regions which cooperate to mediate some of the 
salient behavioural responses to psychosocial stressors, namely the 
noradrenergic locus coeruleus (LC) nucleus and the serotonergic dorsal raphe 
nucleus (DRN) and then determine what effect stress has on such expression 
patterns in the context of such stress-induced behavioural phenotypes. The 
importance of the work arises from the predicted role that GABAAR subtypes 
will have in shaping the pattern and level of neuronal activity within these brain 
regions, thereby influencing serotonin or noradrenaline release in their 
projection regions. It is the ensuing coordinated spatiotemporal release patterns 
of these monoamine neurotransmitters throughout projection regions which 
underlie their modulatory roles in particular brain functions such as mood and 
cognition. It is also the stress-induced changes in LC and DRN function which 
contribute to either the adaptive behavioural responses to psychosocial 
stressors or the stress-induced mental illnesses such as anxiety and 
depression.  
 
In this introductory chapter to my thesis, I will critically review the anatomy and 
function of the LC and the DRN with special emphasis on their roles in the 
pathology of stress-induced mental illnesses such as anxiety and depression. I 
will then review the stress response at the level of the central nervous system 
(CNS). I will then focus on the impact that psychosocial stress has on LC and 
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DRN function and why I think that GABAARs are likely to be central participants 
within such pathways. I will complete this chapter with a review of GABAARs, 
outlining their importance to cell-type and brain region specific function as well 
as highlighting the relative dearth of knowledge in terms of their expression and 
function within the DRN and LC and why such ignorance is a stumbling block to 
further progress in understanding and treating stress-induced mental illnesses.  
1.1. The LC-noradrenergic system 
 
The importance of noradrenaline to overall brain function is underscored by its 
pervasive expression in axons throughout the CNS (Swanson and Hartman, 
1975). Brain functions attributed to central noradrenergic systems include 
attention, arousal, learning and memory, emotion, reproduction, and central 
responses to stress (Sara, 2009, Berridge and Waterhouse, 2003). The brain 
noradrenergic system is composed of seven distinct clusters of brainstem 
noradrenergic nuclei, termed A1 to A7 (Dahlstroem and Fuxe, 1964), which in 
turn project with varying degrees throughout the CNS. The largest of these 
noradrenergic nuclei is the A6 cluster, called the LC (Swanson, 1976).  
1.1.1. LC cellular anatomy 
 
The LC nucleus presents on both hemispheres as a well-delineated cluster of 
neurons located adjacent to the fourth ventricle in the pontine brainstem. The 
numbers of LC noradrenergic neurons range from approximately 1500 per 
nucleus in rat to several thousand in monkey and 10,000–15,000 in human 
(Foote et al., 1983). LC noradrenergic neurons display heterogeneity in terms of 
their morphology and their distribution throughout the nucleus. Up to six 
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noradrenergic cell types have been classified in the LC based on their 
morphology: large multipolar cells within the ventral LC, large multipolar cells in 
the anterior pole of LC, fusiform cells in dorsal LC, posterior pole cells, medium-
sized multipolar cells, and small round cells (Loughlin, 1986). Swanson and 
Hartman (1975) described the nucleus as being divided into dorsal and ventral 
regions based on the morphological phenotypes of cells located within such 
zones. Grzanna and Molliver (1980) further described two additional sub-
populations of LC neurons resulting in the current model that four adjacent 
zones, composed of morphologically heterogeneous noradrenergic neurons 
compose the LC. However, given the compact arrangement of noradrenergic 
cell bodies which comprise the LC nuclear core, the sub-regions of the LC are 
not as well described as, for example, the DRN. More recent LC literature refers 
to two board sub-regions; the nuclear core and the pericoerular dendritic region 
(Figure 1.1). In the pericoerulear region, noradrenergic dendrites extend in the 
rostro-medial and caudo-medial planes (Shipley, 1996). In addition to the 
principal noradrenergic neurons, there is also a population of non-noradrenergic 
neurons which number roughly 10% of the total within the LC. These non-
noradrenergic neurons appear to be neurochemically diverse, expressing 
different neuropeptides such as galanin  and neuropeptide Y (Holets et al., 
1988). Some of these are considered to represent a pool of GABAergic local 
circuit interneurons (Aston-Jones et al., 2004). Taken together, the LC is 
structurally divided into a nuclear core that is composed of cytologically and 
neurochemically distinct somata and proximal dendrites, and a pericoerulear 
region that is composed mainly of distal dendrites together with non-
noradrenergic neurons.   
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Figure 1.1 
The location and sub-divisons of the Locus Coeruleus (LC). 
(A) depicts a saggital brain section at the level of the LC, the LC is located in 
the pons and is highlighted by the red box, image is modified from The Mouse 
Brain Atlas (Franklin and Plaxinos). (B) shows the two sub-regions of the LC in 
the horizontal plane visualised by tyrosine hydroxylase (TH) 
immunohistochemistry. 
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1.1.2. LC afferents  
 
The two main sub-divisions of the LC, namely the nuclear core region of 
noradrenergic cell bodies and the pericoerulear dendritic region, receive 
extensive afferent input from disparate brain regions (Cedarbraum, 1978). 
These afferents convey diverse information to the LC through the release of 
neurotransmitters and neuropeptides such as GABA from forebrain (Dimitrov et 
al., 2013) and brainstem regions such as the nucleus prepositus hypoglossi 
(Ennis and Aston-Jones, 1989), glutamate from the prefrontal cortex (PFC)  and 
sub-cortical regions such as the nucleus paragigantocellularis (Ennis and 
Aston-Jones, 1988), orexin from the hypothalamus (Horvath et al., 1999) and 
the stress hormone corticotrophin releasing hormone (CRH) from barrington’s 
nucleus and the amygdala (Valentino et al., 1992, Van Bockstaele et al., 1998).  
1.1.3. LC projections 
 
LC efferents are diverse and widespread, projecting throughout the neuroaxis 
(Fig. 1.1), innervating all CNS regions apart from the basal ganglia (striatum, 
globus pallidus). While the ventral striatum has modest noradrenergic 
innervation, such axons do not originate from the LC (Delfs et al., 1998). 
Importantly, LC neurons provide the sole source of noradrenaline to the 
cerebral cortex and hippocampus (Samuels, 2008). Evidence from retrograde 
tracing experiments revealed that LC projections innervating distinct brain 
regions arise from topographically distinct cell populations within the LC 
(Mason, 1979) and in turn, neurons from different brain regions project to 
disparate LC sub-regions. Furthermore, recent evidence has come to light for 
the existence of a local pool of inhibitory interneurons within the LC, of which at 
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least two populations have been defined; one population which projects to the 
proximal LC dendrites in the nuclear core, and a second population which 
projects to the more distal dendrites in the pericoerulear dendritic region (Aston-
Jones et al., 2004). The functional significance of such a pool of neurons could 
allow for even more precise control over the firing of LC neuronal sub-
populations. While the LC was once believed to be a homogenous nucleus 
which, when activated, released noradrenaline indiscriminately in its target 
fields, it is now viewed as a type of relay station, integrating the large quantity of 
information it receives and shaping the activity of higher brain regions in a 
stimulus specific as well as brain region specific manner.  
 
Figure 1.2 
Afferent projections of the locus coeruleus 
Afferent projections from the locus coeruleus extend throughout the neuroaxis 
and innervate virtually all brain regions in addition to supplying the sole source 
of noradrenaline to the cortex and hippocampus. ACC, anterior cingulate cortex; 
AON, anterior olfactory nucleus; AP-VAB, ansa peduncularis–ventral 
amygdaloid bundle system; BS, brainstem nuclei; C, cingulum; CC, corpus 
callosum; CER, cerebellum; CTT, central tegmental tract; CTX, cortex; DB, 
dorsal bundle; DPS, dorsal periventricular system; F, fornix; FC, frontal cortex; 
FR, fasiculus retroflexus; H, hypothalamus; HF, hippocampal formation; ML, 
medial lemiscus; MT, mamillothalamic tract; OB, olfactory bulb; OT, olfactory 
tract; pc, pars compacta; PC, piriform cortex; PRC, perirhinal cortex; PT, 
pretectal area; RF, reticular formation; S, septum; SC, spinal cord; ST, stria 
terminalis; T, tectum;TH, thalamus. Taken from Sara and Bouret, (2012).  
28 
 
1.1.4. LC physiology 
 
In vivo extracellular recording from rat have shown that before postnatal day 
(PND) 3, LC neurons are largely quiescent, displaying only sporadic discharges 
which are synchronous throughout the entire LC (Kimura and Nakamura, 1985, 
Sakaguchi and Nakamura, 1987). From PND 7 onwards, the majority of LC 
neurons are spontaneously active with their firing frequency generally ranging 
from 0.5 Hz - 5Hz (Nakamura et al., 1987, Williams et al., 1984). This 
sponteanous activity is apparent in both in vitro and in vivo LC preparations, 
which is in contrast with DRN neurons in which their spontaneous activity is 
dramatically reduced in vitro. The spontaneous activity of LC neurons arises 
from the complement of ion channels expressed and in particular, a persistently 
activate sodium channel and a calcium-activated potassium channel (Williams 
et al., 1991). LC neurons fire in two distinct activity modes, tonic (Fig. 1.2 C1) 
and phasic (Fig. 1.2 C2). Superimposed on top of the spontaneous action 
potentials are sub-threshold rhythmic oscillations in the membrane potential (0.3 
to 3 Hz; 3-15 mV) (Fig. 1.2 B1, arrows) and electronic coupling between the 
majority of LC neurons (Williams and Marshall, 1987, Christie and Jelinek, 
1993). In animals below PND 24, these membrane oscillations show synchrony 
between LC neurons and are dependent upon voltage-gated potassium 
channels allowing for noradrenergic neurons to function like a syncytium 
(Christie et al., 1989). The proportion of neurons displaying synchronised sub-
threshold oscillations of membrane potential decreases with age (Christie et al., 
1989), while the frequencies of sub-threshold oscillations of membrane potential 
and entrained action potentials increase with age (Christie and Jelinek, 1993). 
Importantly, in adulthood, the electronic coupling between LC neurons varies 
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inversely with firing rate with decreased frequencies favouring synchronous 
firing between pairs of neurons (Alvarez et al., 2002).  The synchronous firing of 
the majority of LC neurons during brain development is thought to allow for the 
functional coupling of large cohorts of LC neurons resulting in the global release 
of noradrenaline throughout the brain, a process essential for the trophic role of 
noradrenaline during brain maturation. However, in adulthood, the restriction of 
this synchronous firing to ensembles of LC neurons grouped according to their 
firing frequencies could represent the clustering of functionally distinct cohorts 
of neurons responsible for the modulation of specific brain states or behaviours. 
 
 
Figure 1.3  
Electrophysiological characteristics of LC neurons in vitro 
(A) Representative image of the structure of the LC in the horizontal plane and 
an individual noradrenergic neuron recorded in vitro as revealed by tyrosine 
hydroxylase (green) and biocytin (red) immunohistochemistry respectively. (B1) 
representative trace showing rhythmic oscillations (arrows) of the membrane 
potential of an LC neuron from an animal aged PND 7. (B2) shows the relative 
lack of such membrane oscillations in an LC neuron of an animal aged PND 30. 
(C) representative traces of LC neurons showing (C1) tonic and (C2) phasic 
patterns of activity. Also notable is the vastly different firing frequencies of the 
different neurons. All data (A-C) were obtained using whole cell recordings in 
current clamp mode. Scale bar: (A) 60 µm. (B-C) vertical 20mV, horizontal 1 
second. C, caudal; L, lateral; M, medial; R, rostral; IV, fourth ventricle.  
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JD Swinny, unpublished data 
 
1.1.5. Behavioural correlates of LC function 
 
Due to its widespread efferent output, the LC is associated with a number of 
behavioural correlates such as autonomic regulation, arousal, cognition and 
vigilance (Berridge and Waterhouse, 2003). As described in the previous 
section, the noradrenergic neurons of the LC display spontaneous firing and 
have two modes of activity: tonic and phasic discharge. The level of LC 
noradrenergic tonic activity is positively correlated with levels of arousal, which 
is perhaps one of the most widely studied behavioural correlates of LC function. 
During waking, LC noradrenergic tonic discharge decreases with progression 
across the sleep-wake cycle and is virtually silent during rapid eye movement 
sleep. (Aston-Jones, 1981). This has been elegantly exemplified in a study 
which investigated sleep-wake behaviour following optogenetic stimulation of 
the LC (Carter et al., 2010). In this study, light sensitive channels were 
specifically targeted to LC noradrenergic neurons inducible CRE and adeno-
associated viral vectors. Inhibition of LC noradrenergic activity decreases 
wakefulness, whilst stimulation during sleep induces immediate waking. 
Photostimulation which mimics long term tonic and phasic LC noradrenergic 
firing has contrasting effects on cage activity, with tonic firing resulting in 
increased cage activity and phasic firing resulting in decreased cage activity. 
This demonstrates the causal relationship between LC noradrenergic neuronal 
activity and level of arousal (Carter et al., 2010). 
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Studies assessing vigilance in the visual discrimination task help to elucidate 
the behavioural consequences of variations in tonic discharge rates in the 
awake animal (Usher et al., 1999). During low levels of LC neuronal tonic 
discharge, the animal is insufficiently engaged in the task and exhibits poor 
performance. In contrast, during intermediate levels of tonic discharge, animals 
were able to differentiate between target stimuli and distractor stimuli. 
Interestingly, during higher rates of tonic discharge, animals displayed a 
reduced ability to discriminate between targets. This suggests that during higher 
levels of LC tonic activity, animals are more in tune to distractions from off-
target stimuli compared with animals exhibiting lower levels of tonic activity. 
This could support a role for tonic LC activity in mediating behavioural flexibility 
and promoting scanning and adaptive responses to changing or unpredictable 
environments. From these data, an inverted U-shaped curve was derived 
describing the relationship between performance in the visual discrimination 
task, and the level of tonic LC activity (Fig. 1.3). 
 
Figure 1.4 
Inverted U-shaped curve and LC tonic activity 
An inverted U-shaped curve describes the relationship between performance in 
the visual discrimination task and the level of tonic LC activity (Aston-Jones et 
al., 1999). 
32 
 
 
Phasic LC firing is characterised by bursts of 2-3 action potentials which is 
followed by a period of quiescence (300ms) and represents a response to 
salient sensory stimuli (Rajkowski et al., 1994). Phasic LC noradrenergic activity 
is associated with focussed attention and in keeping with the inverted U-shape 
curve, is optimal when LC noradrenergic tonic discharge is at an intermediate 
level. Much work has been done to attempt to unravel the mechanism through 
which noradrenaline released in LC afferent target regions supports the 
encoding of sensory information within higher brain regions (Devilbiss and 
Waterhouse, 2004, Devilbiss et al., 2006, Devilbiss and Waterhouse, 2011) 
1.1.6. LC and stress 
 
Within the LC, the stress neuropeptide CRH has largely an excitatory role, 
increasing noradrenaline release in LC targets (Curtis et al., 1997). CRH 
specifically elevates tonic discharge of LC noradrenergic neurons, which 
reduces LC phasic activity. Indeed, CRH has been shown to attenuate the 
response of LC neuronal activity to sensory stimuli (Valentino and Foote, 1988). 
In this capacity, the influence of stress on LC function could be to increase 
scanning of the environment and as such may be instrumental in mediating an 
adaptive response to stress.  
Figure 1.5 
The relationship between 
stress and LC discharge 
rate 
The noradrenergic neurons 
of the LC exhibit two firing 
modalities, tonic and phasic 
firing. Each firing mode is 
correlated with a disparate 
but specific behaviour, with 
tonic firing being associated 
with arousal whereas phasic 
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firing more associated with vigilance and focussed attention. Extremes of low 
and high levels of tonic LC-noradrenergic discharge biases the LC’s firing mode 
away from phasic activity. Higher levels of tonic discharge are mediated by 
stress through the stress-related neuropeptide, CRF/CRH. Stress-induced 
increases in LC tonic activity increases scanning of the environment and as 
such, can be tremendously adaptive when negotiating potential threats  
(Valentino and Van Bockstaele, 2008). 
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1.2. The serotonin-Dorsal raphe nucleus (DRN) system 
 
Following the advent of the Falck-Hillarp histochemical fluorescence technique 
in the early sixties, Dahlström and Fuxe (1964) were the first to describe the 
localisation of serotonin-containing cell bodies and axons within the rat brain 
and classified them into 9 clusters; B1-B9. The extensive network of afferent 
outputs from these serotonergic nuclei which project throughout the brain 
results in serotonin occupying an important modulatory role in a host of 
physiological functions such as mood (Lira et al., 2003, Commons et al., 2003), 
respiration (Böhmer et al., 1979, Hilaire et al., 2010) and thermoregulation 
(Schwartz et al., 1995, Lin et al., 1998, Hodges et al., 2008), regulation of the 
sleep-wake cycle (Gervasoni et al., 2000, Urbain et al., 2006), appetite (Hoebel 
et al., 1989, Tecott et al., 1995), cognition (Mendelsohn et al., 2009, Clarke et 
al., 2004), nociception (Zeitz et al., 2002) and aggression (van der Vegt et al., 
2003, de Almeida et al., 2005).  
 
The largest serotonergic nucleus within the CNS is the DRN (Jacobs and 
Azmitia, 1992). The DRN is comprised of clusters B7 and B8 (Dahlström and 
Fuxe, 1964) and contains 50-60% of the brain’s serotonergic neurons. 
Serotonergic projections arising from the DRN extend throughout the neuroaxis 
innervating almost every brain region. Importantly, the DRN does not 
indiscriminately release serotonin throughout the brain. Instead, serotonin 
release in DRN targets is both stimulus and brain region-dependant. This 
suggests the presence of functionally distinct sub-populations of serotonergic 
neurons. 
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1.2.1. DRN cellular anatomy 
 
The DRN is located within the ventral part of the periaqueductal gray. DRN 
serotonergic neurons are morphologically diverse ranging from small round 
cells, medium-sized fusiform and bipolar cells, to large fusiform and large 
multipolar cells. Although no direct correlation between morphology and 
function can be made between DRN serotonergic neurons, it is possible that 
morphological diversity is just one of the many ways in which DRN neurons may 
be organised into functionally distinct subgroups. Indeed, morphologically 
diverse DRN serotonergic neurons are also differentially distributed throughout 
the nucleus, with small serotonergic neurons concentrated near or within 
midline DRN and larger serotonergic neurons predominating within the dorsal 
and lateral extents of the nucleus. The cells of the DRN are topographically 
organised within the rostral-caudal and dorso-ventral planes. Typically, studies 
differentiate between the rostral, midline and caudal thirds of the nucleus in the 
rostral-caudal plane. In the dorso-ventral plane, cell morphology and density 
sub-divide the DRN into five regions; dorsomedial, ventromedial, dorsolateral 
and medial interfascicular regions (Clark et al., 2006). The dorsolateral division 
describes the two lateral wing regions which are only evident at midline 
locations across the rostral-caudal extent and although present in rodents, are 
particularly developed within the human and primate DRN. 
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Figure 1.6. The location and sub-regions of the Dorsal Raphe Nucleus (DRN). 
(A) depicts a coronal brain section at the level of the DRN, image is modified 
from the Mouse Brain Atlas (Franklin and Watson). The DRN is situated ventral 
to the cerebral aqueduct and is highlighted by the red box, at this rostral-caudal 
level the five DRN sub-regions are present. (B) Shows the DRN in the coronal 
plane visualised by tryptophan hydroxylase immunohistochemistry. Distinct 
clusters of TPH immunopositive neuron delinates the dorsal (dDRN), ventral 
(vDRN), medial interfasicular layer (milfDRN) and the two lateral wing (lwDRN) 
regions of the DRN. 
1.2.2. DRN neurons are neurochemically diverse 
 
In contrast to the LC where the majority of the cells are noradrenergic projection 
neurons, only ~40-50% of the DRN neurons are serotonergic. It should be 
noted though that the extent of such neurochemical diversity appears to vary 
between species. In the rat DRN, serotonin-containing neurons co-express the 
GABA synthesising enzyme glutamic acid decarboxylase 67 (GAD67) (Shikanai 
et al., 2012), the vesicular glutamate transporter 3 (VGLUT3) (Fremeau et al., 
2002, Commons, 2009), nitric oxide synthase, galanin (Xu and Hökfelt, 1997), 
and CRH (Commons et al., 2003). However, the neurochemical diversity 
displayed by the mouse DRN is more restricted, with DRN serotonin neurons 
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co-expressing glutamic acid decarboxylase 67 (GAD67) (mRNA), VGLUT3 and 
CRH (Fu et al., 2010). Although ~50% of the DRN neurons do not express 
serotonin, they are likely to have an important role in regulating the excitability 
and consequent release of serotonin from the principal neurons. Within the 
DRN, non-serotonergic neurons also display neurochemical diversity, with 
populations of DRN neuron expressing the dopamine and noradrenaline 
synthesising enzyme tyrosine hydroxylase, GAD, nitric oxide synthase (NOS), 
somatostatin, vasointenstinal peptide (VIP) and choleycystokinin (CCK) (Fu et 
al., 2010). In spite of the potential importance of these non-serotonergic 
neurons within the neuronal networks which comprise the DRN, a correlative 
functional and neurochemical analysis of DRN non-serotonergic neurons is 
severely lacking. It is thus important to investigate the neurochemical diversity 
of the DRN, as it could underlie the presence of functionally distinct sub-
populations of DRN neuron. In light of the apparent species difference in the co-
expression of various neurochemicals, further research should combine 
functional characterisation with post-hoc morphological and neurochemical 
analysis. Particularly as mice are becoming increasingly more prevalent, given 
their use in the development of transgenic models, a deeper understanding of 
the extent of the neurochemistry of mouse DRN serotonin neurons as well as 
non-serotonin neurons may help to improve our understanding of the DRN 
network. DRN serotonergic neurons are not only topographically organised 
according to morphology but also with respect to their afferent innervation and 
efferent output (Abrams et al., 2004) 
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1.2.3. DRN afferents 
 
As with the LC, it is the afferent input to the DRN as well as the repertoire of 
neurotransmitter receptors expressed by DRN neurons which will in part define 
serotonin release in projection fields (other contributing factors will be the 
complement of ion channels expressed and the availability of neurotransmitters 
at the synaptic cleft which will be defined by the expression of transporters on 
the surrounding neuronal and glial cells). Glutamatergic afferents to the DRN 
arise from a variety of brain regions. The differential expression of vesicular 
glutamate transporter subtypes has provided important anatomical information 
about origin of glutamatergic innervation, with vesicular glutamate transporter 1 
(VGLUT1) predominantly expressed by cortical neurons, and vesicular 
glutamate transporter 2 (VGLUT2) predominantly expressed by sub-cortical and 
thalamic neurons (Kaneko and Fujiyama, 2002). The major cortical input to the 
DRN arises from the PFC. Immunohistochemical labelling for VGLUT1 suggests 
that axons from the prefrontal cortex preferentially target more distally located 
dendrites as well as dendritic spines (Commons et al., 2005). The majority of 
PFC inputs to the DRN contact non-serotonergic, GABAergic cell types, with 
synapses onto serotonergic neurons being less abundant (Jankowski and 
Sesack, 2004). Indeed, stimulation of the PFC inhibits DRN serotonergic 
neurons, which is partly mediated by GABAARs (Celada et al., 2001). This 
suggests a top down control of DRN neuronal activity, whereby the PFC can 
regulate serotonin release both directly, through inputs to serotonergic neurons, 
and indirectly, through inputs to the neurochemically diverse neurons 
embedded within the DRN network. Conversely, sub-cortical glutamatergic input 
arises from hypothalamic and medullary nuclei. Based on VGLUT2 
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immunolabelling, sub-cortical glutamatergic innervation to the DRN is more 
extensive than cortical glutamatergic input. Moreover, sub-cortical glutamatergic 
inputs preferentially target proximal dendrites and the somata of DRN neurons 
(Commons et al., 2005). Glutamatergic innervation to the DRN is also 
topographically organised, with the lateral wing region receiving the greatest 
glutamatergic innervation from perifornical and lateral hypothalamic areas and 
caudal sub-nuclei receiving the greatest innervation from the medial PFC (Lee 
et al., 2003). GABAergic afferents to the DRN arise from diverse brain regions, 
including the hypothalamus, substantia nigra pars reticular, the periaquductal 
gray and the paragigantocellular nucleus (Gervasoni et al., 2000). GABAergic 
input onto DRN serotonergic neurons also originates from within this nucleus. In 
contrast to the LC, the presence of GABAergic interneurons within the DRN is 
well accepted (Qing-Ping et al., 1992). A recent paper provided the first 
functional evidence of monosynaptic contacts between DRN GABAergic 
neurons and DRN serotonergic neurons (Challis et al., 2013). In common with 
other well characterised interneuron networks of the cortex and hippocampus 
(Klausberger and Somogyi, 2008), these local GABAergic neurons within the 
DRN no doubt act to coordinate serotonergic neuronal firing and thus determine 
the precise spatial and temporal release of serotonin throughout specific DRN 
target fields. Unfortunately, GABAergic inputs to the DRN have not been 
mapped out with respect to the different sub-divisions of this nucleus. It is thus 
speculative as to whether GABAergic inputs, as with glutamatergic inputs, are 
topographically organised within the DRN to give rise to functionally distinct 
sub-populations of serotonergic neuron which allow for the brain region specific 
release of serotonin. In addition to the glutamate and GABA-containing 
afferents within the DRN,  dopaminergic innervation to the DRN originates from 
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the ventrolateral grey, ventral tegmental area and hypothalamic dopamine 
neurons (Peyron et al., 1995). Furthermore, noradrenergic input to the DRN 
arises from several brainstem cell groups including the LC (Peyron et al., 1996), 
with orexin-containing projections originating from neuronal populations within 
the hypothalamus (Sakurai et al., 1998). Thus, anatomically and 
neurochemically diverse axons innervate and influence the neuronal activity of 
DRN neurons.  
1.2.4. DRN projections 
 
Efferent outputs from the DRN extend throughout the neuroaxis and provide the 
major source of forebrain serotonin (Fig. 1.4). As with the afferent innervation to 
the DRN, the efferent projections are also topographically organised. DRN 
efferents originating from rostrally located neurons provide serotonergic 
innervation to the caudate putamen, substantia nigra and the majority of the 
neocortex (Imai et al., 1986). In contrast, DRN neurons located in caudal 
regions of the DRN innervate other brain regions including the septum, 
hippocampus and entorhinal cortex (Köhler and Steinbusch, 1982). DRN 
efferents are topographically organised within the nucleus, such that 
serotonergic neurons which project to the caudate putamen, will not also project 
to the hippocampus (Imai et al., 1986). Thus, there is a high degree of 
specificity in the innervation pattern of DRN efferents. This supports the theory 
that the DRN is made up of functionally distinct sub-populations of neurons 
which allow precise spatial control over serotonin release. 
 
Although, sub-populations of DRN serotonin neurons do not target overlapping 
brain regions, individual neurons can give rise to collateralised efferents 
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capable of innervating disparate brain regions. Moreover, these collateralised 
serotonergic axons frequently target functionally connected brain regions. 
Individual neurons within midline DRN target both the PVN of the hypothalamus 
as well as the central nucleus of the amygdala (CeA) (Petrov et al., 1994). As 
the PVN and CeA play a central role within the stress response, this co-
regulation of the PVN and CeA by the DRN may have implications for regulating 
responses to stressors. Target regions of collateralised DRN projections are not 
restricted to stress-related circuits. Indeed, collateralised axons also project to 
limbic brain regions; individual neurons projecting to both the ventral 
hippocampus and the amygdala are located within caudal regions of the DRN  
(Imai et al., 1986). This is of particular interest given the role of the 
hippocampus and amygdala in the retrieval of emotion-related information. In 
summary, the neurons which comprise the networks of the DRN are diverse in 
terms of their morphology and neurochemistry together with their inputs and 
projection patterns. As such, it is anticipated that coordinated DRN function 
arises from the cooperation of several cellular networks within this nucleus.  
1.2.5. DRN physiology 
 
In vivo, DRN serotonin neurons are spontaneously active, but the number of 
neurons showing spontaneous activity is markedly reduced when recording in 
vitro using acute brain slices (Vandermaelen and Aghajanian, 1983). This is in 
stark contrast to LC noradrenergic neurons which exhibit spontaneous firing 
both in vivo and in vitro. This suggests that the spontaneous activity of DRN 
serotonergic neurons is dependent on intact afferent drive, particularly 
noradrenergic innervation (Baraban and Aghajanian, 1980, Vandermaelen and 
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Aghajanian, 1983). This is in contrast with LC noradrenergic neurons, as 
detailed in section 1.1.4.  
 
 
Figure 1.7  
Ascending collateral projections of rat DRN neurons  
DRN schematics through representative caudal (-8.72 mm bregma), middle (-
8.00 mm bregma), and rostral (-7.30 mm bregma) levels. Collateral projections 
occurring along the midline (in pink) are represented in the schematics on the 
left. On the right are depicted collaterals known to originate in specific DR 
subregions (dmDR in blue, vmDR in green, dlDR in orange, or lateral in purple) 
at the three rostrocaudal levels. 17, visual cortex, area 17; 4N, trochlear 
nucleus; Amy, amygdala; A-Mfor,anterior-medial forebrain; AO, anterior 
olfactory cortex; CeA, central nucleus of the amygdala; CPu, caudate-
putamen; Crus2, crus 2 of the lateral cerebellum; Ent, entorhinal 
cortex;  GiA, gigantocellular reticular nucleus, alpha part; HC, hippocampus; L-
Cfor, lateral-caudal forebrain; LC, locus coeruleus; LG, lateral 
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geniculate; LH, lateral hypothalamus; LPB, lateral parabrachial 
nucleus; lPFC, lateral prefrontal cortex; LS,lateral septum; M1, primary motor 
cortex; MD, mediodorsal thalamus; nucleus; Mo7, facial motor 
nucleus; mPFC, medial prefrontal cortex; MThal, medial 
thalamus; NAc, nucleus accumbens; PAG, periaqueductal 
gray; PFl, paraflocculus of the cerebellum; Pr5,principal sensory trigeminal 
nucleus; PVN, paraventricular nucleus of the hypothalamus; RVM, rostral 
ventral medulla; S, septum; S1, primary sensory cortex; S1BF, primary 
somatosensory cortex, barrel field; SC, superior colliculus; scp, superior 
cerebellar peduncle; SN,substantia nigra; Sp5, spinal trigeminal 
nucleus; VB, thalamic ventrobasal complex; VL, ventrolateral nucleus of the 
thalamus; VLO, ventrolateral orbital cortex; VN,vestibular nuclei; VPM, ventral 
posteromedial nucleus of the thalamus; xscp, decussation of the superior 
cerebellar peduncle. Taken from Waselus et al. (2011). 
 
Overwhelming evidence points to the functional heterogeneity in DRN serotonin 
neurons. Evidence from electrophysiological studies initially reported two types 
of functionally diverse DRN serotonergic neuron named Type I (typical) and 
Type II (atypical) according to their regular and irregular firing rhythm, 
respectively (Nakahama et al., 1981). More recently, in vivo evidence further 
outlines the functional diversity in DRN serotonergic neurons during the sleep-
wake cycle, with sub-populations of neurons being active during waking, others 
active during sleeping and another population of neurons whose activity 
appeared unrelated to sleep/wake state (Sakai, 2011). A note of caution should 
be sounded since it has been shown in acute brain slice preparations, that it is 
not possible to discriminate between serotonergic and non-serotonergic 
neurons based simply on electrophysiological profiles (Kirby et al., 2003, 
Crawford et al., 2010). It is thus essential to combine the functional data with 
post hoc neurochemical analyses of the recorded neurons. This is important 
since neurochemically diverse populations of DRN neurons display differing 
discharge rates in relation to the different phases of cortical slow wave activity. 
Indeed, serotonergic principal cells exhibit a higher discharge rate in the 
inactive phase of cortical slow waves while non-serotonergic neurons exhibit a 
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higher discharge rate during the active component of cortical slow waves 
(Schweimer et al., 2011). It is the combination of morphological, topographical, 
neurochemical and functional capabilities which endow the DRN neurons with 
the ability to orchestrate a wide variety of brain functions and behaviours. The 
data suggest that this nucleus is organised into a rich repertoire of 
interconnected cellular networks which cooperate to coordinate DRN output and 
thus brain serotonin levels. At the heart of coordinated network activity is the 
precise timing of the release of various transmitters at appropriates sites which 
express the requisite neurotransmitter receptors. My thesis will focus on the 
expression of GABAARs within LC and DRN cellular networks. 
1.2.6. Why consider the LC and DRN in combination 
 
Even though both the LC and DRN are structurally and neurochemically 
separate sub-cortical entities, they are often considered in parallel due to their 
duel involvement in mental function, especially mood. As such, their co-
dysregulation is often found to underlie associated mental illnesses such as 
anxiety and depression (Hercher et al., 2009). Much of the evidence for the 
involvement of the DRN and the LC in mood disorders arises from 
pharmacological studies which indicate that drugs which directly alter the levels 
of serotonin or noradrenaline brain levels provide therapeutic benefits (Blier and 
El Mansari, 2013). Symptoms associated with the psychiatric disorders, such as 
sleep disturbances, highlight some of the key physiological roles of LC and 
DRN function (Breslau et al., 1996). Indeed, experimental evidence has been 
provided for altered LC and DRN function in major depressive disorder (MDD).  
Studies report reduced levels of noradrenaline transporter and increased CRH 
concentrations (Bissette et al., 2003) within the LC of MDD patients (Klimek et 
45 
 
al., 1997), suggesting that hyperfunction of the LC and enhanced noradrenaline 
release is generally associated with the pathophysiology of MDD. In contrast, 
DRN hypofunction is associated with the pathophysiology of MDD. Studies 
report reductions in DRN neuronal number (Baumann et al., 2002), decreased 
DRN neuronal activity (Gos et al., 2008) and increased expression of the auto 
receptor 5-HT1A within the DRN of MDD patients (Stockmeier et al., 1998). A 
further intriguing study has shown that high frequency stimulation of the sub-
thalamic nucleus, a protocol often used to alleviate Parkinsonian symptoms, 
also results in the inhibition of DRN serotonergic neuronal activity and the 
induction of depressive-like behaviour in rats (Temel et al., 2007). Despite 
evidence for DRN hypofunction in MDD, there is also evidence for DRN 
hyperfunction in MDD suicides (Boldrini et al., 2005, Bach-Mizrachi et al., 2005). 
This has been attributed to a homeostatic mechanism to counter the effects of 
reduced DRN function. However, this may represent divergent neurobiology in 
the pathophysiology of MDD compared with MDD suicides. A common trigger in 
initiating LC and DRN dysregulation is psychosocial stress. This is due to both 
these brain regions occupying pivotal roles in mediating the body’s central 
responses to stressors. As such, it is crucial to understand the underlying 
mechanisms by which the LC and DRN process stressful signals if we are to 
devise strategies to combat any ensuing pathological repercussions. This is 
particularly pressing in terms of unmet healthcare needs since the 
monoaminergic hypothesis of affective disorders, which argues for the use of 
drugs which influence serotonergic or noradrenergic targets, is still the mainstay 
of current day pharmacotherapy despite the therapeutic failure of such agents in 
many different patient populations.  
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1.3. The mammalian stress response 
 
1.3.1. Importance of understanding the stress response 
 
Exposure to stressors results in the engagement of a host of central and 
peripheral physiological processes.  These physiological responses to stressors 
are essential survival mechanisms which allow the individual to contend with 
such challenges throughout one’s lifetime. However, exposure to stressors can 
also manifest in maladaptive physiological responses which predispose the 
individual to developing a host of diseases either of the CNS or peripheral 
systems. It is this dichotomy of the stress response, either adaptive or 
maladaptive, which remains the focus of attention since understanding the 
biology of both pathways is essential for treating stress-induced disorders. 
Tremendous strides have been made in terms of unravelling the peripheral, 
endocrine loop of the stress response. However, understanding the neural or 
cognitive loops of the stress response remains challenging given the complexity 
of the brain and mind. This research is particularly important given the host of 
stress-induced mental illnesses. As such, elucidating the neurobiological 
mechanisms underlying the stress response within specific brain regions is a 
prerequisite to devising therapeutic strategies in stress-induced mental illnesses 
such as anxiety and depression. The importance of understanding the neuronal 
mechanisms of stress-induced mental illnesses is particularly compelling given 
the data from the National Institute of Mental Health which revealed that, on 
average, as much as 20% of the population are likely to develop some form of 
mood disorder, with women having a 50% greater chance of developing mood 
disorders compared with men. As such, mood disorders impose a considerable 
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socio-economic burden. In a statement by the Royal College of Psychiatrists 
(Royal College of Psychiatrists, position statement PS4/2012), mental health 
problems currently represent the single largest financial burden to the NHS, 
costing approximately £105 billion per year. Consequently, considerable 
attention is placed on the brain circuitry which underpins the stress response 
particularly in the LC and DRN.  
1.3.2. Definition of the Stress response 
 
When investigating the many different elements of the stress response, it is 
important to first consider an appropriate definition of the term ‘stressor’. An apt 
definition of the term ‘stressor’ is paraphrased from (O'Connor et al., 2000): “a 
stressor can be defined as anything which threatens to perturb the dynamic 
equilibrium maintained within molecular, cellular, physiological and behavioural 
processes”. Importantly, a stressor, whether perceived or real, activates the 
hypothalamic-pituitary-adrenal (HPA) axis which coordinates both central and 
peripheral limbs of the stress response. Activation of the hypothalamic PVN 
causes the release of CRH and arginine vasopressin (AVP) which act 
synergistically within the anterior pituitary to stimulate the release of 
adrenocorticotrophin (ACTH). ACTH is transported via the bloodstream to the 
adrenal cortex and triggers the release of glucocorticoids. The stress response 
hinges on the activation of the CRH-containing neurons of the PVN. Inputs from 
the circumventricular organs, brainstem nuclei and forebrain circuits conveying 
information related to autonomic tone and sensory stimuli converge on the PVN, 
influencing its neuronal activity and thus CRH release (Ziegler and Herman, 
2002). Indeed, it is likely that information stored in forebrain circuits can shape 
HPA axis activation with reference to prior experiences. The ability to respond 
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adaptively to different stressors promotes survival by increasing motivation, 
attention and levels of arousal. However, when there is inappropriate cessation 
of the stress response, or when the magnitude of the stress response is 
disproportionate to the stimulus, the maladaptive effects of stress are often 
precipitated. This type of maladaptive, uncontrollable stress frequently 
contributes to the pathophysiology of neuropsychiatric disorders such as 
depression or anxiety. The resulting dysregulation in monoaminergic signalling 
is thus a signature of stress induced mood disorders. Thus, models of stress 
which can be applied to laboratory animals are utilised to further our 
understanding of the neurobiology of the behavioural responses which arise 
from stress. 
1.3.3. Modelling stress in the laboratory animal 
 
In humans, exposure to stress, in some instances, increases the vulnerability 
towards developing neuropsychiatric disorders such as depression and anxiety 
(Palazidou, 2012). In order to study the pathophysiology of such stress-induced 
disorders, various stress paradigms, such as the tail suspension model (Steru 
et al., 1985)  the forced swim model (Cryan et al., 2005), the social defeat or 
resident intruder model (Koolhaas et al., 2013) and restraint stress model 
(Buynitsky and Mostofsky, 2009) are applied to laboratory animals, in most 
cases rodents, and the ensuing behavioural phenotypes determined (Harro, 
2013, Porsolt, 2000). It should be emphasised that in such animals, the 
associated terminology is restricted to “depression-like” or “anxiety-like” 
behaviour since it is not considered valid to apply such complex human 
conditions such as anxiety and major depressive disorder in a rodent. However, 
it is unknown whether rodents have the emotional capabilities to experience 
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anxiety or depression, as these disorders are diagnosed on the basis of being 
able to vocally communicate feelings and emotions. Nevertheless, these 
paradigms allow a measurable, quantifiable outcome to assess animal 
behaviour. It should also be stated that most of the behavioural paradigms used 
to assess correlates of mental function in lower animals have been designed by 
the pharmaceutical industry in order to assess the potential use of drug 
compounds. As such, they are primarily used to assess changes in behaviour in 
response to administered compounds rather than the characterisation of native 
behaviour or “state of mind” of the animal. Nevertheless, with these caveats in 
mind, one can determine the effect of exposure to various stressors on normal 
or expected behaviour displayed by animals not exposed to various stressors.  
 
Exposure to stressors does not always result in detrimental effects. Indeed, 
some stress paradigms reveal adaptive and potentially survival promoting 
responses. In isolation, stress models and ensuing behaviours provide limited 
information. However, when correlated with molecular and functional plasticity, 
the composite phenotype can inform on the neurobiological basis of the stress 
response. Stress models can be broken down into broad categories depending 
on the age of the animal; a) early life stress which involves a disrupted dam-pup 
relationship during the critical stress hyporesponsive period that occurs at early 
postnatal ages and; b) stressors applied in adolescence/adulthood. Stressors 
can also be psychosocial, such as social isolation, or physical, such as cold 
stress. I will mainly consider the psychosocial type here as it is that which is 
most relevant for understanding the neurobiology of psychiatric disorders which 
arise from stress. Moreover, as the subject of early life stress is beyond the 
scope of this thesis, I will only consider the effects of stress in 
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adolescence/adulthood. This type of stress can be further categorised into the 
following types: i) acute or sub-chronic AND ii) repeated or chronic stressors.  
 
1.3.4. Acute stress 
 
An acute stressor is an adverse event experienced only once. It may be as mild 
as exploring a novel environment for 5 minutes (Walsh and Cummins, 1976) or 
as severe as the tail suspension test (Steru et al., 1985) or forced swim test 
(Cryan et al., 2005). Brief, acute stressors, in most cases, provide insight into 
the adaptive molecular, cellular and behavioural responses to isolated stressful 
experiences. Indeed, acute stress in the form of the forced swim test has been 
shown to induce a glucocorticoid mediated increase in long term potentiation in 
the pre-frontal cortex which is associated with improved spatial memory 
performance in the T maze (Yuen et al., 2009). Responses to acute episodes of 
stress generally engage adaptive mechanisms in order to prime the individual 
for future challenges. This is best exemplified within the LC, where prior 
exposure to a stressor enhances the excitatory effects of CRH on LC 
noradrenergic activity. (Curtis et al., 1995). However, acute stress may also 
induce maladaptive effects; elevated platform stress induces hippocampal long 
term depression and impaired spatial memory (Wong et al., 2007). Whereas 
acute stressors are used to investigate how different brain regions may encode 
information related to stress, sub-chronic and chronic stress types usually aim 
at inducing an anxiety or depressive-like responses in order to understand the 
long-term structural and functional plasticity associated with the development of 
such disorders in humans. 
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1.3.5. Chronic versus sub-chronic stress 
 
There is a blurred line between what constitutes sub-chronic versus chronic 
stress. The use of the term ‘chronic’ could be contentious as it may imply that a 
constant stressor is being applied. This is true of certain types of chronic stress 
such as social defeat stress. In this model, an experimental mouse is placed 
into the home cage of a resident mouse for 5 minutes. The resident mouse is 
usually of a different strain which display high levels of aggression resulting in 
the intruder mouse being physically defeated. After defeat, a plexiglass partition 
is placed between the experimental and the resident mouse so that they are 
separate, but in full sensory contact with each other for 24 hrs. This is repeated 
for 10 consecutive days. Social defeat stress produces robust anxiety and 
depressive-like behaviours (Berton et al., 2006). It could be argued that social 
defeat stress is the only true form of chronic stress and that all other types 
should be described as sub-chronic, because the animal experiences relief from 
the stressor. However, there is limited consensus on what constitutes sub-
chronic and chronic in the literature. Some studies report 14 days of restraint 
stress as chronic (Kim and Han, 2006), others report 15 days of variable 
stressors including wet bedding material and cold forced swimming as sub-
chronic (Kazlauckas et al., 2011) while others also report 7 days of 
immobilisation stress as sub-chronic (Cunha et al., 2006). As a result, it is 
unclear whether the term chronic refers to the number of consecutive days on 
which the stress takes place, or the severity of the applied stressors. Adrenal 
hypertrophy and hyperplasia are indicators of chronic stress as it infers an over 
activation of the stress HPA axis. Chronic variable stress, including 1 hour 
shaking at 4°C as well as restraint and hypoxia (8% O2) was able to increase 
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adrenal weight. Therefore, increased adrenal weight could be a signature of 
chronic stress. However adrenal weight is not analysed in every study which 
applies a ‘chronic’ stress paradigm (Ulrich-Lai et al., 2006).  
1.3.6. Reproducibility and face validity; my choice of animal stress model 
 
The stressor itself also varies between paradigms. Although defeat stress may 
appear to be an optimal model of psychosocial stress since the mouse receives 
the insult from one of its own rather than an investigator, the reproducibility 
between subjects and experiments is problematic since the levels of aggression 
between both resident and intruder subjects vary greatly. As such, each 
experimental animal cannot be exposed to the exact same stressor. Restraint 
stress (Buynitsky and Mostofsky, 2009) provides the highest levels of 
reproducibility. I have therefore used this paradigm during my PhD studies. The 
objective of using animal stress paradigms is to mimic adverse human life 
experiences in the hope that the ensuing changes at the molecular, cellular and 
behavioural levels will direct us with regard to the associated changes in human 
disorders. Therefore it is important to consider how a particular stress paradigm 
may translate to the human condition. I have chosen restraint stress applied for 
30 minutes per day for 8 consecutive days. I hypothesise that this represents a 
transient, though repeated exposure to stress, akin to that experienced on a 
daily basis. I have deliberately avoided some of the extreme stress paradigms 
used in the literature such as the social defeat stress (Berton et al., 2006) and 
chronic immobilisation stress to 6 hours per day (McLaughlin et al., 2007), 
which I believe to have unrealistic face validity. Indeed, the severity level of 
some of the stressors applied is very high, and it is difficult to see how such 
experiences might translate to humans, particularly paradigms which 
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incorporate both physical (i.e. overnight cold exposure) and psychosocial 
(restraint) stressors (Ulrich-Lai et al., 2006). It appears that in some cases, 
emphasis is placed on using the most extreme forms of stress in order to 
observe a robust response (i.e. depressive and anxious behaviours), which may 
not be as informative when it comes to translating findings about the 
neurobiological processes underlying such behaviours into humans. I thus 
believe that the protocol I have adopted will result in repeated exposure to 
stress without any lasting physical harm. The expectation is that such 
experiences will primarily impact on the mental function of the animal which will 
be manifested in changes at the molecular and behavioural level.  
1.3.7. The stress response and the LC 
 
Stressful stimuli potently engage the LC-noradrenergic system. Indeed, 
stressful stimuli have been shown to increase the expression of the immediate 
early gene c-fos and the noradrenaline synthesising enzyme, tyrosine 
hydroxylase (TH) within the LC (Ishida et al., 2002, Chang et al., 2000). The 
involvement of the LC in the stress response is largely mediated by the stress 
neuropeptide CRH. CRH is released within the LC from afferents originating in 
the hypothalamus, nucleus paragigantocellularis, Barrington’s nucleus and 
amygdala, as well as local neurons within the LC itself (Valentino et al., 1992). 
Injection of CRH into the LC increases the level of tonic discharge via the CRH 
receptor 1 (CRH-R1) together with reducing phasic discharge. Importantly, prior 
exposure to an acute stressor sensitises the LC to sub-efficacious 
concentrations of CRH (Curtis, 1999). As such, CRH activity within the LC may 
serve to prepare the reaction of the LC to subsequent stressors, a response 
which is tremendously adaptive and thus essential for survival when negotiating 
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potential future stressors. Furthermore, CRH also has a trophic role within the 
LC by promoting the elongation of LC-noradrenergic dendrites (Swinny and 
Valentino, 2006). This stress-induced increase in LC dendritic length is likely to 
influence the degree of innervation of LC neurons, particularly by extrinsic 
regions such as the amygdala, thus setting the tone for future connectivity 
between such limbic regions. Importantly, a model of early life stress that 
dramatically alters LC neuronal activity and their sensitivity to applied CRH 
(Swinny et al., 2010) also impacts on LC GABAAR subunit expression (Caldji et 
al., 2003). Despite the important role of LC neuronal activity in mediating stress-
related signals and the adoption of adaptive or pathological behavioural 
responses to stress, very little is known about the stress-induced plasticity 
neurotransmitter receptors within this brain region.  
1.3.8. The stress response and the DRN 
 
In common with the LC, the DRN is also integral to mediating the effects of 
stress at the central level. As in the LC, the stress neuropeptide CRH 
orchestrates DRN stress signals.  Unlike the LC, however, the DRN stress-
pathways are more complex due to variations in the expression patterns of CRH 
receptors between these brain regions. CRH released onto LC noradrenergic 
neurons results only in excitation and an increase in LC-noradrenaline release 
since only the CRH-R1 receptor is expressed on such cells. However, the effect 
of CRH within the DRN is biphasic due to the expression of both CRH-R1 and 
CRH-R2.  As a consequence, lower levels of CRH result in inhibition of DRN 
serotonin neurons mediated by CRF-R1 while higher levels of CRH have an 
excitatory effect on DRN serotonin neurons (Kirby et al., 2000).  
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The precise origin of CRH containing axons located within the DRN remains 
equivocal due to the lack of studies which combine retrograde tracing with CRH 
immunolabelling. Nevertheless, potential sources of DRN CRH could be the 
central nucleus of the amygdala, the PVN, the bed nucleus of the stria 
terminalis and Barrington’s nucleus (Valentino et al., 2010). Despite the 
uncertainty surrounding the origin of CRH in the DRN, the pattern of CRH 
innervation is well characterised. CRH-containing axons are predominantly 
localised to the dorsal extent of the DRN in the caudal plane, and moving more 
ventromedially towards the rostral extent of the DRN. Moreover, although CRH 
inputs to serotonin neurons are present, it is CRH innervation onto the 
GABAergic neurons of the DRN which is most abundant (Waselus et al., 2011). 
Therefore, current evidence suggests that stress signals, conveyed via CRH-
containing axons primarily modulate the tone of the local DRN GABAergic 
system which then influences DRN serotonergic neurons and thus the release 
of serotonin throughout the brain.   
 
Afferent topography within the DRN’s sub-regions gives rise to different sub-
populations of neurons which can respond differentially to a particular stressor. 
In turn, an extensive topographically organised efferent network subsequently 
enables the DRN to differentially modulate the activity of multiple brain regions 
in reference to that stressor (Waselus et al., 2011). Acute swim stress 
associated with active coping causes CRF-R1 mediated increases in c-fos 
expression in GABAergic neurons in the lateral wing region of the DRN (Roche 
et al., 2003). Prior work has shown that swim stress alters serotonin release in 
terminal fields resulting in a decrease in serotonin levels from baseline in the 
amygdala and lateral septum. Taken together, it is likely that CRH mediated 
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activation of GABAergic neurons in the DRN reduces serotonin release in some 
target fields. Thus, GABAergic neurotransmission may have an important role in 
mediating the effect of swim stress on altered DRN activity (Kirby et al., 1995). 
Furthermore, application of ovine CRH to DRN slices has been shown to 
increase the frequency of miniature inhibitory postsynaptic currents (mIPSC), 
increase evoked IPSC amplitude and induce an inward current in serotonin 
neurons of the DRN (Kirby et al., 2008). Thus, the principal stress neuropeptide 
within the CNS, namely CRH, predominantly utilises GABAergic 
neurotransmission within the DRN. However, we currently do not know which 
particular GABAAR subtypes are involved in such pathways and whether 
exposure to stressors influences their patterns of expression.  
1.4. The GABA-GABAAR system 
 
The functional properties of any given neuron depend on its intrinsic membrane 
properties, its afferent inputs and also the repertoire and sub-cellular expression 
profile of the neurotransmitter receptor subtypes it expresses. The focus of my 
thesis is on the GABAAR-GABA system in the LC and DR.  
1.4.1. The structure of GABAARs 
 
GABAARs are Cys-loop heteropentameric, ligand gated, chloride permeable ion 
channels composed of five individual proteins called subunits (Fig. 1.6). 
Nineteen subunits have been cloned and classified into eight classes according 
to their sequence homology α1-6, β1-3, γ1-3, δ, ε, π, ρ1-3 and θ (Olsen and 
Sieghart, 2009). Each subunit possesses four transmembrane domains. The 
second transmembrane domain of each subunit faces inwards and creates the 
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hydrophilic environment to conduct chloride ions. When GABA binds to two 
binding sites located between the alpha and beta subunits, a conformational 
change is triggered in the pore causing the passage of chloride ions across the 
membrane. The direction of the chloride flow (either into or out of the cell) is 
determined by the relative concentration gradients of chloride across the cell 
membrane. This in turn determines whether GABAAR activation results in 
inhibitory or excitatory postsynaptic currents.  
 
 
Figure 1.8 
The structure of GABAARs 
GABAAR subunits are composed of four transmembrane domains (a), when the 
receptors are assembled in the endoplasmic reticulum the second 
transmembrane domain from each subunit forms a chloride ion conducting pore 
(b). Specific amino acid residues are responsible for the kinetic and 
pharmacological properties of the receptor and for the precise targeting of 
GABAAR subtypes to specific membrane compartments by intracellular 
scaffolding proteins. Taken from Jacob et al., (2008). 
 
1.4.2. Physiology of GABAARs 
 
GABAARs primarily cluster at postsynaptic cell surface. As such, they have a 
central role in mediating the fast effects of any GABA release at synapses. 
Their gating by synaptically released GABA manifests in postsynaptic currents. 
The general consensus is that two broad forms of GABAAR-mediated currents 
exist in the CNS; namely phasic and tonic currents. See (Farrant and Nusser, 
2005) (Fig. 1.7) for a review. Phasic GABAAR-mediated currents arise from the 
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gating of receptors located adjacent to the GABA release site, thus, within the 
synaptic cleft. Such currents persist in the order of milliseconds before the 
receptors either become desensitised or the GABA within the synaptic cleft is 
removed by GABA transporters located on adjacent glia. In contrast, tonic 
currents arise from the gating of GABAARs located some distance from the 
GABA release site, i.e. on extrasynaptic cell surfaces. Such tonic currents are 
persistent as opposed to their short-lived phasic counterparts since they are 
thought to be gated by ambient GABA that is beyond the reach of GABA 
transporters. While this overall model of GABAAR-mediated currents is 
consistent throughout the CNS, there is immense diversity within their kinetics 
(rise time, decay time, amplitude) and their pharmacological sensitivity. This 
functional and pharmacological diversity of GABAARs arise primarily from the 
subunit combinations which assemble to form the channel. As such, subunit 
expression is critical to GABAAR function within different brain regions.  
1.4.3. GABAAR subunit expression throughout the brain 
 
Different brain regions express different repertoires of GABAAR subunits 
(Wisden et al., 1992, Pirker, 2000) in a cell-type and domain specific manner 
giving rise to considerable diversity in GABAergic transmission. Most of the 
expression work has been carried out in the rat brain. Only recently has similar 
work being published in the mouse brain (Hortnagl et al., 2013). Note that this 
study did not include the midbrain and brainstem regions which contain the LC 
and DRN. Figure 1.8, taken from Hortnagl et al. (2013) illustrates the 
heterogeneity of GABAAR subunit expression throughout the brain. Overall, it 
appears the GABAAR subunit expression in rat, agrees well with that in mouse. 
However, these studies are based on brain-wide low resolution expression 
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patterns of diverse GABAAR subunits, therefore it is possible that differences in 
GABAAR subunit expression at the cellular, and sub-cellular level exist across 
rat and mouse. Enrichment of different GABAAR subunits across diverse brain 
regions  
 
Some GABAAR subunits are widely expressed such as alpha1-beta2-gamma2 
subunit-containing receptors. In contrast, other GABAAR subunits such as the 
alpha4 and the delta subunits are enriched in select brain regions. In addition to 
regional specificity, some subunit-containing receptors are also only expressed 
on specific sub-cellular domains. For example, the gamma2 subunit-containing 
GABAARs are concentrated within synapses (Somogyi et al., 1996). In contrast, 
delta subunit-containing receptors are exclusively located on extrasynaptic 
domains. As such, a picture begins to emerge of functionally distinct GABAAR 
currents (phasic or tonic) being mediated within specific neuronal populations 
due to specific subunit combinations. The alpha subunits endow the receptor 
with their most salient functional and pharmacological signatures. For the sake 
of brevity, I will review our current knowledge on only the alphas 1-3 subunits 
since these are the ones I discovered to be most relevant in the LC and DRN. 
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Figure 1.9 
Phasic and tonic GABAAR-mediated inhibitory currents 
a) depicts the release of a single GABA containing synaptic vesicle from the 
presynaptic membrane. The blue colour represents GABA, which acts 
selectively on the synaptic GABAARs located in the postsynaptic membrane. 
The resulting current trace is a miniature inhibitory post-synaptic potential 
(mIPSC). b) depicts action potential dependent release which is multivesicular. 
GABA released in this way acts on synaptic as well as perisynaptic and 
extrasynaptic GABAARs, the resulting current trace is a spontaneous IPSC 
which is of greater amplitude and of slower decay compared with the mIPSC. c) 
depicts persistent ambient levels of GABA activating extrasynaptic GABA 
receptors which provides a GABAergic tone to control neuronal excitability. 
Tonic GABA is revealed by the application of a GABAAR antagonist (SR-
95531), antagonism of both synaptic and extrasynaptic GABAARs, but it is the 
antagonist activity at the extrasynaptic GABAARs which removes this 
GABAergic tone resulting in an outward shift in current (Farrant and Nusser, 
2005) . 
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1.4.4. The alpha1 subunit 
 
Roughly 50% of GABAARs throughout the brain are composed of the alpha1 
subunit (Benke et al., 1994). Despite this widespread expression profile, 
GABAAR alpha1 subunits do exhibit preferential expression within certain cell-
types. Indeed, while cortical principal cells widely express the alpha1 subunit, its 
level of expression is considerably higher in inhibitory interneurons (Gao and 
Fritschy, 1994). Surprisingly, this widely expressed subunit is not essential for 
survival since mice lacking the alpha1 subunit are viable (Sur et al., 2001). 
However, the constitutive deletion of this subunit is informative in terms of the 
contribution of this subunit in terms of the receptor kinetics, pharmacology and 
its influence on behaviour. The presence of the alpha1 subunit appears to 
endow GABAARs with comparatively fast kinetics since alpha1 subunit-deleted 
mice (alpha1-KO) exhibited slower IPSC kinetics compared to wild type (WT) 
mice (Goldstein et al., 2002). Furthermore, the alpha1 subunit is required for the 
effects of the clinically utilised hypnotic zolpidem (Goldstein et al., 2002) and 
sedative and anterograde amnesiac properties of benzodiazepines (Rudolph et 
al., 1999) but not their anxiolytic effects (McKernan et al., 2000). Therefore, 
whilst GABAARs composed of alpha1 subunits are widely expressed, they do 
endow such receptors with unique functional and pharmacological signatures. 
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Figure 1.10 
Brain-wide immunoreactive patterns of different  GABAAR subunits taken from 
(Hortnagl et al., 2013) 
In general, the localization of the protein resembled that of mRNA. Note the 
widespread distribution of alpha1 and beta2 subunits. In contrast to mRNA 
labelling, the immunoreactivity for gamma2 was less intense in the striatal and 
thalamic area. Alpha4 and delta proteins are co-localized in the striatum and 
thalamus, but not in the cerebellum and CA1–CA3 of the hippocampus. The 
immunoreactivity of the alpha6 subunit is restricted to the cerebellum and the 
spinal trigeminal tract. Note the strong label of alpha1, beta2 and gamma2 
subunits in the dorsal subiculum. Scale bar 2 mm. 
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1.4.5. The alpha2 subunit 
 
The alpha2 subunit is equally widely expressed throughout cortical and sub-
cortical mouse brain regions although not to the same extent as the alpha1 
subunit (Hortnagl et al., 2013). Less is known about the specific kinetic 
properties which this subunit contributes to the receptor. However, from studies 
using gene-deleted mice (alpha2-KO), alpha2 subunits appear to also endow 
receptors with fast decay kinetics since alpha2-KO mice exhibited prolonged 
decay times for mIPSCs (Dixon et al., 2010). Most of the research concerning 
the alpha2 subunit has been focused on the behavioural phenotypes of animals 
in which the subunit is either deleted or pharmacologically manipulated. The 
emerging picture is that this subunit has an important role in mediating the 
anxiolytics rather than the sedative effects of benzodiazepines in contrast to 
alpha1 subunits (Dixon et al., 2008, Rudolph et al., 1999). As such, intense 
focus has been maintained on designing pharmacological agents which show 
selectivity for this subunit (Rudolph and Mohler, 2006) for use in mental 
illnesses such as anxiety. An abiding obstacle to drug design is the co-
assembly of the alpha1 and 2 subunits within specific cell-types which accounts 
for the side-effects of some clinically used drugs.  
1.4.6. The alpha3 subunit 
 
In contrast to the alphas 1 and 2 subunits, the expression of the alpha3 subunit 
is restricted to a relatively smaller number of mouse brain regions and cell 
types. These include sub-populations of the principal cells of the cortex, the 
substantia nigra, the lateral septum, the bed nucleus of the stria terminalis, the 
reticular nucleus, the hypothalamus, the amygdala and olfactory bulb (Hortnagl 
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et al., 2013). Importantly, in studies of the rat brain, the alpha3 subunit appears 
to be enriched in monoaminergic brain centres (Fritschy and Mohler, 1995). At 
the behavioural level, apart from a deficit in sensorimotor information 
processing the deletion of the alpha3 subunit resulted in a relatively mild 
phenotype (Winsky-Sommerer et al., 2008). In contrast to GABAARs composed 
of alpha1 and 2 subunits, alpha3 subunit containing receptors exhibit 
considerably slower activation and decay kinetics and lower sensitivity to GABA  
(Gingrich et al., 1995, Okada et al., 2000) In addition, a recent study has shown 
that alpha3 subunit-containing GABAARs in the amygdala mediate tonic 
inhibitory currents within this limbic brain region (Marowsky et al., 2012). This is 
important since this persistent form of inhibition is thought to arise from 
GABAARs located some distance from the synapse, i.e. on extrasynaptic cell 
surfaces. In other brain regions such as the hippocampus, thalamus or 
cerebellum, tonically active GABAAR currents are mediated exclusively by either 
the alpha4, alpha5, alpha6 or delta subunits (Glykys and Mody, 2007). Thus, 
the identification of a role for alpha3-containing receptors tonic inhibition sets it 
apart from the alphas 1 and 2 which generally are considered to mediate the 
fast phasic components of GABAAR-mediated currents. The expectation is that 
a cell-type which expresses both alpha1-2 as well as 3 subunits might rely on 
the alpha1-2 subunit-containing receptors to mediate the fast inhibitory effects 
of GABA and depend on alpha3-subunit containing receptors to mediate 
persistent tonic currents. This division of labour amongst the repertoire of 
GABAAR subtypes is likely to decide the balance of neuronal activity within a 
particular population of neurons.  
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1.4.7. GABAAR expression is dynamic: the role of stress induced 
plasticity in the GABA-GABAAR system 
 
The effects of stress on the GABAergic system have been largely overlooked. 
Stressors can induce either adaptive or maladaptive response in an organism. 
Indeed, male rats exposed to restraint stress exhibit improved performance in 
the Morris water maze test of declarative memory; an improvement which is 
correlated with a decrease in GABAAR alpha1 subunit mRNA expression in the 
hippocampus and PFC (Zheng et al., 2007). Thus, alterations in GABAAR 
subunit expression could have an important role in mediating the adaptive 
response to stressors. Furthermore, alterations in benzodiazepine binding have 
been shown following acute stress and altered benzodiazepine efficacy is 
associated with some anxiety disorders (Bremner et al., 2000). These sparse 
though compelling data provide fuel for further probing the role of stress in 
shaping the GABAergic system. Such data will not only contribute to the 
identification of the neurobiology of the stress response but also provide novel 
therapeutic targets for stress-induced mental illnesses. As such, we focus on 
stress-induced plasticity of GABAAR in the brains regions implicated in stress-
induced mental illnesses, namely the LC and DRN.  
1.4.8. GABAAR expression in the LC and DR; how little we know  
 
Brain wide GABAAR subunit expression studies have provided little or 
conflicting information in terms of which GABAAR subunits are expressed in the 
LC and DRN. Furthermore, scant evidence exists for the expression patterns of 
GABAAR subunits on the cellular and sub-cellular domains of LC or DRN 
neurons. Luque et al. (1994) reported the expression of the alpha3, beta3, 
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alpha2, beta1 and gamma1 GABAAR subunits in the LC at the mRNA level 
whereas Fritschy and Mohler (1995) reported the expression of the alphas 2, 3 
and gamma2 subunits at the protein level. The data in the Fritschy and Mohler 
(1995) publication pertaining to the LC was in tabular form, rather than actual 
microscopic images with no evidence provided on the expression patterns of 
individual subunits on individual, neurochemically identified neurons. There 
have been conflicting reports on the presence of the GABAAR gamma2 subunit 
by LC noradrenergic neurons, with studies reporting a paucity of gamma2 
subunit mRNA (Luque, 1994)  and a lack of effect of benzodiazepines on the 
spontaneous firing rate of LC neurons (Belujon et al., 2009). However, the 
ability of benzodiazepines to bind in the LC suggests the presence of GABAAR 
subtypes containing the gamma2 subunit (Hellsten et al., 2010). Furthermore, 
evidence supports the expression of the GABAAR epsilon and theta subunits by 
noradrenergic neurons of the LC and serotonergic neurons of the DRN 
(Moragues et al., 2000, Moragues et al., 2002, Sinkkonen, 2000). However, 
these studies have been largely discredited due to the non-specific nature of the 
antibody used. Thus, up till now (see Chapter 2 and Corteen et al., 2011), there 
has been no demonstration of the expression of specific GABAAR subunits, at 
the protein level, on individual neurons of the rodent LC.  
 
In terms of the DRN, there has been a single publication in the early nineties 
(Gao et al., 1993) which showed the expression of the alpha1 and 3 GABAAR 
subunits on GABAergic and serotonergic neurons respectively. The study did 
not report on the expression of any other subunits neither did it provide a high 
resolution description of the location of the alpha1 and 3 subunits on synaptic or 
extrasynaptic cell surfaces or whether they were expressed on certain sub-
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populations of GABAergic and serotonergic neurons located within certain sub-
nuclei of the DRN.  
 
Thus, we know very little about the expression of GABAAR subunits within the 
other neurons which comprise LC and DRN networks, with most studies 
focussing on expression on the principal neurons. Furthermore, there is a 
dearth of knowledge on the sub-cellular expression profiles (synaptic/non-
synaptic) of distinct GABAAR subunits on neurochemically diverse cell types of 
the LC and the DRN. In addition, the influence of stress on such GABAAR 
expression profiles is unreported on. As mentioned in the GABAAR sub-section, 
it is the precise targeting of specific GABAAR subtypes to synaptic and 
extrasynaptic surfaces of neurochemically and functionally diverse neurons 
within defined networks which will determine the role of GABAARs within a 
particular brain region and the associated behaviours which arise from such 
brain activity. Thus, given the central role of GABAARs in brain function and 
behaviour, together with the importance of the combinatorial roles of the LC and 
DRN in mediating the stress response at the CNS level, I feel that 
characterising the expression of the GABAAR subunits within these brain 
regions before and after stress will provide the molecular and cellular correlates 
of specific stress-induced behavioural phenotypes. This, in turn, will inform us 
as to the LC-DRN related adaptive mechanisms associated with the stress 
response or maladaptive mechanisms which underlie a host of mental illnesses.  
Either way, the data are expected to contribute to our understanding of the 
aspects brain function which are essential for well-being.  
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1.5. Aims 
 
There are three over-arching aims to my PhD; 1) determine which particular 
GABAAR subunits are expressed on the sub-cellular surfaces of 
neurochemically defined neurons of the LC and DRN; 2) determine how 
stressful experiences impact on such GABAAR subunit expression patterns in 
the LC and DRN and; 3) determine the stress-induced behavioural phenotypes 
which correlate with such stress-induced GABAAR subunit expression patterns.   
1.6. Objectives 
The above aims will be achieved by the following objectives; 
1.6.1. Objective 1; chapter 2:  
 
Using immunohistochemistry and confocal microscopy, identify the domain 
specific pattern of inhibitory innervation onto LC noradrenaline neurons, the cell 
type specific expression profile of the GABAAR alpha1, alpha2 and alpha3 
subunits on neurochemically defined neurons which comprise the LC and the 
proportion of GABAAR subunit co-localised with an inhibitory synaptic marker. 
Using whole cell patch clamp electrophysiological recordings of acute brain 
slices of the LC, determine how GABAAR subunit-specific ligands influence LC 
neuronal activity. 
1.6.2. Objective 2, chapter 3 
 
Using confocal microscopy, determine the domain specific inhibitory 
innervation pattern of the neurons which make up the DRN, the identity and 
location of particular GABAAR subunits on neurochemically and topographically 
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defined neurons and the association of such GABAAR subunits with inhibitory 
synaptic marker proteins.  
1.6.3. Objective 2, chapter 4 
 
Using a mouse model of uncontrollable repeated stress (restraint stress), 
quantitative RT-PCR, confocal microscopy and various animal models of 
behaviour, determine the changes in the expression of GABAAR subunits at the 
mRNA and protein levels within the LC, DRN and associated limbic brain 
regions together with the stress-induced changes in indices of locomotor, 
anxiogenic-like, depressive-like and cognitive behaviour.  
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2. Chapter 2 
Localisation of GABAAR alpha subunits on neurochemically 
distinct cell-types in the rat locus coeruleus 
 
 
Part of the work contained within this chapter was published in: 
Corteen NL, Cole TM, Sarna A, Sieghart W, Swinny JD (2011). Localisation of 
GABA-A receptor alpha subunits on neurochemically distinct cell-types in the rat 
locus coeruleus. European Journal of Neuroscience. 34(2):250-62 
Author contributions: 
NLC and JDS designed researched 
NLC performed all the research included in the manuscript 
NLC and JDS analysed data 
NLC L and JDS wrote the paper 
TMC & AS provided technical assistance on aspects which were eventually not 
included in the manuscript 
WS provided essential reagents in terms of GABAAR subunit antibodies   
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2.1. Abstract 
 
The locus coeruleus (LC) provides the major source of noradrenaline to the 
central nervous system (CNS) and is modulated by neurochemically diverse 
afferents. LC function is central to arousal, memory, cognition and the stress 
response, with dysfunction of the LC-noradrenergic axis implicated in 
debilitating psychiatric disorders. The precise targeting of neurotransmitter 
receptors within the LC is essential for processing the information contained in 
diverse afferents and thus LC output. Inhibitory modulation of LC neurons is 
thought to be effected mainly through GABA-A receptors (GABAAR). Diverse 
GABAARs are pentameric complexes assembled from a repertoire of subunits 
resulting in substantial diversity in their molecular, functional, and 
pharmacological properties throughout the brain. The precise location of distinct 
GABAAR subunits in sub-regions of the LC, and the neurochemical identity of 
the cells which express them, remains to be determined. Here, we show that 
the GABAAR alpha1 subunit is expressed exclusively in neurochemically and 
morphologically diverse non-noradrenergic cell-types within the LC which may 
innervate the principal noradrenergic cells. Thus, the GABAAR alpha1 subunit 
could provide a neurochemical signature for a pool of local circuit interneurons 
in the LC. In contrast, non-overlapping GABAAR alpha2 and alpha3 subunit 
immunoreactive puncta were enriched on noradrenergic dendrites and to a 
lesser extent on somata. The study reveals a cell-type and domain specific 
expression pattern of distinct GABAAR subunits in the LC. These data will serve 
as a template for understanding inhibitory modulation of this region and facilitate 
more directed pharmacological strategies for disorders arising from impairment 
of LC function.   
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2.2.  Introduction 
 
The principal cells of the noradrenergic LC innervate almost the entire 
neuroaxis and provide the major source of noradrenaline to the CNS (Swanson 
and Hartman, 1975, Dahlstrom and Fuxe, 1964). The topographical 
organisation of LC neurons and their vast projection patterns (Mason and 
Fibiger, 1979, Loughlin, 1986), results in this brain centre having a preeminent 
role in brain functions such as arousal, memory and cognition (Sara, 2009, 
Aston-Jones and Cohen, 2005). Furthermore, the LC is integral to the cognitive 
limb of the stress response (Valentino and Van Bockstaele, 2008). In turn, 
dysregulation in the LC-noradrenergic function is implicated in a number of 
major psychiatric diseases such as psychoses, depression and anxiety 
disorders.   
 
Noradrenaline levels in the CNS are central to brain function as a whole and are 
determined by the level of LC neuronal activity (Berridge and Abercrombie, 
1999, Florin-Lechner et al., 1996). LC neurons are spontaneously active and 
exhibit two modes of activity, phasic and tonic (Aston-Jones, 1981). The firing 
rate of LC neurons is determined by intrinsic membrane properties (Williams et 
al., 1991) and developmental factors (Swinny et al., 2010). In addition, 
neurotransmitters (Singewald and Philippu, 1998, Cherubini et al., 1988) or 
neuromodulators (Olpe and Steinmann, 1991), which are released from diverse 
afferents contacting functionally distinct regions of the nucleus such as the 
nuclear core and the dendritic pericoerulear region (Arnsten and Goldman-
Rakic, 1984, Cedarbaum and Aghajanian, 1978, Van Bockstaele et al., 1998a, 
Ennis et al., 1998) also determine the level of neuronal activity. Apart from 
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modulation by afferents originating from other brain centres, there is also 
evidence for a pool of local circuit GABAergic cells within the LC, of which two 
populations have been identified depending on their domain specific innervation 
of the noradrenergic principal cells (Aston-Jones et al., 2004). To facilitate the 
optimal integration of diverse excitatory and inhibitory inputs, the precise 
targeting of distinct neurotransmitter receptors to specific cellular domains and 
nuclear sub-regions is essential (Lorincz et al., 2002).   
 
GABA, originating predominantly from the nucleus prepositus hypoglossi (Ennis 
and Aston-Jones, 1989), the CeA and the posterior lateral hypothalamic area 
(Dimitrov et al., 2013) provide the major source of inhibitory drive onto LC 
neurons (Somogyi and Llewellyn-Smith, 2001, Van Bockstaele, 1998), 
signalling mainly through GABAAR (Osmanovic and Shefner, 1990). Diverse 
GABAAR ion channels are pentameric complexes assembled from a repertoire 
of subunits (Sieghart, 2006) resulting in substantial molecular (Wisden et al., 
1992), functional (Farrant and Nusser, 2005) and pharmacological (Rudolph et 
al., 1999) diversity in their properties throughout the brain. In the LC, mRNA 
(Luque et al., 1994, Sinkkonen et al., 2000) immunohistochemical (Fritschy et 
al., 1992, Moragues et al., 2002, Moragues et al., 2000, Rodriguez-Pallares et 
al., 2001) and functional  (Belujon et al., 2009) studies indicate that a unique 
repertoire of GABAAR subunits is expressed in this brain region. However, the 
precise location of distinct GABAAR subunits within input-disparate sub-regions 
of the LC, and the neurochemical identity of the cells which express them, 
remains to be determined. In this study, we use immunohistochemistry to 
localise the expression of the GABAAR alphas 1, 2 and 3 subunits within the LC. 
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2.3. Methods 
 
All procedures involving experimental animals were performed in accordance 
with the Animals (Scientific Procedures) Act, 1986 (UK) and associated 
procedures. Every effort was made to minimise any pain or discomfort to the 
animals. 
2.3.1. Tissue preparation 
 
Data presented in this study are derived from ten adult Wistar male rats (250–
350 g body weight). Anaesthesia was induced with isofluorane and maintained 
with urethane (1.25 g/kg of bodyweight; i.p.). The animals were perfused 
transcardially with 0.9 % saline solution for 3 minutes, followed by 15 minutes 
fixation with a fixative consisting of 1% paraformaldehyde, 15% v/v saturated 
picric acid, in 0.1 M phosphate buffer (PB), pH 7.4. The brains were kept in the 
same fixative solution overnight at 4°C. Horizontal and coronal sections of the 
LC, 50 µm thick, were prepared on a Vibratome and stored in 0.1 M PB 
containing 0.05% sodium azide. 
2.3.2. Immunohistochemical reactions 
 
Four animals were used for the qualitative examination of the immunoreactivity. 
In preliminary experiments, a range of antigen retrieval methods were tested 
including microwave treatment (Schneider Gasser et al., 2006, Fritschy et al., 
1998), conventional heat treatment as well as the proteolytic antigen unmasking 
method (Watanabe et al., 1998, Nagy et al., 2004). With the antibodies used in 
this study, we obtained the highest signal to noise ratio using the proteolytic 
antigen unmasking method, therefore this method was adopted as follows. 
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Briefly, the tissue sections were incubated at 37°C for 10 minutes in 0.1 M PB 
followed by 15 minutes in 0.2 M HCl containing 0.2 mg/ml pepsin (Sigma, UK) 
after which they were washed thoroughly in Tris-buffered saline containing 0.3% 
Triton-X100 (TBS-Tx) for 30 minutes. Non specific binding of secondary 
antibodies was blocked by incubating sections with 20% normal horse serum for 
2 hours at room temperature. The tissue sections were incubated with cocktails 
of primary antibodies (Table 2.1), diluted in TBS-Tx, overnight at 4°C. After 
washing with TBS-Tx, sections were incubated in a mixture of appropriate 
secondary antibodies conjugated with either Alexa Fluor 488 (Invitrogen, 
Eugene, OR), indocarbocyanine (Cy3; Jackson ImmunoResearch), and 
indodicarbocyanine (Cy5; Jackson ImmunoResearch) for 2 hours at room 
temperature. Sections were washed in TBS-Tx and mounted in Vectashield 
(Vector Laboratories, Burlingame, CA).  
2.3.3. Antibody specificity 
 
Although all the antisera against the GABAAR subunits used in this study have 
been reported upon extensively in other publications (see Table 2.1), in this 
study we used GABAAR subunit-specific gene deleted mouse tissue to confirm 
the specificity of the signal under our reaction conditions. The labelling pattern 
in tissue obtained from wild type mouse was identical to that obtained in rat 
tissue. However, no specific GABAAR subunit immunoreactivity was detectable 
in tissue from GABAAR alpha1 subunit gene deleted mice (Sur et al., 2001) 
(kindly provided by Drs D. Belleli and J. Lambert at the Neurosciences Institute, 
University of Dundee, and originated from Dr Thomas Rosahl, Merck Sharp & 
Dohme), GABAAR alpha2 subunit gene deleted mice (Dixon et al., 2008) (kindly 
provided by Professor David Stephens, Department of Psychology University of 
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Sussex) and GABAAR alpha3 subunit gene deleted mice (Yee et al., 2005) 
(kindly provided by Professor Uwe Rudolph, Laboratory of Genetic 
Neuropharmacology, McLean Hospital, Department of Psychiatry, Harvard 
Medical School) (Fig. 2.1). Method specificity was also tested by omitting the 
primary antibodies in the incubation sequence. To confirm the absence of cross 
reactivity between IgGs in double and triple immunolabelling experiments, some 
sections were processed through the same immunohistochemical sequence, 
except that only an individual primary antibody was applied with the full 
complement of secondary antibodies.  
2.3.4. Image acquisition 
 
Sections were examined with a confocal laser-scanning microscope (LSM710; 
Zeiss, Oberkochen, Germany) using either a Plan Apochromatic 63x DIC oil 
objective (NA1.4) or a Plan Apochromatic 100x DIC oil objective (NA1.46). Z-
stacks were used for routine evaluation of the labelling. All images presented 
represent a single optical section. These images were acquired using 
sequential acquisition of the different channels to avoid cross-talk between 
fluorophores, with the pinholes first adjusted to one airy unit and then optimised 
to ensure equal optical section thicknesses of 1 µm for all channels. Images 
were processed with the software Zen2008 Light Edition (Zeiss, Oberkochen, 
Germany) and exported into Adobe Photoshop. Only brightness and contrast 
were adjusted for the whole frame, and no part of a frame was enhanced or 
modified in any way.  
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2.3.5. Quantification of the ratio of cells expressing different 
neurochemical markers 
 
Of the ten animals used in the study, four were used to quantify the ratio of TH-
immunopositive cells to TH-immunonegative GABAAR alpha1 subunit 
immunopositive cells. For this part of the study, the following combinations of 
reactions were performed: 1) TH-GABAAR alpha1 subunit-calretinin (in 1 
animal); 2) TH-GABAAR alpha1 subunit-calbindin (in 1 animal); 3) TH-GABAAR 
alpha1 subunit-NPY (in 1 animal) and; 4) TH-GABAAR alpha1 subunit-
somatostatin (in 1 animal). Entire LC nuclei were sectioned in the horizontal 
plane (100µm-thick sections) using a Vibratome. TH-immunoreactivity was used 
to delineate the nuclear core and pericoerulear region of a particular LC 
nucleus. In total, 8 LC nuclei (both left and right-sided from 4 animals) were 
imaged using a Plan Apochromatic 40X DIC oil objective (NA1.3) with optical 
sections spaced 8 µm apart in the Z-plane. All TH-immunopositive cells of a 
particular LC nucleus were counted using ImageJ software (NIH). Only 
GABAAR alpha1 subunit immunopositive cells (or cells positive for markers 
mentioned above) which were clearly contained within the border of TH-
immunoreactivity (nuclear core and pericoerulear region) were considered to be 
part of the LC and included for analysis. Within these four animals, the 
percentage of GABAAR alpha1 subunit immunopositive cells expressing 
calretinin, calbindin, NPY and somatostatin was quantified.  
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2.3.6. Quantification of the relative proportion of gephyrin and GABAAR 
alpha2 & 3 subunit co-localisation on TH-immunopositive somata 
and dendrites 
 
The quantitative method used is according to (Lorenzo et al., 2007). Tissue 
from two animals was used to quantify the relative proportion and degree of co-
localisation of gephyrin, a protein enriched at the inhibitory post-synaptic 
membrane owing to its role in clustering GABAARs, with GABAAR alpha2 and 
GABAAR alpha3 subunit immunoreactive puncta on TH-immunopositive 
dendrites and somata within the nuclear core. Tissue sections at the dorso-
ventral midline level of an LC from each animal were selected for each of the 
following immunohistochemical reactions: 1) TH-GABAAR alpha2 subunit-
gephyrin (2 sections, one section from each animal) and; 2) TH-GABAAR 
alpha3 subunit-gephyrin (2 sections, one section from each animal).  Three 
fields of view (FOV) were randomly selected within the LC nuclear core of each 
tissue section.  A z-stack consisting of three-six optical sections was acquired 
for each FOV with a Plan Apochromat 63 (NA1.4) DIC oil immersion objective. 
The dimensions of the optical sections were 134µm x 134.µm in the X & Y 
planes and 1µm thick in the Z plane. Optical sections were spaced 2 µm apart. 
In all cases, triple immunofluorescence (TH-gephyrin-alpha2 or TH-gephyrin-
alpha3) was acquired using sequential acquisition of the different channels. The 
number of puncta within an optical section was manually counted using ImageJ 
software and recorded as being located on either dendritic or somatic TH-
immunoreactive profiles. The numbers of puncta for each optical section within 
a field of view were combined and the means ± SD for all FOV within and 
between sections were compared for statistical differences using Kruskal–Wallis 
one-way analysis of variance. These values were then pooled since there were 
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no statistical differences between FOV and between animals. The proportion of 
gephyrin puncta which co-localised with either GABAAR alpha2 or alpha3 
subunit puncta on either dendritic or somatic compartments was computed from 
the pooled data and expressed as a percentage of the total number of gephyrin 
puncta located on each cellular domain. 
Table 2.1: Details of the antibodies used in this chapter 
Primary 
antibodies 
Species 
(raised in) 
Source/code Dilution Specificity reference 
GABA-A Alpha1 
subunit  
 
Rabbit Werner Sieghart,  
Antigen sequence -
α1N amino acids 1-9 
Rabbit # 21/7,  
bleed # 04/10/1999 
1:1000 (Pirker et al., 2000, Poltl 
et al., 2003) 
Knockout mouse, this 
study 
GABA-A Alpha2 
subunit 
 
Guinea 
pig 
Jean-Marc Fritschy, 
University of Zurich, 
Zurich, Switzerland 
Antigen sequence α 
2N.  amino acids 1-9  
1:2000 (Fritschy and Mohler, 
1995)  
Knockout mouse, this 
study 
GABA-A Alpha3 
subunit 
 
Rabbit Werner Sieghart 
Antigen sequence α 
3N  
amino acids 1-11 
Rabbit # 14/15  
bleed # 17/04/1997 
1:1000 (Poltl et al., 2003, Pirker 
et al., 2000) 
Knockout mouse, this 
study 
GABA-A Alpha3 
Subunit 
Guinea 
pig 
Jean-Marc Fritschy, 
University of Zurich, 
Zurich, Switzerland 
Antigen sequence α 
3N.  amino acids 1-15  
1: 25,000 (Fritschy and Mohler, 
1995) 
Tyrosine 
hydroxylase 
Sheep Abcam, # ab113 1: 4000 Raised to rat 
recombinant 
TH. Labelling pattern as 
published with other 
antibodies 
Gephyrin mouse Synaptic Systems 
#147 021 
1: 500 (Pfeiffer et al., 1984) 
GAD67 mouse Millipore,# MAB5406 1: 500 (Fong et al., 2005) 
Somatostatin mouse GeneTex,  
# GTX71935 
1: 500 Raised to human 
recombinant 
somatostatin. Labelling 
pattern as published 
with other antibodies 
Calretinin mouse Swant, # 6B3 1: 2000 (Zimmermann and 
Schwaller, 2002) 
Calbindin mouse Swant, # 300 1: 2000 (Celio et al., 1990) 
NPY mouse Sigma 
# WH0004852M1 
1: 500 Raised to human 
recombinant 
NPY. Labelling pattern 
as published with other 
antibodies 
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2.3.7. Whole-cell patch electrophysiological recording of acute brain 
slices of the LC 
 
Recordings were performed according to previously published protocols 
(Swinny et al., 2010). Briefly, animals ranging in age from PND 22 to PND 35 
were rapidly decapitated and the head placed in ice-cold oxygenated artificial 
cerebrospinal fluid (aCSF) in which sucrose (248mM) was substituted for 
sodium. The brain was rapidly removed and blocked to isolate the brainstem 
region. The trimmed brain was affixed to a Vibratome equipped with a ceramic 
blade and submerged in ice cold sucrose aCSF. Horizontal 200μm slices of the 
brainstem containing the LC were cut and placed in a holding vial containing 
aCSF composed of (in mM) NaCl 124, KCl 3.0, NaH2PO4 1.25, MgSO4 2.0, 
CaCl2 2.5, dextrose 10 and NaHCO3 26 at 37°C bubbled with 95% O2-5% CO2 
for 1 hour. After 1 hour the slices were kept in room temperature (~ 24°C) aCSF 
bubbled with 95% O2-5% CO2 and transferred one at a time to the recording 
chamber. A single slice was placed in a recording chamber and continuously 
superfused with oxygenated aCSF at 1.5–2 ml/min at room temperature. LC 
neurons were visualized using an Olympus B50 upright microscope fitted with a 
40x water-immersion objective, differential interference contrast and infrared 
filter. Recording pipettes were fashioned on a P-97 micropipette puller (Sutter 
Instruments, USA) using borosilicate glass capillary tubing (1.2 mm o.d., 0.69 
mm i.d.; Warner Instruments). Pipettes were filled with electrolyte of the 
following composition (in mM) : K-gluconate 70, KCl 70, NaCl 2.0, EGTA 4.0, 
HEPES 10, MgATP 4.0, Na2GTP 0.3, and 0.1% biocytin (pH 7.3). Putative, 
visualised noradrenergic neurons were targeted based on their relatively larger 
sized, fusiform somata. The cell was approached with the electrode, a GΩ seal 
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established, the membrane potential clamped to -60mV and the cell membrane 
ruptured to obtain the whole-cell recording configuration using a Multiclamp 
700B amplifier (Molecular Devices, USA). Access resistance was monitored 
throughout the experiment. If the access resistance of the electrode was 
unstable or exceeded four times the electrode resistance, electrophysiological 
data from the cell were discarded. Signals were digitized by Digidata 1320-
series analogue-to-digital converter and stored online using pClamp 10 software 
(Molecular Devices). Only one cell per slice was recorded. The experimental 
protocol involved recording the baseline spontaneous firing rate (Hz) in current 
clamp for 10 minutes followed by the application of GABAAR ligands for a 
further 10 minutes, and then a further 10 minute epoch during which time the 
drug was washed out. Following the recording, the pipette was gently retracted, 
the slice removed from the recording chamber and submerged in a vial 
containing 1% paraformaldehyde fixative overnight. The following day, 
immunohistochemistry for tyrosine hydroxylase and biocytin was performed to 
confirm that the recorded cell was a noradrenergic neuron located within the 
LC. 
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2.4. Results 
 
In the current study, we investigated the expression of the alpha 1, 2 and 3 
subunits of the GABAAR in the LC. The specificity of all the anti-GABAAR 
subunit antibodies was verified in tissue from subunit-specific gene-deleted 
mice (Fig. 2.1). 
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Figure legend overleaf 
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Figure 2.1  
Localisation of GABAAR alpha 1, 2 & 3 subunits in tissue from wild type (WT) 
and subunit-specific gene deleted (KO) mice  
(A1-3) shows GABAAR alpha1 subunit labelling in WT tissue and (A4-6) shows 
comparative labelling in tissue from KO mice. In (A2), the characteristic labelling 
pattern of the GABAAR alpha1 subunit obtained in rat tissue, namely weak 
immunoreactivity in the nuclear core and dense staining in dendritic regions 
(see figure 2.3) is replicated in tissue from WT mice. However, in (A5), no 
specific labelling pattern was detected in tissue from GABAAR alpha1 subunit 
KO mice. GABAAR alpha3 subunit immunoreactivity in tissue from (B1-3) WT 
mice showed a similar pattern of labelling to that obtained in rat tissue (see 
figure 2.8). No detectable signal was evident from reactions performed on (B4-
6) tissue from GABAAR alpha3 subunit KO mice. (C1-3) shows magnified view 
of GABAAR alpha2 subunit immunoreactivity in the LC in tissue from WT mouse 
which is absent in (C5-8) in tissue from GABAAR alpha2 subunit KO mice. D, 
dorsal; V, ventral; M, medial; L, lateral. Scale bars (A, B) 80 µm; (C) 20 µm 
 
Since the principal noradrenergic neurons of the LC receive diverse sources of 
input which might selectively innervate the nuclear core and the pericoerulear 
dendritic region, a central focus of the study was to determine whether certain 
GABAAR subunits are targeted to different regions of the LC as well as different 
functional domains (soma, proximal/distal dendrites) of LC cells. Previous 
studies (Shipley et al., 1996, Travagli et al., 1996) have shown that the 
dendrites of the principal noradrenergic cells project in the rostro-caudal plane. 
Therefore, all the results presented are from the LC sectioned in the horizontal 
plane. This rostro-caudal visualisation of the LC allows for the examination of 
somatic as well as both proximal and distal noradrenergic dendritic processes in 
an individual field of view (Fig. 2.2A). However, the dorso-ventral labelling 
consistency was also evaluated in coronal sections of the LC (data not shown).  
2.4.1. Localisation of inhibitory synaptic markers 
 
We firstly used pre- and postsynaptic markers of inhibitory synapses to gain a 
perspective of the inhibitory innervation of the LC neurons since in some cell-
types, cortical neurons for example, the pattern of innervation is domain specific 
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(Megias et al., 2001). Immunolabelling for gephyrin, a multifunctional protein 
selectively located at inhibitory synapses (Essrich et al., 1998), appeared to be 
restricted to the proximal (Fig. 2.2B1) and (Fig. 2.2B2) distal dendritic domains 
of TH-immunopositive neurons, with only a few puncta evident on somata. To 
confirm the apparent segregation of gephyrin puncta on different domains of 
TH-immunopositive cells, we quantified the proportion of gephyrin puncta 
located on dendrites and somata in randomly selected fields of view of the 
nuclear core of the LC. There were no statistical differences between the 
number (mean ± SD) of gephyrin puncta counted between fields of view within 
and between tissue sections obtained from 2 animals (N=11 fields of view, 
Kruskal Wallis test, P = 0.24). Therefore, data from optical sections of all fields 
of view (N= 38 optical sections each measuring 134µm x 134µm x 1 µm [x-y-z]) 
were pooled. We obtained a mean ± SD of 308±21 (17 puncta per 1000μm2) 
total gephyrin puncta per optical section, of which 5 ± 2 were located on 
somata, and 302 ± 21 were located on dendrites. From these analyses, we 
computed that only 1.8% of total gephyrin puncta were located on 
noradrenergic somata with the remaining 98.2% were located on noradrenergic 
dendrites. This domain-specific pattern of inhibitory innervation was confirmed 
by the predominance of immunoreactivity for a presynaptic marker of 
GABAergic terminals (GAD67) being localised mainly on TH- immunopositive 
dendrites rather than cell bodies (Fig. 2.2C). 
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Figure legend overleaf 
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Figure 2.2  
Overview of the inhibitory innervation of noradrenergic neurons in the locus 
coeruleus (LC) 
(A) shows the LC in the horizontal plane visualised by tyrosine hydroxylase (TH) 
immunoreactivity. The horizontal arrow points to the nuclear core region of the 
LC, which is composed of densely packed cell bodies and proximal dendrites of 
the principal noradrenergic neurons. The vertical arrow indicates the 
pericoerulear region of the LC which contains the distal dendrites of the 
noradrenergic neurons. (B1) and (B2) show the distribution of inhibitory 
synapses in the nuclear core and pericoerulear region respectively, using 
gephyrin immunoreactivity (red), a protein selectively located in inhibitory 
synapses. Note that gephyrin immunoreactive puncta appear to be 
preferentially located on dendritic compartments of noradrenergic neurons 
(green) with sparse immunoreactivity on somatic domains. (C1) and (C2) show 
GABAergic innervation of noradrenergic profiles in the nuclear core and 
pericoerulear region, respectively, using GAD immunoreactivity (red). In 
agreement with (B), the principal noradrenergic neurons (green) appear to 
preferentially receive GABAergic input onto their dendrites. C, caudal; L, lateral; 
M, medial; R, rostral; TH, tyrosine hydroxylase; IV, fourth ventricle. Scale bars 
(A) 50µm; (B,C) 10µm  
 
2.4.2. GABAAR alpha1 subunit immunoreactivity 
 
Labelling in the LC with an antibody specific for the GABAAR alpha1 subunit 
gave rise to a highly distinctive staining pattern. Intense GABAAR alpha1 
subunit immunoreactivity was concentrated in the pericoerulear dendritic region 
with only a few isolated immunopositive profiles evident in the nuclear core. 
This labelling pattern was consistent throughout the rostro-caudal (Fig. 2.3) as 
well as the dorso-ventral extent of the LC. Close inspection of the nuclear core 
revealed isolated GABAAR alpha1 subunit immunopositive cells. In most cases, 
these GABAAR alpha1 subunit immunopositive cells were intensely stained, 
with the immunoreactivity appearing continuous on the somatic and dendritic 
cell membranes rather than punctate (Fig. 2.4A). Also conspicuous, were 
numerous GABAAR alpha1 subunit immunoreactive dendritic processes within 
the nuclear core. Examination throughout the Z-plane failed to reveal any 
immunoreactive somata which might be associated with these isolated dendritic 
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profiles. This suggests that in the nuclear core, the GABAAR alpha1 subunit 
expression could be restricted to only the dendritic domains of some non-
noradrenergic cells in contrast to another population of non-noradrenergic cells 
(Fig. 2.4A) which appear to have the GABAAR alpha1 subunit enriched on their 
somatic and dendritic compartments.  
 
Figure 2.3 
Overview of GABAAR alpha1 subunit immunoreactivity in the LC 
(A) a horizontal view of TH immunoreactivity showing the nuclear core and 
pericoerulear region of the LC. (B) an overview of GABAAR alpha1 subunit 
immunoreactivity showing a distinct gradient in the labelling intensity between 
the nuclear core and the pericoerulear regions. While intense labelling is 
evident in the pericoerulear region, only isolated immunoreactive profiles 
(arrows) are evident in the nuclear core region. (C) an overlay of (A) and (B). 
Scale bar 40 µm 
 
We found no convincing evidence for GABAAR alpha1 subunit-TH co-
localisation suggesting that this subunit has a limited role to play in GABAAR 
mediated inhibition of noradrenergic cells. Double labelling with gephyrin 
revealed sparse co-localisation suggesting that the majority of the GABAAR 
alpha1 subunit on these cells is not expressed in synapses (Fig. 2.4B). The 
sparse association between GABAAR alpha1 subunit immunoreactivity and 
immunoreactivity for a GABAergic presynaptic marker, GAD67 (see Fig. 2.5A), 
is further evidence of the largely extrasynaptic expression of this subunit. In 
contrast to the sparse number of labelled profiles in the nuclear core, the 
antibody for the GABAAR alpha1 subunit labelled numerous cells and dendritic 
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profiles in the pericoerulear dendritic region. Again, we found no evidence of 
GABAAR alpha1 subunit co-localising with TH immunopositive profiles (Fig. 
2.4D).  As with the labelling pattern in the nuclear core, GABAAR alpha1 subunit 
immunoreactivity lacked any characteristic punctate appearance and was 
continuous on cell membranes, with infrequent co-localisation with gephyrin 
(Fig.  2.4E).  
 
We quantified the ratio of TH and GABAAR alpha1 subunit immunopositive cells 
in 4 rats (8 LC nuclei). In the nuclear core of the LC which contains the cell 
bodies of the principal noradrenergic cells, we obtained a mean ± SD of 1710 ± 
214 TH-immunopositive cells and 198 ± 54 non-TH, GABAAR alpha1 subunit 
immunopositive cells. This is in close accordance with previous reports of the 
number of noradrenergic and non-noradrenergic cells within the LC (Swanson, 
1976). This computes to a ratio of 1 GABAAR alpha1 subunit immunopositive 
cell for every 9 TH immunopositive cell. However, as is evident in Figure 2.3D, 
the majority of GABAAR alpha1 subunit immunopositive cells were located in 
the pericoerulear dendritic region and these amounted to (mean ± SD) 509 ± 
169 per LC nucleus. 
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Figure legend overleaf 
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Figure 2.4 
Magnified view of GABAAR alpha1 subunit immunoreactivity in the LC  
(A-C) and (D-F) show the comparative alpha1 labelling in the nuclear core and 
pericoerulear region of the LC, respectively. (A) in the nuclear core, the 
GABAAR alpha1 subunit immunoreactivity (green) is restricted to non TH-
immunopositive profiles, including somata (asterisk) and dendrites (arrows), 
with the principal noradrenergic cells (blue) appearing to be devoid of any 
GABAAR alpha1 subunit signal. (B) the sparse co-localisation of GABAAR 
alpha1 subunit (green) and (gephyrin) (arrows) suggests that the majority of 
alpha1 subunit containing GABAAR are located extrasynaptically or that these 
cells receive restricted GABAergic input (compare with alpha2,alpha3, figures 
2.7,9). (D) in contrast to the limited number of GABAAR alpha1 subunit 
immunoreactive profiles in the nuclear core  (A),  GABAAR alpha1 subunit 
immunoreactivity in the pericoerulear region is contained on numerous non-
noradrenergic cell-types (asterisks) and dendritic profiles (arrows). (E) double 
labelling for GABAAR alpha1 subunit (green) and gephyrin (red) shows sparse 
co-localisation (arrows).  (C) and (F) are overlays of A, B and D, E respectively. 
Scale bars (A-C) and (D-F) 20µm 
 
The most striking aspect of the GABAAR alpha1 subunit labelling was the 
apparent diversity of non-noradrenergic cell-types revealed. In terms of their 
morphology, GABAAR alpha1 subunit immunopositive neurons ranged from 
being round or ovoid (Fig. 2.5A1), fusiform (Fig. 2.5A2) as well as triangular or 
pyramidal (Fig. 2.5A3). We employed a range of cellular markers to gain at least 
a neurochemical perspective of these non-noradrenergic cell-types within the 
LC. All of the GABAAR alpha1 subunit immunopositive cells were contacted by 
GAD67 immunoreactive puncta confirming that they receive GABAergic input 
(Fig. 2.5A). However, there were far fewer GAD67 immunoreactive puncta 
compared to the pronounced GABAAR alpha1 subunit immunoreactivity, 
suggesting that the expression of GABAAR alpha1 subunit may be largely 
extrasynaptic, in agreement with the gephyrin studies, or that these cells 
receive sparse GABAergic input (Fig. 2.4B). A sub-population of GABAAR 
alpha1 subunit immunopositive cells expressed GAD67 (Fig. 2.5A4), suggesting 
that some of these GABAAR alpha1 subunit immunopositive cells are 
GABAergic. A sub-population of GABAAR alpha1 subunit immunopositive cells 
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was also positive for a range of other neurochemical markers including 
somatostatin (Fig. 2.5B), the calcium binding proteins calretinin (Fig. 2.5C) and 
calbindin (Fig. 2.5D) and neuropeptide Y (Fig. 2.5E). In contrast, we found no 
convincing co-localisation between cholecystokinin, parvalbumin, calcitonin 
gene-related protein and the GABAAR alpha1 subunit (see Appendix I).  
 
Figure legend overleaf 
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Figure 2.5 
The GABAAR alpha1 subunit is expressed in morphologically and 
neurochemically diverse non-noradrenergic cell types in the LC 
(A 1-3) show that the somata (arrows) of these non-noradrenergic, GABAAR 
alpha1 subunit immunopositive cells vary in shape and size. (A4) The insert is a 
magnified view of the boxed area. Some cells are weakly GABAAR alpha1 
subunit immunopositive (arrow) while some are more heavily labelled and 
express GAD67 (arrowheads) suggesting that some GABAAR alpha1 subunit 
immunopositive cells are GABAergic. Non-noradrenergic, GABAAR alpha1 
subunit immunopositive cells express a range of neuronal markers including (B) 
somatostatin, (C) calretinin, (D) calbindin and (E) neuropeptide Y. Scale bars 10 
µm  
 
We quantified the proportion of GABAAR alpha1 subunit immunopositive cells 
which also expressed somatostatin, calbindin, calretinin and NPY in 4 animals 
(1 animal, 2 LC nuclei per marker) (Fig. 2.6). Calretinin was the most widely 
expressed marker, being expressed in 67% of GABAAR alpha1 subunit 
immunopositive cells. (Average of 510 calretinin-alpha1 labelled cells out of 760 
alpha1 labelled cells per LC). Of these alpha1-calretinin positive cells, 77% 
were located in the pericoerulear region and 23% were in the nuclear core. A 
further 24% of GABAAR alpha1 subunit immunopositive cells were 
immunopositive for calbindin (average of 227 calbindin- alpha1 labelled cells out 
of 956 alpha1 labelled cells per LC), with 82% of these calbindin-alpha1 labelled 
cells being located in the pericoerulear region and 18% in the nuclear core. 
NPY was expressed in 9% of GABAAR alpha1 subunit immunopositive cells 
(average of 45 NPY-alpha1 labelled cells out of 490 alpha1 labelled cells per 
LC), of which 56% were located in the pericoerulear region and 44% were in the 
nuclear core. Only 5% of GABAAR alpha1 subunit immunopositive cells also 
expressed somatostatin (average of 28 somatostatin-alpha1 labelled cells out of 
624 alpha1 labelled cells per LC). It was notable that the majority of the 
somatostatin-GABAAR alpha1 subunit immunopositive cells (93%) were located 
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in the nuclear core region of the LC with only 7 % located in the pericoerulear 
region. These data are summarised in Table 2.2. 
 
Figure 2.6 
Neurochemically diverse GABAAR alpha1 subunit expressing cells are 
differentially distributed within LC sub-regions 
(A) shows the proportion of GABAAR alpha1 subunit immunopositive cells co-
expressing different neurochemicals within the LC, with calretinin expressing 
cells being most abundant, and somatostatin positive cells least abundant. (B) 
shows the relative percentages of neurochemically diverse GABAAR alpha1 
cells within the core and dendritic region of the LC.  
 
Table 2.2 
Summary table of the quantification and location of GABAAR alpha1 subunit 
immunopositive (+ve) cells within the LC nuclear core (LC core) and 
pericoerulear dendritic region (LC PCDR) expressing different markers. N= the 
number of LC nuclei from the same animal.  
 
Marker 
 
 
Average number 
of alpha1 subunit 
+ve cells per LC 
nucleus 
Percentage of alpha1 
subunit +ve cells co-
expressing 
neurochemical marker 
Location of double labelled cells (%) 
 
LC core LC PCDR 
Calretinin 
(n=2) 760 67 23 77 
Calbindin (n=2) 956 24 18 82 
Neuropeptide y 
(n=2) 490 9 44 56 
Somatostatin 
(n=2) 624 5 93 7 
 
These non-noradrenergic GABAAR alpha1 subunit immunopositive cells in the 
LC could be projection neurons to other brain regions or they could restrict their 
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axonal arbours to the LC. To investigate whether some of these non-
noradrenergic GABAAR alpha1 subunit immunopositive cells could possibly 
innervate the principal noradrenergic cells, we co-stained for calretinin or 
calbindin, (which both label the alpha1 positive cells) together with TH and 
gephyrin. Only the calcium binding proteins calbindin and calretinin are 
expressed somatically as well as in axon terminals, allowing for visualisation 
and confirmation of such domains. Both calretinin and calbindin immunopositive 
puncta decorated mainly the nuclear core of the LC and were closely 
associated with TH immunopositive dendrites. Furthermore, both calbindin and 
calretinin immunopositive puncta were opposed to gephyrin immunopositive 
puncta, particularly those gephyrin puncta localised to TH immunopositive 
dendrites (Fig. 2.7). This suggests that at least some of these non-
noradrenergic GABAAR alpha1 subunit immunopositive cells form inhibitory 
synapses onto the principal noradrenergic neurons of the LC.  
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Figure legend overleaf 
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Figure 2.7 
Axonal puncta of putative GABAAR alpha1 subunit immunopositive non-
noradrenergic cells are closely associated with inhibitory synapses on 
noradrenergic cells of the LC 
(A) and (B)  show the cell bodies of calretinin and calbindin immunopositive 
cells (asterisks) respectively, which are all TH immunonegative. Numerous 
calretinin and calbindin immunopositive puncta are closely associated with TH 
immunopositive dendrites (highlighted on a few occasions with arrowheads). (C) 
and (D) calretinin and calbindin immunopositive puncta respectively, are often 
closely apposed to punctate gephyrin signal, suggesting that such calretinin and 
calbindin puncta are inhibitory presynaptic terminals. (E) and (F) the overlays 
show that many of the gephyrin puncta which are apposed to calretinin and 
calbindin puncta are located on TH immunopositive profiles (arrowheads) 
suggesting these cells innervate the principal noradrenergic cells. Scale bar 10 
µm 
2.4.3. The GABAAR alpha2 subunit 
 
GABAAR alpha2 subunit immunoreactivity in the LC was the most restricted of 
the 3 subunits investigated. The limited immunoreactivity for this subunit is in 
agreement with previous data (Luque et al., 1994) showing weak expression of 
this subunit in the LC. In contrast to the dense, continuous immunoreactive 
pattern of the GABAAR alpha1 subunit, the signal for the GABAAR alpha2 
subunit was wholly punctate. Most of the immunoreactive puncta appeared to 
be associated with TH-immunopositive dendrites, with fewer puncta localised to 
cell bodies (Fig. 2.8A). The GABAAR alpha2 subunit immunoreactive puncta 
predominantly co-localised with gephyrin (Fig. 2.8B) indicating that GABAAR 
receptors in the LC containing the alpha2 subunit are located in synapses. It 
was notable that many gephyrin immunoreactive puncta did not co-localise with 
GABAAR alpha2 subunit signal indicating that inhibitory synapses on 
noradrenergic cells containing receptors composed of the alpha2 subunit are in 
the minority. To confirm this, we performed triple immunofluorescence with TH, 
GABAAR alpha2 subunit and gephyrin antibodies and quantified the number of 
GABAAR alpha2 subunit immunoreactive puncta which co-localise with gephyrin 
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immunoreactive puncta located on TH-immunopositive profiles. The 
quantification was carried out in two tissue sections obtained from 2 animals. 
Two to three fields of view of the LC nuclear core were randomly selected per 
tissue section. Each field of view consisted of a z-stack composed of 3-6 optical 
sections, with each optical section measuring 134µm x 134µm x 1 µm (x-y-z). 
There were no statistical differences between the number (mean ± SD) of 
gephyrin puncta across fields of view (N=5, Kruskal Wallis test, P = 0.45). 
Furthermore, there were no statistical differences between the number (mean ± 
SD) of gephyrin puncta co-localised with GABAAR alpha2 subunit 
immunoreactive puncta across fields of view (N=5, Kruskal Wallis test, P = 
0.67). Because of this, data from the optical sections of all fields of view (N= 20 
optical sections) were pooled and used for the quantification. On the somata of 
TH-immunopositive cells, we detected 2 ± 1 (mean ± SD) GABAAR alpha2 
subunit immunoreactive puncta co-localised with gephyrin out of a total of 5 ± 1 
gephyrin puncta. In contrast, we detected 80 ± 10 (mean ± SD) GABAAR alpha2 
subunit immunoreactive puncta co-localised with gephyrin on TH-
immunopositive dendrites out of a total of 297 ± 25 gephyrin puncta. This 
computes to a percentage of 27% of gephyrin immunoreactive puncta on TH-
immunopositive dendrites and 40% of gephyrin immunoreactive puncta on TH 
somata which co-localise with GABAAR alpha2 subunit immunoreactive puncta. 
A summary of the above data is provided in Table 2.3. 
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Figure 2.8 
GABAAR alpha2 subunit 
immunoreactivity in the LC 
(A) dispersed GABAAR alpha2 
subunit (green) immunoreactivity 
was clustered with gephyrin 
immunoreactive  puncta 
(arrowheads) preferentially on 
the proximal dendrites of TH-
immunopositive cells, with few 
immunoreactive puncta evident 
on somata. (B) The majority of 
GABAAR alpha2 subunit 
immunopositive puncta co-
localise with gephyrin 
(arrowheads) suggesting that 
receptors containing the alpha2 
subunit are located in synapses 
and not extrasynaptically. Note 
that a significant number of 
gephyrin immunoreactive puncta 
(arrows) do not co-localise with 
GABAAR alpha2 subunit 
immunopositive puncta 
suggesting that GABAAR 
receptors on noradrenergic cells 
will be composed of additional 
alpha subunits, mostly likely 
alpha3 (see figure 7). (C) is an 
overlay of A and B.  
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2.4.4. The GABAAR alpha3 subunit  
 
In stark contrast to the labelling for the GABAAR alpha1 and alpha2 subunits, 
labelling for the GABAAR alpha3 subunit was ubiquitous throughout the LC with 
no apparent gradient evident between the LC core and pericoerulear region 
(Fig. 2.9).  
 
Figure 2.9 
Overview of GABAAR alpha3 subunit immunoreactivity in the LC 
(A) a horizontal view of TH immunoreactivity showing the nuclear core and 
pericoerulear region of the LC. (B) an overview of GABAAR alpha3 subunit 
immunoreactivity showing consistent, intense labelling throughout both the 
nuclear core and the pericoerulear regions. (C) an overlay of (A) and (B). Scale 
bar 50 µm 
 
GABAAR alpha3 signal appeared punctate and decorated dendritic processes 
which were TH-immunopositive in the LC core (Fig. 2.10A-C) and pericoerulear 
region (Fig. 2.10D-F). Notably, very few puncta were located on somatic 
domains (Fig. 2.10A). The majority of GABAAR alpha3 subunit immunoreactive 
puncta on TH immunoreactive processes co-localised with gephyrin (Fig. 
2.10C,F). We performed triple immunofluorescence with TH, GABAAR alpha3 
subunit and gephyrin antibodies and quantified the number of GABAAR alpha3 
subunit immunoreactive puncta which co-localise with gephyrin immunoreactive 
puncta located on TH-immunopositive profiles. The quantification was 
performed as for the GABAAR alpha2 subunit above. There were no statistical 
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differences between the mean ± SD number of gephyrin puncta (N=6, Kruskal 
Wallis test, P = 0.44) and gephyrin puncta co-localised with GABAAR alpha3 
subunit immunoreactive puncta (N=6, Kruskal Wallis test, P = 0.25) between 
fields of view. Data from all optical sections (N= 18) were combined and used 
for the quantification. On the somata of TH-immunopositive cells, we detected 3 
± 2 (mean ± SD) GABAAR alpha3 subunit immunoreactive puncta co-localised 
with gephyrin out of a total of 6 ± 2 gephyrin puncta (mean ± SD). In contrast, 
we detected 110 ± 14 (mean ± SD) GABAAR alpha3 subunit immunoreactive 
puncta co-localised with gephyrin on TH-immunopositive dendrites out of a total 
of 309 ± 15 gephyrin puncta (mean ± SD). This computes to a percentage of 
36% of gephyrin immunoreactive puncta on TH-immunopositive dendrites and 
50% on TH somata which co-localise with GABAAR alpha3 subunit 
immunoreactive puncta. A summary of the above data is provided in Table 2.3. 
Table 2.3 
Summary table of the quantification of gephyrin and GABAAR alpha2&3 subunit 
immunoreactive puncta and degree of co-localisation on TH+ profiles of the LC. 
n = optical sections 
 
  
Mean number ± SD of GABAAR alpha 
subunit puncta/gephyrin puncta 
  
Percentage of gephyrin co-
localised with GABAAR alpha 
subunit puncta 
GABAAR 
subunit Somatic membranes 
Dendritic 
membranes somata dendrite 
alpha2 
(n=20) 4 ± 2 / 5 ± 1 86 ± 10 / 297 ± 25 40 27 
alpha3 
(n=18) 4 ± 3 / 6 ± 2 116 ± 17 / 309 ± 15 50 36 
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Legend overleaf 
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Figure 2.10 
Magnified view of GABAAR alpha3 subunit immunoreactivity in the nuclear core 
and pericoerulear region of the LC 
(A) in the nuclear core and (D), the pericoerulear region, the GABAAR alpha3 
subunit immunoreactivity appears as clusters of varying sizes and decorates the 
TH immunoreactive profiles. Note that in (A), the majority of the GABAAR 
alpha3 subunit labelling is on the dendrites and not on the somata of TH 
immunoreactive cells. (C) in the nuclear core and (F) the pericoerulear region, 
the majority of  GABAAR alpha3 subunit immunoreactive puncta co-localise with 
gephyrin (arrowheads) suggesting that in the LC, a significant amount of 
GABAARs composed of the alpha3 subunit are expressed within synapses. 
However, some GABAAR alpha3 subunit immunoreactive puncta do not co-
localise with gephyrin suggesting that extrasynaptic GABAARs composed of the 
alpha3 subunit could also be expressed on TH immunopositive cells. (C) and 
(F) are overlays of (A,B) and (D,E) respectively. Scale bar 10 µm  
 
2.4.5. Co-localisation of the 3 GABAAR alpha subunits in the LC 
 
Triple immunofluorescence labelling was performed with GABAAR alpha1 
subunit, GABAAR alpha2 & 3 subunit antibodies to ascertain whether the 
GABAAR alpha 2 & 3 subunit were expressed on GABAAR alpha1 
immunolabelled cells. Gephyrin immunoreactive puncta predominantly 
decorated the dendritic domains of GABAAR alpha1 subunit immunopositive 
cells (Fig. 2.11). In contrast to the considerable co-localisation of gephyrin and 
GABAAR alpha3 subunit immunoreactive clusters observed on TH 
immunopositive cells (see figure 2.10), a limited number of GABAAR alpha3 
subunit immunoreactive puncta were located on GABAAR alpha1 subunit 
immunolabelled profiles (Fig. 2.11A-D). Furthermore, we did not obtain any 
convincing evidence of GABAAR alpha2 subunit immunoreactivity on GABAAR 
alpha1 subunit-labelled cells. This limited expression of the GABAAR alpha3 
subunit on GABAAR  alpha1 subunit positive profiles suggests that in the LC, 
synaptically expressed GABAAR subtypes containing the GABAAR alpha3 
subunit have a minor role in mediating the inhibitory currents on GABAAR 
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alpha1 subunit immunopositive cells. The extensive co-localisation between the 
GABAAR alpha3 subunit and gephyrin on TH-immunopositive profiles suggests 
that GABAARs composed of the alpha3 subunit will make up the majority of 
synaptically localised receptors on LC noradrenergic cells. However, GABAAR 
alpha3 subunit immunoreactive puncta which did not co-localise with gephyrin 
were evident, indicating that some alpha3 subunit containing GABAAR receptors 
might be expressed in synapses which do not contain gephyrin, but another 
clustering protein, or they could be located on extrasynaptic cell surfaces of 
noradrenergic cells. Since both the GABAAR alpha2 and the alpha3 subunits 
appeared to be expressed on noradrenergic cells, we used double labelling to 
estimate the level of co-localisation between these 2 subunits. We were not 
able to detect any convincing co-localisation between GABAAR alpha2 and 
alpha3 subunit immunoreactive puncta (Fig. 2.11E-G). This suggests that in the 
LC, GABAAR receptors composed of the alpha2 and the alpha3 subunits are 
targeted to distinct populations of synapses on the principal noradrenergic cells.  
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Figure 2.11 
Triple immunofluorescence labelling of GABAAR alpha1, 2 and 3 subunits in the 
LC 
(A) shows GABAAR alpha1 subunit immunoreactivity on the somatic membrane 
of a cell (asterisk) as well as on other dendritic profiles. (B) shows clustered 
GABAAR alpha3 subunit immunoreactivity with (C) showing the characteristic 
puncta staining for gephyrin and (D) overlay of (A-C) showing extensive co-
localisation between GABAAR alpha3 subunit and gephyrin puncta 
(arrowheads) and isolated co-localisation between GABAAR alpha1, GABAAR 
alpha3 and gephyrin puncta (arrows). (E) the GABAAR alpha2 subunit 
(arrowheads) and (F) the GABAAR alpha3 subunit (arrows) within the LC 
revealed (G) no co-localisation between these two subunits suggesting that 
GABAAR alpha2 and alpha3 subunits are targeted to different populations of 
inhibitory synapses on noradrenergic neurons.  Scale bar 5 µm 
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2.4.6. Effect of the pharmacological activation of subunit-specific 
GABAARs on LC neuronal activity 
 
The GABAAR subunit localisation data presented in this chapter suggest that 
functionally and pharmacologically distinct GABAARs are targeted to principal 
and non-principal cells of the LC. We hypothesise that alpha1 subunit-
containing GABAARs located on non-noradrenergic cells provide inhibitory input 
onto the principal noradrenergic neurons (see Fig. 2.13, discussion). If so, the 
application of the GABAAR alpha1 subunit-specific ligand zolpidem (100nM) 
should decrease the activity of these alpha1-subunit expressing non-
noradrenergic neurons resulting in excitation of the noradrenergic neurons. To 
begin to explore this hypothesis, we performed whole cell patch clamp 
recordings of visually identified LC noradrenergic neurons in acute brain slices 
of juvenile rats age PNDs 20-30 (Fig. 2.12A). The intracellular electrolyte 
contained biocytin allowing for the post-hoc immunohistochemical identification 
(Fig. 2.12B). Putative noradrenergic neurons were recorded in current clamp 
mode and the changes in their spontaneous discharge determined before and 
after the application of zolpidem 100nM. At this concentration, zolpidem shows 
selectivity for only alpha1-subunit containing GABAARs (Peden et al., 2008) and 
is clinically used as a hypnotic in cases of insomnia (Nutt and Stahl, 2010). In 
acute brain slices, LC neurons were spontaneously active, firing rhythmically at 
2.99 ± 3.3 Hz, N = 4 cells, (Fig. 2.12 C, T 0 seconds). Even though we only 
have an N of 1 cell (for the zolpidem experiments), the application of zolpidem 
induced a bursting pattern (Fig. 2.12 C, T 360-900 seconds) in the 
noradrenergic neuron. The maximum firing frequency during such burst 
discharges was 15.1 ± 2.3 Hz.  The bursting pattern was shown to be due to the 
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applied zolpidem since the washout of the drug resulted in the re-emergence of 
the basal firing pattern (Fig. 2.12 C, T 1080 seconds onwards). As zolpidem at 
the concentration used here potentiates the inhibitory effects of GABA at alpha1 
subunit containing GABAARs, and as the GABAAR alpha1 subunit is expressed 
by the non-noradrenergic, putative interneurons within the LC, we interpret this 
zolpidem-induced burst firing pattern in the principal neurons as sporadic 
episodes of excitation as a consequence of a decrease in the inhibitory drive 
onto such neurons. To further explore this supposition, we used muscimol 
which at 1 µM concentration functions as a pan-GABAAR agonist. Thus, it is 
likely to activate both the alpha1 subunit-containing GABAARs on the non-
noradrenergic neurons as well the alpha3-subunit containing GABAARs on the 
noradrenergic neurons. However, the effect of muscimol should manifest first on 
the alpha1 subunit-containing GABAARs since GABAARs containing the alpha1 
subunit exhibit faster activation kinetics  (Okada et al., 2000). In contrast, 
GABAARs containing the alpha3 subunits exhibit slower activation kinetics 
(Gingrich et al., 1995, Okada et al., 2000). Indeed, the application of muscimol 
produced a biphasic response on the spontaneous activity of LC neurons. 
Muscimol initially resulted in excitation (Fig. 2.12 T 180-360 seconds) which 
was followed by a period of reduced spontaneous activity and eventual 
silencing (Fig. 2.12 T 720 seconds onwards), N=3 cells. The implication is that 
drugs administered for the purposes of producing sedation in insomniac 
patients, such as alpha1-subunit specific benzodiazepines, actually cause 
excitation of the key brain arousal centre (Carter et al., 2010), the LC. These 
are pilot experiments performed at the end of my PhD. Future studies will 
include paired recordings between identified alpha1 subunit expressing non-
noradrenergic neurons and principal cells to unequivocally determine the 
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functional (neurotransmitters) and structural (mono or poly synaptic) 
connectivity with LC cellular networks. 
 
Figure 2.12 
The application of GABAAR-subunit specific ligands result in both excitation and 
inhibition of LC neuronal activity 
(A) Infra-red differential interference contrast image of the whole-cell patch-
clamp recording configuration of a putative noradrenergic neuron in an acute 
brain slice of the LC. (B) post-hoc immunohistochemical confirmation that the 
recorded cell (green) was located within the LC (red) using biocytin and tyrosine 
hydroxylase immunoreactivity respectively. (C) a representative trace of an LC 
neuron recorded in the current clamp configuration. The neuron was 
spontaneously active, characteristic of most LC neurons. The application of 
zolpidem, which at a concentration of 100nM is selective for alpha1 subunit-
containing GABAARs, induced a characteristic bursting pattern of activity which 
was abolished upon the washout of the drug. (D) a representative trace of an 
LC neuron recorded in the current clamp configuration. The application of 
muscimol at a concentration which activates all GABAAR subtypes produced an 
initial increase in the spontaneous firing rate followed by a complete silencing of 
the recorded neuron. Scale bars (B) 20μm; (C, D) vertical 50mV, horizontal 10 
seconds. 
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2.5. Discussion 
 
In the current study, we show that 3 major GABAAR alpha subunits are 
expressed within the LC, but their location is region, cell-type and domain 
specific. The GABAAR alpha1 subunit appeared diffuse on cell-membranes of 
morphologically and neurochemically diverse non-noradrenergic cell-types 
which may innervate the principal cells of the LC. In contrast, the GABAAR 
alpha3 subunit signal was clustered, and co-localised with inhibitory synaptic 
marker gephyrin on noradrenergic cells, preferentially on their dendritic 
domains. Furthermore, while the GABAAR alpha2 subunit was expressed in a 
minority of synapses on noradrenergic cells, its expression appears to be 
distinct to that of the GABAAR alpha3 subunit. Collectively, the data suggest the 
subunit-specific targeting of GABAAR subtypes to neurochemically distinct cell-
types which compose the cellular networks of the LC (see Fig. 2.13 for a 
summary diagram). 
2.5.1. The GABAAR alpha1 subunit is exclusively expressed on non-
noradrenergic cells of the LC 
 
Up to 50% of GABAAR subtypes throughout the brain contain the alpha1 
subunit (Benke et al., 1994) highlighting the central role that this subunit plays in 
GABAAR -mediated inhibition in the CNS. Despite the ubiquitous distribution of 
the GABAAR alpha1 subunit throughout different brain regions (Sperk et al., 
1997, Pirker et al., 2000, Wisden et al., 1992), its expression within particular 
regions is cell-type specific (Gao and Fritschy, 1994) and is notably not 
expressed in monoaminergic cell-types (Gao and Fritschy, 1994, Rodriguez-
Pallares et al., 2001, Fritschy and Mohler, 1995). This targeting of the GABAAR 
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alpha1 subunit to specific cell-types confers unique functional properties to such 
cells since the fast decay kinetics endowed by the presence of the alpha1 
subunit in GABAARs (Okada et al., 2000) ensures fast inhibitory transmission. 
This type of cellular communication, which needs to be constrained within strict 
temporal windows, is essential for functionally distinct ensembles of neurons to 
cooperate synchronously in a network (Klausberger and Somogyi, 2008). In the 
current study, the GABAAR alpha1 subunit immunoreactivity was notable in the 
pericoerulear dendritic region of the LC. However, only isolated cell bodies and 
dendrites in the nuclear core were labelled. None of the GABAAR alpha1 
subunit immunoreactive cells within the LC were immunopositive for TH. The 
inference is that inhibitory input onto the principal, noradrenergic cells of the LC 
is not mediated by GABAAR containing alpha1 subunits, in agreement with 
recent functional studies (Belujon et al., 2009).  
 
Despite the apparent absence of the GABAAR alpha1 subunit expression in LC 
noradrenergic neurons, alpha1 subunit containing receptors may yet play a 
crucial role in the output of the LC since numerous non-noradrenergic cell-types 
within the LC did express the subunit. We propose that the GABAAR alpha1 
subunit could be a neurochemical signature of a purported pool of local circuit 
interneurons, thought to modulate the activity of the principal noradrenergic 
cells (Aston-Jones et al., 2004). These GABAAR alpha1 subunit immunopositive 
cells are neurochemically diverse, expressing markers commonly found in 
cortical interneurons such as the calcium binding proteins calretinin and 
calbindin as well as neuropeptides such as somatostatin and NPY. Generally, 
the neurochemical content of cortical interneurons is predictive of the function of 
that cell-type (Baraban and Tallent, 2004). Functionally, interneurons, as 
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exemplified in cortical regions, play an essential role in modulating the activity of 
principal cells (Klausberger and Somogyi, 2008). For example, in the 
hippocampus, functionally, neurochemically and morphologically distinct 
interneurons cooperate to shape the activity of pyramidal cells within acutely 
defined time-scales and brain-states (Klausberger et al., 2004, Klausberger et 
al., 2003). It is currently unclear whether afferents arising from these alpha1-
subunit-expressing non-noradrenergic cells within the LC shape the activity of 
the principal cells either in terms of enhancing or dampening excitability. Our 
very pilot studies using patch clamp recordings of acute LC slices suggests that 
the activation of alpha1-subunit containing GABAAR have a potent effect on the 
excitability of noradrenergic neurons (Fig. 2.12) despite these neurons not 
expressing these subunits. The inference is that such alpha1 subunit activation 
arises from non-noradrenergic neurons within the LC thus providing the first 
functional evidence of the importance of LC cellular network activity in 
determining overall LC output.  If so, administered subunit-specific GABAAR 
ligands could have complex influences on LC neuronal activity (see summary 
Figure 2.13) and LC-mediated behaviours which are inextricably linked to LC 
spontaneous neuronal activity. LC neurons are spontaneously active and exhibit 
two distinguishable modes of activity, phasic and tonic firing (Aston-Jones and 
Bloom, 1981). The particular firing pattern,  which is under the influence of 
afferents , is closely related to the behavioural state (Rajkowski et al., 1994)  
and thought to correlate with strategies adopted in terms of achieving a 
particular task (Valentino and Van Bockstaele, 2008). 
 
A surprising finding of the study was the infrequent association of inhibitory 
synaptic markers such as gephyrin and GAD67 with GABAAR alpha1 subunit 
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immunoreactivity. Moreover, GABAAR alpha1 subunit immunoreactivity rarely 
appeared punctate and was more commonly found to be diffuse on the 
membranes of cell bodies and dendrites. The limited co-localisation between 
GABAAR alpha1 subunit and gephyrin immunoreactive puncta in the LC may be 
indicative of sparse GABAergic inputs to GABAAR alpha1 subunit 
immunoreactive cells. Alternatively, there may be a greater proportion of the 
GABAAR alpha1 subunit complement located on extrasynaptic cell surfaces 
compared to that in synapses (Kasugai et al., 2010). This is important since 
receptors predominantly expressed within synapses have a different kinetic 
profile to those predominantly expressed on extrasynaptic membranes (Glykys 
and Mody, 2007). Phasic and tonic inhibitory currents occupy unique functional 
roles in terms of regulating network excitability. In the hippocampus, 
synaptically enriched alpha1 or 2 subunit-containing GABAAR are thought to 
mediate mainly fast phasic currents, with the purportedly extrasynaptic alpha5 
subunit-containing GABAAR responsible for tonic currents (Prenosil et al., 2006, 
Glykys et al., 2008). Importantly, tonic currents appear to be essential for 
controlling network excitability and oscillations (Glykys et al., 2008). The largely 
extrasynaptic expression of the GABAAR alpha1 subunit in these non-
noradrenergic neurons of the LC suggests a unique kinetic profile for GABAAR 
containing this subunit in this region. This may have implications in terms of the 
regulation of network oscillations (Glykys et al., 2008) within this brain region.  
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2.5.2. Alpha2 and 3 subunit containing GABAAR receptors are targeted 
to non-overlapping populations of synapses on noradrenergic cells 
of the LC 
 
The overall appearance of the GABAAR alpha 2 and 3 subunit immunoreactivity 
contrasted greatly with that of the alpha1 subunit. GABAAR alpha2 and 3 
labelling appeared punctate in contrast to the diffuse appearance of the 
GABAAR alpha1 subunit signal. Our quantitative data suggest that the majority 
of gephyrin immunoreactive puncta located on TH positive profiles co-localised 
with either GABAAR alpha2 or alpha3 subunit immunoreactive puncta, implying 
that these subunits are the major components of GABAAR in synapses on the 
principal noradrenergic cells of the LC. A consistent finding was the location of 
GABAAR alpha2 and 3 subunit immunoreactivity mainly on dendritic 
compartments of TH profiles, with rare signal evident on somata. However, 
these 2 subunits appeared to be targeted to non-overlapping populations of 
synapses on noradrenergic cells since we found no co-localisation between 
them. This suggests an input-dependent segregation of GABAAR alpha2 and 3 
subunit containing receptors on noradrenergic cells.  
 
The widespread expression of the GABAAR alpha3 subunit suggested by the 
current data implies that this subunit is a central component of GABAAR 
mediated inhibition within the LC. However, the ubiquitous expression of the 
GABAAR alpha3 subunit throughout the principal noradrenergic neurons of the 
LC should not necessarily infer uniformity in the pharmacological and kinetic 
profiles of GABAAR receptor mediated signalling onto LC neurons. This is 
because the other subunits which co-assemble with the alpha3 subunit to form 
the pentameric receptor complex will influence the pharmacological and kinetic 
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profile of the particular receptor channel. The exact subunit combinations 
formed within the LC is currently unclear. While previous localisation studies 
have shown the expression of the GABAAR gamma2 subunit (Fritschy et al., 
1992) (Fritschy and Mohler, 1995) and the GABAAR gamma1 subunit (Luque et 
al., 1994) in the LC,  other studies suggest the expression of other GABAAR 
subunits such as epsilon and theta within the LC (Moragues et al., 2002, 
Sinkkonen et al., 2000, Belujon et al., 2009).  
 
In the current study, GABAAR alpha3 subunit immunoreactive puncta were 
mostly co-localised with gephyrin suggesting the majority of alpha3 subunit 
containing GABAAR receptors are located in synapses. However, there was 
clearly evidence of GABAAR alpha3 subunit immunoreactive puncta which did 
not co-localise with gephyrin, suggesting that some GABAAR composed of the 
alpha3 subunit are expressed on extrasynaptic cell membranes or are synaptic 
receptors associated with other anchoring proteins. This disparate location is 
functionally important since receptors at varying distances from the 
neurotransmitter release site are exposed to different levels of the 
neurotransmitter and this results in a distinctive kinetic profile for that receptor 
channel (Mody and Pearce, 2004). Indeed, GABAAR located within synapses 
are thought to mediate phasic currents and are rapidly desensitising. In 
contrast, extrasynaptically located GABAAR are thought to exhibit greater 
sensitivity to GABA since ambient levels decrease at increasing distances from 
the synaptic cleft. This results in persistent, tonic currents with slow deactivation 
profiles (Farrant and Nusser, 2005). Previous studies using recombinant 
receptors, which are purportedly expressed in the LC, show that GABAAR 
alpha3/epsilon/theta subunit combinations show almost 100 fold greater 
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sensitivity to GABA compared to GABAAR alpha3/gamma2 subunit 
combinations (Ranna et al., 2006). It is thus tempting to speculate that a sub-
population of GABAAR alpha3 subunits on noradrenergic cells of the LC co-
assemble with GABAAR gamma2 subunits to form a GABAAR subtype which is 
localised to synaptic membranes. Whereas, another population of GABAAR 
alpha3 subunits co-assemble with the GABAAR epsilon/theta subunits to form a 
GABAAR subtype which is perhaps located on extrasynaptic membranes. If so, 
this has implications for the pharmacology of GABAAR mediated inhibition of LC 
noradrenergic neurons since gamma2 containing GABAAR are sensitive to 
benzodiazepines, a widely used class of pharmacological agents. The clinical 
effects of these agents closely mirror some of the most salient aspects of LC 
function such as modulating levels of arousal (sedation; alpha1 subunit), 
regulating the stress response (anxiolysis; alpha2 and 3 subunits) and memory 
formation (the alpha5 subunit) (Rudolph and Mohler, 2006). A correlative 
GABAAR subunit/input specific study to determine which particular subunits 
mediate the effects of diverse brain afferents and how these change in disease 
will allow for more directed pharmacological interventions in many debilitating 
psychiatric disorders resulting from LC pathology. 
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Summary of GABAAR subunit localisation data and functional implications of 
GABAAR subunit expression within the LC  
 
Figure 2.13 
Summary diagram of the localisation of distinct GABAAR subunits within the 
cellular networks of the LC 
The principal, noradrenergic neurons express alpha2/3 subunit containing 
GABAARs whereas the non-noradrenergic neurons express alpha1 subunit 
containing GABAARs. Based on the neurochemical profiles of these non-
noradrenergic alpha1-subunit expressing neurons, we hypothesise that they are 
GABAergic and provide local inhibitory input onto the principal cells. Against 
these expression data, we speculate that the time-course of the responses of 
the noradrenergic and non-noradrenergic neurons to GABA or administered 
GABAAR ligands will be divergent with faster responses manifesting in the 
alpha1 subunit expressing non-noradrenergic neurons and slower responses in 
the alpha2/3 subunit expressing noradrenergic neurons. Furthermore, any 
administered ligands selective for alpha1-subunit GABAARs are likely to result 
in the excitation of the noradrenergic neurons as a result of decreased inhibitory 
tone originating the non-noradrenergic neurons. We put forward this proposition 
as a framework for future functional studies. 
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3. Chapter 3 
Immunohistochemical localisation of diverse GABAAR 
subunits in the cellular networks of the mouse dorsal raphe 
nucleus 
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3.1. Abstract 
 
The dorsal raphe nucleus (DRN) provides the major source of serotonin 
throughout the central nervous system. As such, the DRN is associated with 
diverse neural functions including emotion. In turn, dysregulation in DRN 
function is implicated in psychiatric disorders such as depression and anxiety. 
Therefore, identifying the molecules which underlie the regulation of the DRN-
serotonin system is fundamental to addressing such debilitating disorders. 
GABAARs are functionally and pharmacologically diverse chloride-permeable 
ion channels which mediate the fast inhibitory effects of GABA and thus set the 
tone for neuronal activity at the single cell and network level. As such, they are 
likely to be integral to DRN neuronal activity and serotonin release, yet their 
expression within this brain region is poorly understood. Therefore, the aim of 
the study is to identify and characterise the GABAAR subunit expression within 
the cell-types of the DRN. Using high-resolution confocal microscopy, we 
provide the first report of the precise cell-type and domain-specific expression 
profile of GABAAR alpha subunits 1, 2 and 3 as well as the gamma2 subunit on 
the neurons which comprise the networks of the DRN. The alpha1 subunit was 
localised within all DRN GABAergic neurons with only a selective, 
topographically located population of serotoninergic neurons expressing this 
subunit. The alpha2 and 3 subunits were both enriched on the serotonergic 
dendrites. However, the alpha2 subunit exhibited the greater degree of co-
localisation with inhibitory synaptic marker proteins suggesting differential 
targeting of alpha2-3 subunit containing  GABAAR subtypes to synaptic and 
extrasynaptic cell-surfaces and thus distinct contributions to phasic and tonic 
inhibitory currents. Importantly, the gamma2 subunit, the target of commonly 
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used anxiolytic agents, was predominantly expressed by non-serotonergic DRN 
neurons. Collectively, these data provide the first demonstration of the cell-type 
and domain-specific expression patterns of GABAAR machinery that determines 
GABA-mediated control of the DRN function and thus serotonin release. These 
data provide a foundation for understanding the functional plasticity of the DRN 
system during different behavioural states or disease conditions.  
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3.2. Introduction 
 
Serotonin is one of the major monoamine neurotransmitters present throughout 
the brain and has a major influence over a broad range of physiological 
functions and behaviours. These include mood (Lira et al., 2003, Commons et 
al., 2003), respiration (Böhmer et al., 1979, Hilaire et al., 2010) and 
thermoregulation (Schwartz et al., 1995, Lin et al., 1998, Hodges et al., 2008), 
regulation of the sleep-wake cycle (Gervasoni et al., 2000, Urbain et al., 2006), 
appetite (Hoebel et al., 1989, Tecott et al., 1995), cognition (Mendelsohn et al., 
2009, Clarke et al., 2004), nociception (Zeitz et al., 2002) and aggression (van 
der Vegt et al., 2003, de Almeida et al., 2005). The ability of serotonin to 
modulate such diverse physiological functions and behaviours arises not only 
from the brain region, cell-type and sub-cellular domain specific expression 
profile of different classes of serotonin receptors, but also from the 
topographically organised network of serotonin-containing afferent inputs to 
functionally distinct brain regions. 
 
The collection of raphe nuclei located within the brainstem and pons provide the 
sole source of serotonin within the CNS with the DRN being the major 
contributor out of all raphe sub-nuclei (Jacobs and Azmitia, 1992). The focus of 
our research is on the DRN because of its important role in serotonin-mediated 
mental functions such as mood (Bach-Mizrachi et al., 2005). One of the 
mechanisms by which the DRN contributes to the regulation of mood is by 
processing environmental signals such as psychosocial stressors and 
modulating serotonin levels in a brain region and stressor specific manner 
(Kirby et al., 1995, Kirby et al., 1997, Adell et al., 1997), which then allows for 
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adaptive behavioural responses to such challenges. However, dysregulation of 
the DRN-serotonin homeostatic response to stressors, particularly upon chronic 
exposure, is thought to contribute to the pathophysiology of various mental 
illnesses such as anxiety and depression (Stockmeier et al., 1998, Baumann et 
al., 2002). Therefore, identifying the mechanisms by which DRN neurons 
regulate brain serotonin levels is integral to understanding the neurobiological 
basis for adaptive responses to stressors and devising therapeutic strategies for 
associated pathologies such as affective disorders.  
 
Experiments combining microdialysis and HPLC with electrical stimulation of the 
DRN has shown that the release of serotonin is correlated with the levels of 
DRN neuronal activity (McQuade and Sharp, 1997). The dorsal-ventral extent of 
the DRN is divided into the following sub-regions based on cellular morphology 
and pattern of afferent innervation and efferent output; dorsomedial, 
ventromedial, dorsolateral and medial interfasicular regions (Jacobs and 
Azmitia, 1992). The excitability of the principal serotonin DRN neurons is, in 
part, determined by extensive afferent innervation which carries information 
from diverse brain regions to specific sub-divisions of the DRN. For instance, 
afferents containing the stress hormone CRH which are disparately distributed 
throughout the DRN appear most abundant in rostral DRN (Valentino et al., 
2001). Although the DRN is the largest serotonergic nucleus, only 
approximately 50% of its neurons are serotonergic. Furthermore, stimulation of 
the PFC inhibits DRN serotonin neurons (Celada et al., 2001, Varga et al., 
2001) due to preferential targeting of PFC glutamatergic inputs to DRN 
GABAergic neurons (Jankowski and Sesack, 2004). Thus, the excitability of the 
principal DRN serotonin neurons is not only shaped by the pattern of afferent 
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innervation, but also by the neurochemical and functional diversity of the 
neurons embedded within the networks of the DRN. DRN serotonin neurons 
have been shown to co-express different neurochemicals such as VGLUT3 
(Commons, 2009), GAD67 (Fu et al., 2010), calcium binding proteins such as 
parvalbumin (Charara and Parent, 1998) and the stress neuropeptide CRH 
(Commons et al., 2003). The existence of neurochemically diverse sub-
populations of serotonergic and non-serotonergic neurons within the DRN, 
could point towards the presence of functionally distinct sub-groups of DRN 
neuron which may cooperate to regulate serotonin release in DRN efferent 
targets.  
 
Serotonin neurons of the DRN display considerable functional diversity. At the 
level of the individual neuron, passive and active membrane characteristics of 
serotonin neurons within the DRN differ across subfields. Whereas previously it 
was thought that the expression of the 5HT1A receptor was indicative of 
serotonin neurons, it has since been shown that non-serotonin DRN neurons 
also express this receptor. Thus, such conventional markers cannot be used as 
an unequivocal predictors of cell-type (Calizo et al., 2011). In the context of 
whole brain activity, functional heterogeneity of DRN neurons has been known 
for some time. Initial studies reported two functionally distinct types of DRN 
serotonin neuron depending on their firing rhythm (Nakahama et al., 1981). 
More recent studies investigating DRN neuronal firing in anesthetised rats 
demonstrated further functional diversity by defining four electrophysiologically 
distinct groups of DRN neurons which also displayed differing neurochemistry 
such as the serotonergic clock-like neurons and non-serotonergic fast spiking 
neurons (Schweimer et al., 2011). Moreover, these groups of cells displayed 
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differing discharge rates in relation to the different phases of cortical slow wave 
activity; a sub-population of serotonergic neurons generally displayed a high 
firing rate during the inactive component of cortical slow waves, whereas non-
serotonergic neurons displayed a higher firing rate during the active component 
of cortical slow waves. The functional significance of such extensive 
neuroanatomical, neurochemical and functional diversity within the DRN could 
be to regulate the neuronal activity of disparate or functionally connected brain 
regions, with respect to a specific stimulus. If so, exquisite choreography 
between such diverse neuronal sub-groups is essential for coordinated DRN 
activity. The precise location of neurotransmitter receptors at appropriate 
neurotransmitter release sites is likely to be key to such synchrony. 
 
A sizeable proportion of these non-serotonin DRN neurons, together with 
pontine and hypothalamic inputs utilise the inhibitory neurotransmitter GABA to 
regulate DRN serotonin neuronal activity (Gervasoni et al., 2000, Celada et al., 
2001). Thus, the targeting of GABA receptors, in particular GABAARs, within the 
cellular networks of the DRN will be important in contributing to the overall 
levels of DRN neuronal activity and hence serotonin release, in both health and 
disease. In the CNS, GABAAR mediate the fast inhibitory effects of GABA. 
GABAAR subtypes are heteropentameric ion channels, comprised of five 
subunits which interact to form a chloride ion conducting pore. Nineteen 
GABAAR subunits have been cloned and classified into eight classes according 
to their sequence homology α1-6, β1-3, γ1-3, δ, ε, π, ρ1-3 and θ (Olsen and 
Sieghart, 2009). GABAAR subunit composition defines the kinetic and 
pharmacological properties of the receptor and creates considerable diversity in 
GABAergic neurotransmission (Gingrich et al., 1995, Okada et al., 2000, Eyre et 
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al., 2012). In common with other monoaminergic brain centres like the LC, the 
DRN is purported to possess an unusual complement of GABAAR subunits such 
as the θ and ε subunits (Sinkkonen, 2000, Moragues et al., 2000, Pape et al., 
2009). Brain-wide GABAAR subunit expression studies have revealed certain 
subunits, such as the GABAAR alpha3 subunit, to be enriched in the DRN (Gao 
et al., 1993, Pirker, 2000), but the precise cell type, domain specific and sub-
cellular expression profile of different GABAAR subunits within the cellular 
networks of the DRN has yet to be described. In this chapter, the first high 
resolution localisation of the GABAAR alpha1, alpha2, alpha3 and gamma2 
subunits in neurochemically diverse cell types of the DRN using confocal 
microscopy is demonstrated.  
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3.3. Methods 
 
All procedures involving experimental animals were performed in accordance 
with the Animals (Scientific Procedures) Act, 1986 (UK) and associated 
procedures. Every effort was made to minimise any pain or discomfort to the 
animals. 
3.3.1. Tissue preparation 
 
Note that in the previous LC chapter all experiments were conducted in rat. Rat 
was used from the outset since this was the species in which all previous data 
from my supervisor was obtained and we sought to obtain continuity. However, 
at the commencement of this study, we were provided access to a range of 
GABAAR subunit-specific gene-deleted mice. In light of the immense utility of 
such animal models, we decided to undertake the rest of the studies in mouse.  
 
Data presented in this study are derived from six adult C57BL/6J male mice and 
two transgenic mice which expressed green fluorescent protein as a reporter 
molecule under the GAD67 promoter (Tamamaki et al., 2003). Anaesthesia was 
induced with isofluorane and maintained with pentobarbitone (1.25 mg/kg of 
bodyweight; i.p.). The animals were perfused transcardially with 0.9 % saline 
solution for 1 minute, followed by 12 minutes fixation with a fixative consisting of 
1% paraformaldehyde, 15% v/v saturated picric acid, in 0.1 M PB, pH 7.4. The 
brains were kept in the same fixative solution overnight at 4°C. Coronal sections 
of the DRN, 50 µm thick, were prepared on a Vibratome and stored in 0.1 M PB 
containing 0.05% sodium azide. 
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3.3.2. Immunohistochemical reactions 
 
Four animals were used for the qualitative examination of the immunoreactivity. 
A proteolytic antigen retrieval method was used to localise membrane–bound 
epitopes (Watanabe et al., 1998) . Briefly, the tissue sections were incubated at 
37°C for 10 minutes in 0.1 M PB followed by 15 minutes in 0.2 M HCl containing 
1 mg/ml pepsin (Sigma, UK) after which they were washed thoroughly in Tris-
buffered saline containing 0.3% triton (TBS-Tx) for 30 minutes. Non-specific 
binding of secondary antibodies was blocked by incubating sections with 20% 
normal horse serum for 2 hours at room temperature. The tissue sections were 
incubated with cocktails of primary antibodies (Table 3.1), diluted in TBS-Tx, 
overnight at 4°C. After washing with TBS-Tx, sections were incubated in a 
mixture of appropriate secondary antibodies conjugated with either Alexa Fluor 
405 (Jackson ImmunoReserach) Alexa Fluor 488 (Invitrogen, Eugene, OR), 
indocarbocyanine (Cy3; Jackson ImmunoResearch), and indodicarbocyanine 
(Cy5; Jackson ImmunoResearch) for 2 hours at room temperature. Sections 
were washed in TBS-Tx and mounted in Vectashield (Vector Laboratories, 
Burlingame, CA).  
3.3.3. Antibody specificity 
 
Although all the antisera against the GABAAR subunits used in this study have 
been reported upon extensively in other publications (see Table 3.1), in the 
work detailed in this chapter, we used tissue from GABAAR subunit-specific 
gene deleted mice to confirm the specificity of the signal under our reaction 
conditions and specific brain regions investigated. No specific GABAAR subunit 
immunoreactivity was detectable in tissue from GABAAR alpha1 subunit gene 
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deleted mice (Sur et al., 2001) (Fig. 3.2), GABAAR alpha2 subunit gene deleted 
mice (Dixon et al., 2008) (kindly provided by Drs D. Belleli and J. Lambert at the 
Neurosciences Institute, University of Dundee, and originated from Dr Thomas 
Rosahl, Merck Sharp & Dohme) (Fig. 3.5), and GABAAR alpha3 subunit gene 
deleted mice (Yee et al., 2005) (kindly provided by Professor Uwe Rudolph, 
Laboratory of Genetic Neuropharmacology, McLean Hospital, Department of 
Psychiatry, Harvard Medical School) (Fig. 3.5). Method specificity was also 
tested by omitting the primary antibodies in the incubation sequence. To confirm 
the absence of cross reactivity between IgGs in double and triple 
immunolabelling experiments, some sections were processed through the same 
immunohistochemical sequence, except that only an individual primary antibody 
was applied with the full complement of secondary antibodies.  
3.3.4. Image acquisition 
 
Sections were examined with a confocal laser-scanning microscope (LSM710; 
Zeiss, Oberkochen, Germany) using either a Plan Apochromatic 63x DIC oil 
objective (NA1.4) (pixel size 0.13 μm) or a Plan Apochromatic 100x DIC oil 
objective (NA1.46) (pixel size 0.08 μm). Z-stacks were used for routine 
evaluation of the labelling. All images presented represent a single optical 
section. These images were acquired using sequential acquisition of the 
different channels to avoid cross-talk between fluorophores, with the pinholes 
first adjusted to one airy unit and then optimised to ensure equal optical section 
thicknesses for all channels. Images were processed with the software Zen2008 
Light Edition (Zeiss, Oberkochen, Germany) and exported into Adobe 
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Photoshop. Only brightness and contrast were adjusted for the whole frame, 
and no part of a frame was enhanced or modified in any way.  
3.3.5. Quantification of the relative proportion of TPH-immunopositive 
cells expressing GABAAR alpha1 subunit immunoreactivity 
 
Tryptophan hydroxylase (TPH) immunohistochemistry was used as a marker of 
serotonin neurons. A previous report showed that the GABAAR alpha1 subunit 
is predominantly expressed on GABAergic non-serotonin neurons with only a 
cursory description of the expression of this subunit on serotonin neurons in the 
DRN. From the outset, we sought to quantify the ratio of TPH immunopositive 
cells displaying immunoreactivity for the GABAAR alpha1 subunit out of the total 
number of TPH immunopositive cells. Entire DRN nuclei were sectioned in the 
coronal plane (60um thick sections) using a Vibratome. From these, three 
sections representing the rostral (~ -3.78mm bregma), midline (~ -4.5mm 
bregma) and caudal (~ -4.86mm bregma) extent of the DRN were used for 
quantification. For each section, the proportion of TPH- GABAAR alpha1 
immunopositive cells to TPH-immunopositive cells was quantified within the 
distinct sub-regions of the DRN. For the rostral sections, the DRN was 
subdivided into dorsal (dDRN) ventral (vDRN), medial interfasicular (milfDRN) 
regions. For the midline sections, the DRN was subdivided into dorsal, ventral, 
medial interfasicular and lateral wing (lwDRN) regions. For the caudal sections, 
the DRN was subdivided into dorsal and ventral regions. Sections were imaged 
using a Plan Apochromatic 63X DIC oil objective (NA1.3), zoom 0.6, with optical 
sections spaced 7 µm apart in the Z-plane. ImageJ software (NIH) was used to 
count the number of TPH-GABAAR alpha1 subunit-immunopositive neurons in 
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relation to the total number of TPH-immunopositive neurons within the different 
DRN sub-regions. 
3.3.6. Quantification of the relative proportion of neuroligin2 
immunoreactive clusters which co-localise with GABAAR alpha2 & 3 
subunit immunoreactive clusters on TPH-immunopositive somata 
and dendrites 
 
The quantitative method used is according to (Corteen et al., 2011). Tissue from 
two animals was used to quantify the relative proportion of neuroligin2 
immunoreactive clusters which co-localised with GABAAR alpha2 and GABAAR 
alpha3 subunit immunoreactive puncta on TPH-immunopositive dendrites and 
somata. Neuroligin2 is a protein found exclusively at inhibitory synapses 
(Poulopoulos et al., 2009), therefore the intention of this experiment was to 
estimate what proportion of inhibitory synapses on such cell surfaces contained 
GABAARs composed of the alpha2 and alpha3 subunits. Preliminary 
investigations revealed no discernible gradients in the intensity for signal for 
either the GABAAR alpha2 or GABAAR alpha3 subunits in the rostro-caudal 
planes. Therefore, tissue sections at the rostral-caudal midline level of the DRN 
from each animal were selected for each of the following immunohistochemical 
reactions: 1) TPH-GABAAR alpha2 subunit-neuroligin2 (2 sections, one section 
from each animal) and; 2) TPH-GABAAR alpha3 subunit- neuroligin2 (2 
sections, one section from each animal).  Two fields of view (FOV) were 
randomly selected within the DRN ventromedial sub-region of each tissue 
section.  A z-stack consisting of three optical sections was acquired for each 
FOV with a Plan Apochromat x100 (NA1.4) DIC oil immersion objective. The 
dimensions of the optical sections were 84.94µm x 84.94µm in the X & Y planes 
and 1µm thick in the Z plane. Optical sections were spaced 2 µm apart. In all 
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cases, triple immunofluorescence (TPH-neuroligin-alpha2 or TPH-neuroligin-
alpha3) was acquired using sequential acquisition of the different channels. The 
number of puncta within an optical section associated with TPH 
immunoreactivity was manually counted using ImageJ software. The proportion 
of neuroligin2 puncta which co-localised with either GABAAR alpha2 or alpha3 
subunit puncta was computed and expressed as a percentage of the total 
number of neuroligin2 puncta located on each cellular domain.   
Table 3.1 
Details of antibodies used in this chapter 
Primary antibodies Species 
(raised in) 
Source/code Dilution Specificity 
reference 
GABAAR alpha1 
subunit  
 
Rabbit Werner Sieghart,  
Antigen sequence -α1N 
amino acids 1-9 
Rabbit # 21/7,  
bleed # 04/10/1999 
1:5000 (Pirker et al., 2000, 
Poltl et al., 2003, 
Corteen et al., 
2011) 
Knockout mouse, 
this study 
GABAAR alpha2 
subunit 
 
Guinea pig Jean-Marc Fritschy, 
University of Zurich, 
Zurich, Switzerland 
Antigen sequence α 2N.  
amino acids 1-9  
1:1000 (Fritschy and 
Mohler, 1995, 
Corteen et al., 
2011) 
Knockout mouse, 
this study 
GABAAR alpha3 
Subunit 
Guinea pig Jean-Marc Fritschy, 
University of Zurich, 
Zurich, Switzerland 
Antigen sequence α 3N.  
amino acids 1-15  
1: 5000 (Fritschy and 
Mohler, 1995, 
Corteen et al., 
2011) 
Knockout mouse, 
this study 
GABAAR gamma2 
subunit 
Guinea pig Jean-Marc Fritschy, 
University of Zurich, 
Zurich, Switzerland 
Antigen sequence  
Antigen sequence α 3N.  
amino acids 1-29 
1: 3000 (Fritschy and 
Mohler, 1995) 
GABAAR gamma2 
subunit 
Rabbit Synaptic systems 
#224 003 
1: 1000 Labelling pattern as 
published with 
other antibodies. 
Antibody 
extensively used in 
the literature. (Fan 
et al., 2012, Eyre et 
al., 2012, Essrich et 
al., 1998) 
Tryptophan 
hydroxylase 
Sheep Millipore 
#AB1541 
1: 3000 Raised to rabbit 
recombinant 
TPH. Labelling 
pattern as 
published with 
other antibodies 
Gephyrin Mouse Synaptic Systems 1: 500 (Pfeiffer et al., 
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#147 021 1984) 
Neuroligin2 Rabbit Synaptic Systems 
#129 203 
1: 1000 Labelling pattern as 
published with 
other antibodies.  
GFP Chicken Aves Labs Inc. 
#GFP-1020 
1: 5000  
Parvalbumin Mouse Swant 
#253 
1: 2000 Labelling pattern as 
published with 
other antibodies. 
3.4. Results 
 
In the current study, we investigated the expression profiles of the GABAAR 
alpha1, 2, 3 and gamma2 subunits in the DRN. We also confirmed that the 
alphas 4, 5 and delta subunits were not expressed within this brain region (data 
not shown) in agreement with mRNA data (Wisden et al., 1992). A central focus 
of this study was to determine whether certain GABAAR subunits are expressed 
by neurochemically diverse cell types within the DRN and whether they are 
preferentially targeted to certain cellular domains. Previous studies have 
characterised the topographical organisation of the DRN with respect to its 
inputs and outputs in the dorsal ventral plane (Abrams et al., 2004). For this 
reason, all results are presented from the DRN sectioned in the coronal plane. 
3.4.1. The majority of GABAergic synapses on serotonin neurons are 
located on dendrites 
 
We first used molecular markers of inhibitory synapses to gain a perspective of 
the location of GABAergic synapses on the somatic and dendritic domains of 
serotonin neurons within the DRN. Immunolabelling for gephyrin, a protein 
enriched at inhibitory synapses due to its role in clustering GABAAR subtypes in 
the plasma membrane (Essrich et al., 1998), clustered preferentially on the 
dendritic domains of TPH-immunopositive neurons, with only a few clusters 
evident on the somata (Fig. 3.1A1). This domain specific pattern of inhibitory 
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innervation was confirmed by the predominant dendritic location of 
immunoreactivity for neuroligin2 (NLG2) (Fig. 3.1A2), a protein exclusively 
found at inhibitory synapses (Varoqueaux et al., 2004) and is critical for the 
correct alignment of the pre and post-synaptic membranes (Poulopoulos et al., 
2009).  
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Figure legend overleaf 
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Figure 3.1 
Immunohistochemical localisation of inhibitory synaptic markers on serotonergic 
neurons of the DRN 
(A1) gephyrin immunoreactive clusters were enriched on dendritic 
compartments of tryptophan hydroxylase (TPH)-immunopositive neurons, with 
fewer gephyrin puncta present on somatic domains. (A2) neuroligin2 (NLG2) 
immunoreactive puncta displayed a similar distribution pattern to that of 
gephyrin, with NLG2 immunoreactivity being enriched on TPH-immunopositive 
dendrites. (A3) virtually all NLG2 puncta co-localise with gephyrin. (B1-4) a 
magnified view of the boxed area illustrates the widespread co-localisation 
(arrowheads) of gephyrin and NLG2 immunoreactivity. Scale bar (A) 10 μm, (B) 
5 μm. 
 
3.4.2. The GABAAR alpha1 subunit is expressed by a minority of 
serotonin neurons and all GABAergic neurons within the DRN 
 
The specificity of the GABAAR alpha1 subunit antibody was confirmed in tissue 
sections containing the DRN obtained from wild type (WT) and GABAAR alpha1 
subunit gene-deleted mice (alpha1-KO) (Fig. 3.2). There was no discernible 
difference in the intensity of TPH immunoreactivity with the DRN of WT and 
GABAAR alpha1-KO mice suggesting that the absence of the GABAAR alpha1 
subunit did not impact on the levels of serotonin production within the DRN (Fig. 
3.2). GABAAR alpha1 subunit immunoreactivity was consistent throughout the 
DRN (Fig. 3.2) in both rostral-caudal and dorso-ventral extents. Labelling for the 
GABAAR alpha1 subunit was particularly enriched in sub-fields which showed 
lower levels of TPH-immunopositive profiles. GABAAR alpha1 subunit 
immunoreactivity appeared to be equally enriched on somatic as well as 
dendritic compartments of cells (Fig. 3.3). This is in stark contrast to the signal 
for the GABAAR alphas 2 and 3 subunits which was preferentially restricted to 
dendritic domains (see below). Previous studies indicate that the GABAAR 
alpha1 subunit is mainly expressed by non-serotonergic neurons of the DRN 
which are likely to be GABAergic (Gao et al., 1993). We used a transgenic 
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mouse model which expressed the reporter green fluorescent protein (GFP) 
under the promoter GAD67 (GAD67-GFP mice) (Tamamaki et al., 2003) in 
order to identify putative GABAergic neurons. GAD67-GFP mice were 
generated through homologous recombination, by targeting cDNA encoding 
enhanced GFP to the locus encoding GAD67. Homologous recombinant 
embryonic stem cells were used to derive chimeric mice which were used for 
initial breeding. Subsequently, heterozygous progeny were backcrossed to 
C57BL/6 mice. Using both WT and GAD67-GFP mice, GABAAR alpha1 
immunoreactive signal was localised to three neurochemically diverse cell types 
within the DRN (Fig. 3.3A,B); i) a sub-population of TPH-immunopositive 
neurons which displayed diffuse GABAAR alpha1 subunit signal on their 
somata, ii) all GFP immunopositive neurons and iii) a population of DRN 
neuron, immunonegative for both TPH and GAD67-GFP.  
 
Double labelling with gephyrin revealed extensive co-localisation between 
gephyrin signal and GABAAR alpha1 subunit immunoreactive puncta (Fig. 
3.3A3). Gephyrin signal was predominantly enriched on dendritic domains apart 
from a subpopulation of GAD67-GFP labelled non-TPH neurons situated within 
the ventral DRN which exhibited uncharacteristically intense somatic gephyrin 
signal (Fig. 3.3C3). This could suggest the presence of at least two sub-
populations of GABAergic neurons within the DRN; i) one sub-population which 
possesses lower levels of synaptically localised alpha1 subunit containing 
GABAARs on their somata and; ii) a second sub-population which possess 
higher levels of synaptically localised alpha1 containing GABAARs on their 
somata. The predominance of GABAAR alpha1 subunit signal on most of the 
non-TPH immunopositive neurons suggests that GABAARs containing this 
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subunit will have a major influence on the excitability and function of the cell-
types which are thought to provide local circuit inhibition on to the principal 
serotonergic neurons of the DRN. Therefore, while GABAAR alpha1 subunit-
containing receptors are not widely expressed on serotonin neurons, their 
modulation, for example with ingested subunit-specific ligands, could have a 
profound impact upon brain serotonin levels simply by altering DRN network 
activity. 
 
Figure 3.2 
138 
 
Confirmation of the specificity of the GABAAR alpha1 subunit antibody in the 
DRN of WT and GABAAR alpha1 subunit-specific gene-deleted (alpha1-KO) 
mouse processed and imaged under identical condition 
(A1) an overview of TPH immunoreactivity used to identify serotonin neurons 
within the DRN. (A2) an overview of the pattern of GABAAR alpha1 subunit 
immunoreactivity in the DRN of WT tissue showing extensive signal throughout 
most of the DRN sub-nuclei. (B1) an overview of TPH immunoreactivity in the 
DRN of an alpha1-KO mouse. Note that there is no detectable differences in the 
level of TPH signal in the DRN of WT and alpha1-KO mice (B2) shows that no 
specific GABAAR alpha1 subunit immunoreactivity was detectable in tissue from 
alpha1-KO mouse. Scale bar 200 μm. 
 
 
Figure 2.3 
Immunolocalisation of the GABAAR alpha1 subunit in neurochemically diverse 
cell-types of the DRN   
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(A1 - A4) the GABAAR alpha1 subunit is widely expressed throughout the DRN. 
(A1) the majority of the GABAAR alpha1 signal was co-localised with the 
structural protein microtubule associated protein 2 (MAP2). (A2) numerous 
MAP2 immunolabelled dendrites which, although TPH- immunonegative, were 
widely distributed amongst TPH-labelled profiles. (A3) an overlay which 
illustrates the abundance of GABAAR alpha1 subunit immunopositive profiles 
within the DRN suggesting that such non-serotonergic cells comprise a 
significant proportion of the neurons composing the DRN. (B) the GABAAR 
alpha1 subunit is expressed by (B1) a sub-population of TPH immunopositive 
cells (#), (B2) non-TPH, GAD67-GFP immunopositive cells (*) and (B1 & 2) a 
discrete population of cells not labelled by either TPH or GAD67-GFP (+). (B3) 
throughout the DRN, gephyrin immunoreactive puncta decorate predominantly 
GABAAR alpha1 immunopositive dendrites rather than somata, apart from (C1 
and C4) which show a sub-population of GAD67-GFP, GABAAR alpha1 subunit 
labelled neurons located towards the ventral extent of the DRN have gephyrin 
immunoreactivity enriched within their somata and proximal dendrites. All 
gephyrin signal on GABAAR alpha1 subunit immunoreactive profiles co-
localised with alpha1 subunit immunoreactivity. Note that a proportion of 
GABAAR alpha1 subunit immunoreactivity is not co-localised with gephyrin 
which could represent extrasynaptically located alpha1 subunit containing 
GABAAR subtypes. Scale bar 10μm. 
 
We quantified the ratio of TPH and GABAAR alpha1 subunit immunopositive 
cells in two mice from sections sampled from the rostral, midline and caudal 
extents of the DRN (Fig. 3.4). TPH and GABAAR alpha1 subunit 
immunopositive cells were enriched at the rostral extent of the DRN, with 29% 
of TPH labelled cells in rostral DRN also displaying GABAAR alpha1 subunit 
signal (average of 31 GABAAR alpha1 labelled cells out of 106 TPH labelled 
cells). The proportion of TPH labelled cells also displaying GABAAR alpha1 
subunit signal decreased from rostral to caudal planes. Although midline DRN 
has the majority of TPH immunopositive cells, only 7% of TPH labelled cells 
were also labelled with GABAAR alpha1 subunit signal (average of 51 GABAAR 
alpha1 labelled cells out of 681 TPH labelled cells). TPH and GABAAR alpha1 
subunit immunopositive cells were least abundant in caudal DRN, with only 3% 
of TPH labelled cells also displaying immunoreactivity for the GABAAR alpha1 
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subunit (average of 5 GABAAR alpha1 labelled cells out of 176 TPH labelled 
cells).  
 
Previous anatomical studies have shown that DRN neurons are topographically 
organised within the nucleus according to their efferent input and afferent 
output. Therefore, we also quantified the ratio of TPH and GABAAR alpha1 
subunit immunopositive cells within the different sub-regions of rostral, midline 
and caudal DRN. Within the rostral DRN, TPH and GABAAR alpha1 subunit 
immunopositive cells were enriched in dorsal and ventral DRN, with 38% of 
TPH immunopositive cells in dorsal DRN also displaying GABAAR alpha1 
subunit signal (average of 9 GABAAR alpha1 labelled cells out of 24 TPH 
labelled cells), and 33% of TPH immunopositive cells in ventral DRN also 
displaying GABAAR alpha1 subunit signal (average of 4 GABAAR alpha1 
labelled cells out of 12 TPH labelled cells). However, TPH and GABAAR alpha1 
subunit immunopositive cells were less abundant in the medial interfasicular 
layer DRN, with 27% of TPH immunopositive cells also displaying GABAAR 
alpha1 subunit signal (average of 19 GABAAR alpha1 subunit labelled cells out 
of 70 TPH labelled cells).  
 
Within midline of the DRN, TPH and GABAAR alpha1 subunit immunopositive 
cells were enriched within the dorsal sub-region, with 15% of TPH 
immunopositive cells also displaying GABAAR alpha1 subunit signal (average of 
34 GABAAR alpha1 labelled cells out of 233 TPH labelled cells). Whereas, in 
the lateral wings of the DRN, 6% of TPH immunopositive cells displayed 
GABAAR alpha1 subunit signal (average of 11 GABAAR alpha1 labelled cells out 
of 194 TPH labelled cells). TPH and GABAAR alpha1 subunit immunopositive 
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cells were least abundant in ventral and medial interfasicular layer DRN sub-
regions, with only 4% (average of 6 GABAAR alpha1 labelled cells out of 166 
TPH immunopositive cells) and 1% (average of 1 GABAAR alpha1 labelled cells 
out of 89 TPH immunopositive cells), respectively.  
 
Within caudal DRN, GABAAR alpha1 subunit labelled TPH immunopositive cells 
were relatively scarce, with no evidence of GABAAR alpha1 subunit signal on 
dorsally situated TPH labelled cells (0 GABAAR alpha1 subunit labelled cells out 
of 121 TPH labelled cells) and with only 9% of TPH immunopositive cells also 
displaying GABAAR alpha1 subunit signal in ventral DRN (average of 5 
GABAAR alpha1 labelled cells out of 54 TPH labelled cells). Taken together, it 
appears that these serotonergic GABAAR alpha1 immunopositive cells have a 
highly specific distribution pattern within the DRN with the highest proportion of 
GABAAR alpha1 TPH immunolabelled cells situated in the dorsal sub-division of 
rostral DRN and the lowest proportion situated in caudal DRN. Considering the 
extensive topographical organisation of the DRN in terms of its efferent output, 
with different sub-division of the DRN projecting to disparate brain regions, the 
distribution pattern of the GABAAR alpha1 subunit signal on TPH 
immunopositive neurons could have a major influence over DRN-serotonin 
mediated regulation of specific brain regions. 
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Figure 3.4 
GABAAR alpha1 subunit-immunopositive TPH labelled cells are differentially 
distributed throughout the rostra-caudal and ventro-medial extents of the DRN.  
(A) the proportion of alpha1 subunit-TPH immunopositive cells decreases with 
increasing distance from the rostral to caudal extents of the nucleus, with the 
highest proportion (25%) of such neurons located in the rostral DRN. (B) DRN 
subdivisions of a section located at the rostral-caudal midline of the DRN. The 
proportion of alpha1 subunit-TPH immunopositive cells was quantified within 
DRN subdivisions: dorsal (dDRN), ventral (vDRN), lateral wings (lwDRN) and 
medial interfacsicular region (mifDRN). (C) graphical representation of the 
differential distribution of alpha1 subunit-TPH immunopositive neurons across 
DRN subdivision and the rostral-caudal axis. Alpha1 subunit-TPH 
immunopositive neurons were particularly enriched in dorsal and ventral DRN. 
Taken together, the data show that alpha1 subunit-TPH immunopositive cells 
are preferentially located dorsally, towards the rostral extent of the DRN. Scale 
bar (B) 200 μm 
 
3.4.3. The GABAAR alpha2 subunit immunoreactivity co-localises with 
inhibitory synaptic markers predominantly on the dendrites of 
serotonin neurons  
 
The specificity of the GABAAR alpha2 subunit antibody was confirmed in tissue 
sections containing the DRN obtained from WT and GABAAR alpha2 subunit 
gene-deleted mice (GABAAR alpha2-KO) (Fig. 3.5). In contrast with the 
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continuous immunoreactive pattern of the GABAAR alpha1 subunit, 
immunoreactivity for the GABAAR alpha2 subunit was wholly punctate. Most of 
the immunoreactive puncta were associated with TPH immunopositive neurons 
and was particularly enriched on TPH immunolabelled dendrites, with fewer 
puncta localised to the cell bodies (Fig. 3.6A2). Qualitatively, immunoreactivity 
of the GABAAR alpha2 subunit exhibited the highest degree of co-localisation 
with NLG2 out of all subunits examined. To confirm this we performed triple 
immunofluorescence with antibodies raised against TPH, GABAAR alpha2 
subunit and NLG2 and quantified the number of GABAAR alpha2 subunit 
immunoreactive puncta which co-localised with NLG2 immunoreactive puncta 
on TPH-immunopositive profiles. TPH immunopositive cells and their dendrites 
are most abundant in the ventral DRN sub-division. As we have previously 
shown that the pattern of inhibitory innervation is most enriched at the dendritic 
domains, quantification was carried out within the ventral DRN sub-division of 
coronal sections located at the rostral-caudal midline from two animals. The 
mean density (number of clusters per 1000 µm2 ± SD) of NLG2 immunoreactive 
clusters located on TPH immunopositive profiles was 50 ± 7 of which 22 ± 7 
were co-localised with GABAAR alpha2 subunit immunoreactive puncta.  This 
indicates that ~ 45% of inhibitory synapses on TPH immunopositive neurons 
express alpha2-subunit-containing GABAARs suggesting that close to half of the 
fast, phasic synaptic currents onto the principal serotonergic neurons of the 
DRN are likely to be mediated by alpha2 subunit containing GABAAR subtypes.  
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Figure 3.5 
Confirmation of the specificity of the GABAAR alpha2 subunit antibody in the 
DRN of WT and GABAAR alpha2 subunit-specific gene-deleted (alpha2-KO) 
mouse processed and imaged under identical conditions  
(A1) localisation of neuroligin2 (NLG2) on tryptophan hydroxylase (TPH) 
immunoreactive profiles of the DRN indicating the distribution of inhibitory 
synapses on serotonergic processes within the DRN of WT mouse. (A2) shows 
the pattern of GABAAR alpha2 subunit immunoreactivity in the same field of 
view. Note that the signal is preferentially associated with TPH-immunopositive 
profiles suggesting that, within the DRN, the GABAAR alpha2 subunit appears 
exclusively expressed on serotonergic cells. (B1) shows the distribution and 
intensity of TPH and NLG2 immunoreactivity in the DRN of an alpha2-KO 
mouse. There were no discernible differences in the TPH-immunopositive 
profiles compared to WT mice (B2) shows that no specific GABAAR alpha2 
subunit immunoreactivity was detectable in tissue from alpha-KO mouse.  Scale 
bar 10 μm. 
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Figure legend overleaf 
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Figure 3.6 
Immunolocalisation of the GABAAR alpha2 subunit in the DRN  
(A1) shows an overview of NLG2 immunoreactivity in the DRN indicating the 
distribution of putative inhibitory synapses. (A2) shows an overview of GABAAR 
alpha2 subunit immunoreactivity. Note how the immunoreactive clusters are 
uniformly sized and largely associated with the dendrites of TPH 
immunopositive cells with only dispersed clusters evident on TPH 
immunopositive somata.  (A3) an overlay of (A1 and A2) indicating the 
extensive co-localisation of GABAAR alpha2 puncta with those of NLG2. (B) 
magnified views of the boxed regions in (A). The arrowheads point to (B1) 
NLG2 immunopositive clusters and (B2) GABAAR alpha2 subunit 
immunopositive clusters which co-localise. Note that a number of NLG2 
immunopositive puncta do not co-localise with GABAAR alpha2-immunoreactive 
puncta (arrows). These are likely to represent synaptically located GABAAR 
subtypes containing other GABAAR alpha subunits, most probably the alpha3 
subunit (see Figure 3.8). Scale bar (A) 10 μm, (B) 5 μm. 
 
3.4.4. The GABAAR alpha3 subunit is expressed on serotonergic and 
GABAergic neurons of the DRN 
 
The specificity of the GABAAR alpha3 subunit antibody was confirmed in tissue 
sections containing the DRN obtained from WT and GABAAR alpha3 subunit 
gene-deleted mice (GABAAR alpha3-KO) (Fig. 3.7). GABAAR alpha3 subunit 
immunolabelling was able to delineate the TPH immunopositive cells of the 
DRN and appeared most abundant within the ventral DRN sub-division, 
possibly due to the high density of TPH-immunopositive dendrites located in 
ventral DRN. The signal appeared punctate and predominantly decorated TPH-
immunopositive dendrites, with few puncta evident on somatic domains (Fig. 
3.8A). In contrast to the GABAAR alpha2 subunit immunoreactive puncta which 
were uniformly sized, the GABAAR alpha3 subunit immunopositive puncta were 
more variable in both size and shape. Compared with the GABAAR alpha2 
signal, fewer NLG2 immunoreactive puncta appeared to co-localise with 
GABAAR alpha3. To confirm this we performed triple immunofluorescence for 
TPH, GABAAR alpha3 and NLG2 and quantified the proportion of NLG2 puncta 
which co-localised with GABAAR alpha3 puncta on TPH-immunopositive 
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profiles. The quantification was performed as for the GABAAR alpha2 subunit 
above. The mean density (number of clusters per 1000 µm2 ± SD) of NLG2 
immunoreactive clusters located on TPH immunopositive profiles was   42 ± 14 
of which 15 ± 1 were co-localised with GABAAR alpha3 subunit immunoreactive 
puncta. This computes to ~ 35% of inhibitory synapses on serotonergic neurons 
expressing alpha3-subunit-containing GABAARs. A sizeable proportion of 
GABAAR alpha3 subunit immunopositive puncta did not appear to co-localise 
with NLG2. This could denote the presence of extrasynaptically located alpha3 
containing GABAAR subtypes on the serotonergic neurons of the DRN. As the 
enrichment of GABAAR alpha3 receptor expression in monoaminergic brain 
centres including the DRN has been extensively reported upon, and in light of 
our finding, that the alpha2 subunit is the most abundant synaptically located 
alpha subunit at inhibitory synapses on TPH-immunopositive profiles, we used 
the thalamic reticular nucleus (nRT) to validate the GABAAR alpha3 antibody 
labelling under identical experimental conditions since this brain region, in 
adulthood, exclusively expresses the GABAAR alpha3 subunit which are located 
within inhibitory synapses (Fritschy, 1998, Browne et al., 2001, Studer et al., 
2006) (Fig. 3.8B). As expected, large GABAAR alpha3 subunit immunoreactive 
puncta decorated parvalbumin positive profiles of the nRT and displayed 
complete co-localisation with NLG2 (Fig. 3.8B3). This disparate 
immunolocalisation pattern of the GABAAR alpha3 subunit across different brain 
regions provides evidence for a brain region and cell-type specific expression 
profile of the GABAAR alpha3 subunit. Within the DRN, we also observed a 
proportion of GABAAR alpha3 subunit which was not associated with TPH 
immunopositive profiles. In order to identify which non-serotonergic cell types 
express the GABAAR alpha3 subunit in the DRN, we again used the GAD67-
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GFP mouse model and performed quadruple immunofluorescence for TPH, the 
GABAAR alpha1 subunit, the GABAAR alpha3 subunit and GFP (Fig. 3.8C). 
Consistent with what we have shown, the GABAAR alpha3 subunit 
immunoreactive puncta is predominantly localised to TPH immunopositive 
profiles in the DRN. However, sparse discrete GABAAR alpha3 subunit puncta 
co-localised with GABAAR alpha1 subunit puncta on non-serotonergic profiles in 
the DRN. GABAAR alpha3 subunit immunoreactivity was localised to GAD67-
GFP somata and GABAAR alpha1 subunit labelled dendrites. At least a 
proportion of GABAAR alpha3 subunit immunopositive non-serotonergic 
neurons were GABAergic. However, because GAD67-GFP immunoreactivity 
does not appear to label distal dendrites of GABAergic neurons of the DRN, we 
cannot rule out the possibility it that a third, non-serotonergic, non-GABAergic, 
cell type in the DRN also expresses the GABAAR alpha3 subunit. This 
expression of the GABAAR alpha3 subunit in GABAergic neurons which we 
have shown to also express the GABAAR alpha1 subunit, suggests that these 
subunits could possibly be assembly partners for specific GABAAR subtypes 
within some cell-types of the DRN. Co-assembly of different GABAAR subunits 
is often inferred by changes in the levels of putative partner subunits following 
the constitutive deletion of a particular subunit (Peng et al., 2002). To explore a 
possible association between the expression of the GABAAR alpha1 and 3 
subunits, we investigated the levels of GABAAR alpha3 subunit 
immunoreactivity in tissue from GABAAR alpha1-KO mice. We noticed a striking 
increase in the intensity of GABAAR alpha3 subunit immunoreactivity in the 
DRN, on both TPH immunopositive and immunonegative profiles, of GABAAR 
alpha1-KO mice (Fig. 3.9).  
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Based on the expression patterns revealed by immunohistochemistry, GABAAR 
subtypes containing the alpha3 subunit could have a major role in GABAAR 
mediated inhibition of the serotonergic neurons of the DRN, and possibly 
participate in non-synaptic GABAergic neurotransmission. Moreover, alpha3 
subunit-containing GABAAR subtypes may have a comparatively smaller role in 
GABAAR mediated inhibition of the GABAergic neurons of the DRN, but may 
cluster with alpha1 containing GABAAR subtypes in overlapping synaptic 
populations. The striking compensatory changes in GABAAR alpha3 subunit 
expression in the DRN of GABAAR apha1 subunit deleted mice highlight the 
importance of the GABAAR alpha1 subunit within DRN circuitry. 
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Figure 3.7 
Confirmation of the specificity of the GABAAR alpha3 subunit antibody in the 
DRN of WT and GABAAR alpha3 subunit-specific gene-deleted (alpha3-KO) 
mouse processed and imaged under identical conditions.  
(A1) shows a low magnification overview of TPH and GABAAR alpha3 subunit 
immunoreactivity within the DRN of WT mouse. (A2) an overview of the pattern 
of TPH and GABAAR alpha3 subunit immunoreactivity in the DRN of an alpha3-
KO mouse showing the complete lack of any specific signal for this subunit. 
Note that there were no detectable differences in the level of TPH signal in the 
DRN of WT and alpha3-KO mice. (B1) and (B2) are magnified view of (A1) and 
(A2) respectively indicating only non-specific GABAAR alpha3 subunit signal in 
alpha3-KO tissue. (C) further confirmation of the specificity of the GABAAR 
alpha3 subunit immunoreactivity was obtained by in a brain region known to be 
enriched in this subunit, namely the reticular nucleus of the thalamus (nRT). 
(C2) no GABAAR alpha3 subunit immunoreactivity was evident in this brain 
region of alpha3-KO mice. Scale bars (A) 200 μm, (B) 10 μm, (C) 500 μm. 
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Figure 3.8 
Distribution of GABAAR alpha3 subunit immunoreactivity in the DRN  
(A1) NLG2 immunoreactivity, as shown in previous figures, was preferentially 
located on TPH immunopositive dendrites. (A2) GABAAR alpha3-
immunoreactivity was localised to the somata but mainly dendrites of TPH-
immunopositive profiles. GABAAR alpha3-immunopositive puncta were more 
variable in both size and shape when compared with those of the GABAAR 
alpha2 subunit. (A3) a minority of NLG2 immunoreactive puncta was present on 
TPH immunopositive profiles co-localised with GABAAR alpha3 subunit puncta 
(arrowheads). A number of NLG2-immunoreactive puncta did not co-localise 
with GABAAR alpha3 immunoreactivity (arrows). These could represent 
synapses which contain additional GABAAR alpha subunits, such as the alpha2 
subunit (see Figure 6). A proportion of GABAAR alpha3 subunit immunopositive 
puncta did not co-localise with NLG2 which could be indicative of non-
synaptically located alpha3 containing GABAAR subtypes in the DRN. (B1-3) 
shows the distribution of GABAAR alpha3 subunit immunoreactivity in the 
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thalamic reticular nucleus (nRT). (B1) NLG2 immunoreactive puncta decorated 
parvalbumin labelled processes within the nRT. (B2) GABAAR alpha3 subunit 
immunoreactivity presented as large distinct puncta associated with 
parvalbumin immunopositive positive profiles. (B3) GABAAR alpha3 subunit 
immunoreactive puncta displayed complete co-localisation with NLG2 
immunoreactivity within the nRT. (C1-4) Sparse, discrete GABAAR alpha3 
subunit immunopositive puncta decorated non-serotonergic, GABAAR alpha1 
subunit immunopositive profiles in the DRN. (C1) GABAAR alpha3 
immunoreactive puncta are enriched on serotonergic profiles (arrowheads). 
However, a proportion of GABAAR alpha3 immunoreactive puncta were not 
associated with TPH immunopositive profiles (arrows). (C2) These GABAAR 
alpha3 puncta were found to co-localise with GABAAR alpha1 immunopositive 
signal on non-serotonergic cell types of the DRN. (C3) some of these GABAAR 
alpha3 immunopositive non-serotonergic neurons were GABAergic, Scale bar 
10μm. 
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Figure 3.9 
The constitutive brain-wide deletion of the GABAAR alpha1 subunit increases 
GABAAR alpha3 subunit expression in the DRN  
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(A1, B1) no discernible differences were evident in the intensity of gephyrin 
immunoreactivity in the DRN of WT and alpha1-KO mice. (A2, B2) the deletion 
of the alpha1 subunit results in a dramatic up-regulation in the intensity of 
GABAAR alpha3 subunit immunoreactivity on both TPH immunopositive and 
immunonegative profiles. The inset box shows dense alpha3 subunit 
immunoreactivity outlining the membrane of a non-TPH labelled cell in the DRN, 
reminiscent of GABAAR alpha1 subunit-immunopositive neurons shown in 
Figure 3.3B. There was no evidence of such GABAAR alpha3 subunit-enriched 
cells in DRN tissue from WT mice. (A3, B3) An overlay shows gephyrin 
immunoreactive puncta co-localised with GABAAR alpha3 subunit puncta on 
TPH and non-TPH labelled profiles. 
 
3.4.5. The GABAAR gamma2 subunit is enriched on non-serotonergic 
neurons 
 
Gamma2 subunit-containing GABAARs are the most abundantly expressed 
subtypes throughout the brain (Sieghart, 2006). Furthermore, the GABAAR 
gamma2 subunit is required for the incorporation of GABAARs into synapses 
(Essrich et al., 1998) as well as the pharmacological effect of benzodiazepines 
(Rudolph et al., 1999, Gunther et al., 1995), Importantly, mouse models with 
lower levels of GABAAR gamma2 subunit expression showed heightened levels 
of anxiety (Crestani et al., 1999) . As such, this subunit within the DRN is likely 
to occupy a central role in DRN-serotonin function. Either of the alpha 1, 2, 3 
and 5 subunits are the obligatory assembly partners of gamma2 subunits 
(Sieghart, 2006) and the alpha subunit co-assembled with the gamma2 subunit 
determines the pharmacological profile of benzodiazepines (Rudolph et al., 
1999). We thus investigated the comparative expression of the GABAAR 
gamma2 subunit with the alpha1, alpha2 and alpha3 subunits on 
neurochemically diverse cell types of the DRN since the alpha5 subunit is not 
expressed in the DRN. GAD67-GFP immunopositive neurons are distributed 
throughout the DRN and at least a proportion of these cells act as local 
GABAergic interneurons which serve to regulate the excitability of serotonergic 
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neurons. These, non-serotonergic cell types exhibited the highest levels of 
GABAAR gamma2 subunit immunoreactivity (Fig. 3.10A2). GABAAR gamma2 
subunit signal was localised to somatic and dendritic compartments on these 
putative GABAergic neurons. In line with previous data (see Fig. 3.3), 
immunoreactivity for the GABAAR alpha1 subunit outlined the somata and 
dendrites of GAD67-GFP immunopositive neurons, as well as non-TPH non-
GAD67-GFP labelled neurons. We observed widespread co-localisation 
between the GABAAR alpha1 subunit signal and gamma2 signal on non-TPH 
neurons. This could suggest that GABAARs containing the alpha1 subunit are 
clustered with GABAARs containing the gamma2 subunit at overlapping 
synaptic populations on the non-serotonergic neurons of the DRN. Alternatively, 
the alpha1 and gamma2 subunits may co-assemble within the same GABAAR 
subtype. In contrast to the GABAAR gamma2 signal on non-TPH 
immunopositive profiles, GABAAR gamma2 signal was sparse and with discrete 
puncta on TPH-immunopositive profiles. There appeared to be a much lower 
degree of co-localisation between the GABAAR gamma2 subunit signal with 
alpha2 and alpha3 subunit signal. These data could suggest that GABAARs 
containing the gamma2 subunit could preferentially occupy a larger role in 
mediating the effects of GABA released directly onto non-serotonergic 
interneurons within the DRN while having a lesser role in terms of GABA 
released onto the principal serotonergic neurons. However, such receptor 
subtypes are still likely to influence serotonin neuronal excitability and release 
(see discussion).  
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Figure 3.10 
The association between the expression of the GABAAR gamma2 subunit with 
that of the alpha1, 2 and 3 subunits in the DRN  
(A) in the DRN, the majority of the GABAAR gamma2 subunit immunoreactivity 
is contained on GABAAR alpha1 subunit GAD67-GFP-immunopositive neurons. 
(A1) non-TPH labelled GFP-immunopositive cells are distributed throughout the 
DRN and represent populations of local-circuit inhibitory interneurons. (A2) 
these GAD67-GFP-immunopositive neurons exhibited strong immunoreactivity 
for the GABAAR gamma2 subunit which was localised to their somatic and 
dendritic compartments. (A3) consistent with what we have shown previously 
within the DRN (see Figure 3.2), GABAAR alpha1 subunit immunoreactivity was 
localised to the somatic and dendritic domains of these GAD67-GFP-
immunopositive neurons. (A4) we observe widespread co-localisation between 
GABAAR gamma2 subunit and GABAAR alpha1 subunit immunoreactive 
clusters within the DRN. The insert is a magnified view of a GAD67-GFP 
immunopositive neuron (*) and highlights the high degree of co-localisation 
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between GABAAR gamma2 and GABAAR alpha1 subunit immunoreactive 
clusters on a GAD67-GFP positive cell. (B-C) a proportion of GABAAR gamma2 
subunit immunopositive puncta co-localised with GABAAR alpha2 subunit and 
GABAAR alpha3 subunit puncta on TPH immunopositive profiles. (B1) and (C1) 
show GABAAR gamma2 subunit immunoreactive puncta on the somatic and 
dendritic compartments, but enriched on the dendritic domains of TPH 
immunopositive and TPH immunonegative profiles (arrows). (B2, C2) shows 
GABAAR alpha2 and alpha3 subunit immunoreactivity decorating the dendritic 
and somatic domains of TPH immunopositive profiles with a notable enrichment 
on dendritic compartments. Note that a number of GABAAR gamma2 subunit 
puncta are not associated with TPH immunoreactive profiles; these are likely to 
represent the GABAAR gamma2 subunit puncta associated with non-TPH 
GABAAR alpha1 subunit immunoreactive profiles. (B3, C3) GABAAR gamma2 
subunit immunoreactive puncta displayed minimal co-localisation with GABAAR 
alpha2 and alpha3 subunit immunoreactive puncta. A magnified view of the 
boxed area highlights the sparse co-localisation of GABAAR gamma2 subunit 
immunoreactive puncta with GABAAR alpha2 and with alpha3 immunoreactive 
puncta (arrowheads). Scale bars 10μm. 
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3.5. Discussion 
 
In this chapter, it is demonstrated that four major GABAAR subunits are 
expressed within the DRN and that their location of expression is region, cell-
type and domain specific. Expression of the GABAAR alpha1 subunit 
predominated in non-serotonergic neurons of the DRN with only a minor, 
topographically located proportion of serotonergic neurons being 
immunopositive. In contrast, the pattern of GABAAR alpha2 and GABAAR 
alpha3 subunit immunoreactivity indicated these to be the predominant alpha 
subunits which compose GABAARs on the principal serotonergic neurons. 
However, their disparate targeting to cell surfaces occupied by inhibitory 
synaptic markers suggests that they are likely to make varying contributions to 
synaptic and extrasynaptically-mediated GABAergic currents. Finally, the 
GABAAR gamma2 subunit was predominantly expressed by the non-
serotonergic neurons of the DRN indicating that, within the DRN, the site of 
action of ligands which gate GABAARs receptors such as benzodiazepines is 
likely to be GABAergic neurons rather than serotonergic neurons themselves. 
This could manifest in complex changes in serotonin release. Collectively, these 
data demonstrate the rich molecular repertoire of the GABAAR apparatus within 
the neurochemically and functionally diverse cell-types of the DRN. The 
prediction is that the unique patterns of inhibitory transmission arising from 
these complex GABAAR expression patterns are essential for the coordination 
of network activity within the DRN and the eventual brain-wide release of 
serotonin.  
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3.5.1. The functional consequences of GABAAR alpha1 subunit 
expression by DRN GABAergic neurons  
 
Native GABAAR subtypes comprised of the alpha1 subunit along with the beta 
and gamma2 subunits represent the most widely expressed GABAAR subtype 
throughout the brain (Benke et al., 1994, Benke et al., 2004). Drugs which 
selectively target alpha1 subunit containing GABAARs such as zolpidem have 
hypnotic properties (Crestani et al., 2000). This widespread expression profile 
and signature pharmacological profile distinguishes the GABAAR alpha1 subunit 
in GABAAR-mediated inhibition in the CNS. Although the GABAAR alpha1 
subunit is distributed throughout the brain (Pirker, 2000), its expression within 
particular regions is cell-type specific. In the current study, GABAAR alpha1 
subunit immunoreactivity was predominantly localised to non-serotonergic, 
GABAergic neurons of the DRN. This is particularly pertinent in the context of 
GABAAR-mediated inhibition of monoaminergic brain regions where the 
principal cells do not express the GABAAR alpha1 subunit (Gao et al., 1993, 
Corteen et al., 2011). A caveat to this is the select population of GABAAR 
alpha1 subunit-serotonin expressing neurons characterised in this study as 
discussed below.  
 
In Chapter 2 of this thesis, it was demonstrated that the GABAAR alpha1 
subunit is exclusively expressed by the non-principal, non-noradrenergic 
neurons of the LC (Corteen et al., 2011). Using the GAD67-GFP knock-in 
mouse, all GABAergic neurons within the DRN appeared to express the 
GABAAR alpha1 subunit. A proportion of these neurons may well be GABAergic 
projection neurons which have recently been shown to be present throughout 
the DRN (Bang and Commons, 2012). A further sub-population of these alpha1 
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subunit-GABAergic neurons within the DRN is likely to be local circuit 
interneurons (Qing-Ping et al., 1992, Gervasoni et al., 2000, Challis et al., 
2013). This near selective expression of the alpha1 subunit on non-principal 
neurons of the DRN and other monoaminergic brain regions is in contrast to the 
expression patterns of this subunit in cortical brain regions where both 
interneurons and principal cells express the GABAAR alpha1 subunit (Gao and 
Fritschy, 1994, Kasugai et al., 2010). Notably, within such cortical regions, the 
GABAAR alpha1 subunit expression is more enriched on the GABAergic 
interneurons, compared with the pyramidal cells suggesting that the cell type 
specific expression profiles of alpha1 containing GABAARs is essential for 
coordinated activity of neuronal assemblies. The functional consequences of 
such expression profiles on neuronal excitability are, in part, a result of the 
divergent kinetics displayed by different GABAAR subtypes. GABAAR alpha1 
containing receptors have fast kinetics; this is due to their high affinity for GABA 
(Böhme et al., 2004), high activation rate (Gingrich et al., 1995) and rapid 
desensitisation (Tia et al., 1996). In the hippocampus, there appears to be a 
correlation between the kinetics of inhibitory post-synaptic currents (IPSCs) and 
the firing characteristics of interneuron sub-groups. For example, fast spiking 
parvalbumin immunopositive basket cells are enriched with the GABAAR alpha1 
subunit, whereas slower firing parvalbumin immunopositive axo-axonic cells 
express lower levels of the GABAAR alpha1 subunit along their dendritic profiles 
(Baude et al., 2007). Thus, the differential expression of GABAAR subunits may 
contribute to the considerable functional diversity displayed by the interneurons 
which comprise cortical networks. Future studies should focus on determining 
whether there are variations in the levels of expression of the GABAAR alpha1 
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subunit within GABAergic neurons of the DRN as this might help to identify 
functionally distinct sub-classes of such neuron. 
 
Interneuron diversity has evolved to shape the activity patterns of neurons 
within a network. These activity patterns give rise to different types of 
oscillations which represent different brain states and behaviours. For example, 
theta oscillations (4-8 Hz) are associated with exploratory behaviour. The 
presence of fast GABAergic neurotransmission conferred by the expression of 
alpha1 subunit containing GABAARs may be a contributing factor in allowing 
neuronal firing to be constrained within strict temporal windows, such as that 
required for the generation of rhythmic oscillations. Indeed, different interneuron 
sub-populations fire during different phases of theta oscillations (Klausberger 
and Somogyi, 2008). Parvalbumin positive basket cells fire on the descending 
phase of the theta oscillation whereas parvalbumin positive axo-axonic cells fire 
just after the peak of the theta oscillation (Klausberger et al., 2003). These 
examples illustrate how the cell-type expression profiles of the GABAAR 
subunits can contribute to the development of synchronous network activity. 
The breadth of anatomical and neurochemical research of cortical regions has 
enabled investigation of cortical network dynamics. In contrast, the 
neuroanatomy of sub-cortical regions, particularly brainstem regions like the 
DRN and LC is less known, and so knowledge of the contribution of functionally 
and neurochemically distinct sub-populations of neurons to DRN and LC 
networks lags behind that of the cortex. What is known is that neurochemically 
distinct neuron types within the DRN appear to obey similar roles in terms of 
their entrainment to cortical network activity. DRN serotonergic principal 
neurons generally exhibited higher discharge rates in the inactive phase of 
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cortical slow waves while non-serotonergic neurons exhibited a higher 
discharge rate during the active component of cortical slow waves (Schweimer 
et al., 2011).  
 
While most of the GABAAR alpha1 subunit expression is not on the principal 
cells of the DRN, the sheer density of expression of this subunit within this brain 
region indicates a prominent role in regulating DRN activity and thus serotonin 
release. To interpret the functional significance of such expression, it should 
also be borne in mind that the GABAAR alpha1 subunit expression was not 
restricted to the non-serotonergic cell types of the DRN, but also by a discrete 
sub-population of serotonergic DRN neurons. This is in contrast to our findings 
for the LC where none of the principal neurons expressed the GABAAR alpha1 
subunit. These GABAAR alpha1 expressing DRN serotonergic neurons were not 
randomly distributed throughout the nucleus, but rather restricted to specific 
DRN sub-regions, and particularly enriched dorsally within rostral DRN. The 
presence of the GABAAR alpha1 subunit on specific subpopulations of 
serotonergic neuron may endow those neurons with unique functional 
characteristics. Generally activation of the LC results in increased noradrenaline 
release in LC targets, but the same is not true of the DRN. Taking the influence 
of stress as an example, the LC and DRN are both regions which modulate the 
stress response. Stress increases noradrenaline release in LC target fields 
(Korf et al., 1973, Kawahara et al., 2000), but the effects of stress on DRN 
activity and consequent serotonin release are dependent on the type of stressor 
and the brain region (Kirby et al., 1995, Kirby et al., 1997, Adell et al., 1997). 
The expression of the GABAAR alpha1 subunit by a select population of DRN 
serotonergic neurons could be a potential mechanism through which DRN 
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serotonin release is regulated in a brain region specific manner. The current 
study showed that 25% of DRN serotonergic cells expressed the GABAAR 
alpha1 subunit. This is at odds with the only previous report on the cell-type 
specific expression profile of the GABAAR alpha1 subunit in the DRN, in which it 
was reported that only 2% of DRN serotonergic neurons co-expressed the 
GABAAR alpha1 subunit (Gao et al., 1993). A possible explanation for this 
disparity could be due to species difference (rat versus mouse), different 
antibodies used or differences in the method of quantification. Gao et al. (1993) 
reportedly analysed GABAAR alpha1 subunit expression in a sample of 50-100 
serotonergic neurons per DRN. However, this current study indicates that the 
percentage of DRN serotonergic neurons co-expressing the GABAAR alpha1 
subunit varies dramatically along the rostral-caudal and dorso-ventral extents of 
the DRN necessitating the consideration of all sub-regions of the DRN, rather 
than isolated serotonergic neurons. 
  
This differential expression pattern of the GABAAR alpha1 subunit on putative 
interneurons and on a sub-population of principal cells could have contrasting 
implications in terms of the levels of serotonin released in the DRN terminal 
fields following the activation of these receptors. Based on these data, we 
speculate that activation of alpha1 subunit-containing GABAARs on non-
serotonergic local circuit interneurons may disinhibit the principal cells due to 
the silencing of such local inhibitory inputs leading to increased serotonin 
release. Conversely, activation of alpha1 subunit-containing GABAARs on the 
principal serotonergic neurons should decrease their neuronal activity leading to 
a decrease in serotonin release. It is likely that these two processes act in 
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concert, to finely control DRN serotonin release in a brain region specific 
manner. 
3.5.2. Alpha2 and alpha3 subunit containing GABAARs are targeted with 
varying degrees to synaptic and extrasynaptic compartments of 
DRN serotonergic neurons 
 
The overall appearance of the GABAAR alpha2 and alpha3 subunit 
immunoreactivity differed greatly to that of the alpha1 subunit. GABAAR alpha2 
and alpha3 subunit labelling was punctate and was enriched on the 
serotonergic neurons of the DRN, appearing preferentially targeted to their 
dendritic domains. Our quantitative data suggest that a majority of NLG2 
immunopositive puncta localised to serotonergic profiles co-localised with the 
alpha2 and alpha3 subunit puncta indicating that the majority of GABAergic 
postsynaptic inhibitory currents on DRN principal neurons are mediated by 
alpha2 and/or the alpha3 subunit-containing GABAARs. This is similar to the 
synaptic GABAAR subunit content on LC noradrenergic neurons (Chapter 2). 
However, the alpha3 subunit occupied a greater proportion of inhibitory 
synapses in LC noradrenergic neurons compared to DRN serotonergic neurons. 
Thus, the composite kinetics and pharmacology of GABAAR-mediated inhibition 
at the whole cell level is likely to be dissimilar in LC and DRN principal cells and 
needs to be considered when addressing the patho/physiology and 
pharmacology of brain region-dependent disorders. A further point of note was 
the proportion of GABAAR alpha3 immunoreactive puncta which did not co-
localise with NLG2, these puncta are indicative of non-synaptically located 
alpha3 containing GABAAR subtypes which predictably might mediate tonic 
GABAergic inhibition in the DRN. Although, tonic GABAergic inhibitory currents 
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on DRN serotonergic neurons have yet to be reported on, a recent study has 
provided evidence for a GABAAR alpha3 subunit mediated tonic conductance in 
the basolateral amygdala (Marowsky et al., 2012). Extrasynaptic GABAAR 
subtypes respond to low ambient concentrations of GABA and exhibit disparate 
kinetics to that of their synaptic counterparts, a function directly related to the 
subunit composition of the receptor. Tonic GABAergic currents do not occur in 
all neurons. Thus, the importance of the presence of such persistent patterns of 
inhibitory influence in particular neurons is likely to indicate the requirement for 
long-term (compared to short phasic periods) modulation of neuronal activity. 
This pattern of sustained inhibitory regulation of neuronal activity is particular 
resonant for diffuse modulatory systems such as serotonergic pathways which 
provide brain-wide release of their neurotransmitters during the processing of 
on-going sensory stimuli or a specific behavioural state. One might speculate 
that tonic inhibitory current allows for the fine sculpting of the level of neuronal 
activity and thus serotonin release that results in this neurotransmitter being 
able to seamlessly modulate such diverse neural and behavioural functions. In 
turn, one might also expect that alterations in the levels of expression of such 
extrasynaptically located GABAAR subtypes will dynamically regulate serotonin 
release resulting in altered behaviours or even DRN-serotonin associated 
disorders. Thus, alterations in the molecular and functional components of DRN 
tonic inhibitory currents should become an area of focus in the study of DRN 
associated pathologies.  
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3.5.3. Gamma2 subunit containing GABAAR subtypes are enriched on 
the non-serotonergic cells of the DRN 
 
GABAAR receptors containing the gamma2 subunit are one of the most 
abundantly expressed subtypes throughout the brain. In terms of the focus of 
this work, it is important that gamma2 subunit heterozygous knockout mice 
displayed reduced GABAAR clustering and exhibited an anxiogenic-like 
behavioural phenotype (Crestani et al., 1999) . This could suggest a possible 
role for disrupted GABAAR mediated inhibition in the neurobiology of anxiety 
disorders. Indeed, anxiolytic agents such as alprazolam, belonging to the 
benzodiazepine class of drugs, potentiate GABAergic neurotransmission at 
gamma2 containing GABAAR subtypes. Importantly, such anxiolysis-inducing 
benzodiazepines preferentially act on alpha2/3 subunit containing GABAAR 
(Rudolph et al., 1999). Within the DRN, GABAAR gamma2 subunit 
immunoreactive puncta were sparsely distributed on the serotonergic principal 
cells and displayed minimal co-localisation with GABAAR alpha2 and alpha3 
puncta. If the immunolocalisation pattern of the GABAAR gamma2 subunit 
within the DRN reflects its expression profile in vivo, it is possible that within the 
DRN at least, benzodiazepines could preferentially act upon the GABAergic 
interneurons, and consequently disinhibit the principal serotonergic neurons, 
leading to increased serotonin release. Thus, based on this data, it is unlikely 
that the anxiolytic effects of benzodiazepines functions arise from direct effects 
on serotonergic neurons of the DRN. The cell-types within the DRN which did 
heavily express the GABAAR gamma2 subunit were the GABAergic neurons. 
These neurons also preferentially expressed the GABAAR alpha1 subunit. 
Benzodiazepines which show selectivity for gamma2-alpha1 subunit containing 
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receptors show hypnotic and amnesic central effects (Rudolph et al., 1999). 
Conceptually, it is difficult to dissect the hypnotic effects of GABAAR gamma2-
alpha1 activation on GABAergic interneurons within a nucleus that is part of the 
brain’s arousal systems. GABAAR gamma2-alpha1 mediated silencing of the 
cells which one expects to provide local circuit inhibition onto the principal DRN 
neurons is likely to lead to overall excitation of the DRN and thus enhanced 
serotonin release which is opposite to what one expects during hypnotic states.  
Nevertheless, this cell-type specific expression profile of the gamma2 subunit 
may have important implications for the influence of benzodiazepines on the 
neuronal networks which make up the DRN, and consequently, on serotonin 
release in DRN target fields. Brain serotonin levels are closely linked to mood, 
with alterations in DRN neuronal activity being implicated in the pathophysiology 
of neuropsychiatric disorders such as depression and anxiety. Frequently, the 
pathophysiology of neuropsychiatric disorders has been linked to reductions in 
DRN neuronal activity (Klimek et al., 1997, Gos et al., 2008). Based on this 
data, one mechanism through which benzodiazepines may exert their anxiolytic 
effects could be to increase serotonin release through disinhibition of DRN 
principal neurons.  
 
In light of the complexity of the molecular phenotypes of GABAAR subunits 
expressed on the different cell-types of the DRN, it is now imperative that the 
functional characterisation of the expression patterns is understood, requiring a 
dedicated attention at the single DRN cell, DRN network and behaving animal 
level using GABAAR subunit specific tools. The importance of such data arises 
from the central role of the DRN in the stress response as well as need to 
define newer and more effective drug targets for the treatment of stress-related 
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neuropsychiatric disorders which arise from the dysregulation of the DRN. 
Therefore, elucidating the molecules which underlie such DRN function and 
dysfunction is vital.  
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4. Chapter 4 
Stress-induced changes in the expression of GABAAR 
subunits and animal behaviour 
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4.1. Abstract 
The mammalian stress response has evolved to allow for the successful 
negotiation of environmental and physiological challenges thus allowing for 
adaptation and survival. However, while the stress response is designed to be 
of limited duration or at least until the stressor abates, prolonged engagement of 
the response, often in the absence of any overt triggers, manifests in a host of 
debilitating pathologies, especially mental illnesses. In order to treat such 
mental disorders, it is essential to determine the neural pathways and biological 
mechanisms which underlie such maladaptive processes. Dysregulation of the 
patterns of neuronal activity with two specific brain regions, namely the 
noradrenergic locus coeruleus (LC) and the serotonergic dorsal raphe nucleus 
(DRN) is implicated in the pathophysiology of such stress-related 
neuropsychiatric disorders. Therefore, in this chapter, we exposed animals to a 
mild, though repeated uncontrollable stressor and determined what effect such 
an experience would have on the expression of GABAAR alpha subunits in 
neurochemically diverse cell types of the LC and DRN since these receptors are 
likely to be central to determining neuronal excitability. Repeated stress 
increased the mRNA and protein expression of only the GABAAR alpha3 
subunit within the DRN, and GABAAR alpha3 subunit protein in the basolateral 
nucleus of the amygdala. This paradigm had no effect on the mRNA expression 
levels of the GABAAR alphas 1, 2 subunits, the serotonin synthesising enzyme 
tryptophan hydroxylase and the serotonin transporter in the DRN. The mRNA 
expression levels of the GABAAR alphas 1, 2, 3 subunits and the noradrenaline 
synthesising enzyme tyrosine hydroxylase in the LC were also unaffected by 
this stress protocol. Behavioural analyses of the animals following exposure to a 
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repeated stressor, and in the context of these specific changes in GABAAR 
expression, suggested a phenotype geared towards behavioural adaption to 
future novelty such as the absence of anxiogenic behaviour, increased 
locomotion, exploration and escape-directed behaviour, together with enhanced 
cognitive performance. These data collectively provide the first demonstration of 
stress-induced correlative molecular and behavioural parameters which are 
suggestive of biological pathways which could underpin the adaptive loops of 
the stress response.     
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4.2. Introduction 
 
Stress, whether real or perceived, results in the body engaging a cascade of 
physiological processes which have evolved to ensure the availability of both 
the metabolic and cognitive tools required for dealing with such challenges. The 
stress response is thus essential for surviving and adapting in an ever changing 
environment. However, the very biological mechanisms which underlie adaptive 
responses to stress are also prone to inducing a host of pathologies in 
vulnerable individuals such as disorders of the cardiovascular system or mental 
illnesses. Thus, the holy grail of research into stress biology is to understand 
why certain processes, while adaptive in certain individuals, confer a 
vulnerability to developing stress related disorders in others. To achieve this, it 
is essential to fully understand the biological processes which contribute to both 
adaptive and maladaptive stress responses, at the molecular, cellular and 
behavioural level.   
The see-saw of the stress response rests on the fulcrum that is the HPA axis as 
it coordinates both the CNS and peripheral limbs of the stress response. Stress-
related information contained in fibres originating from the amygdala, the cortex 
and the autonomic nervous system activate the CRH-AVP-containing 
parvocellular neurons of the PVN. These neuropeptides act synergistically 
within the anterior pituitary to stimulate the release of ACTH into the 
bloodstream, which in turn results in the release of glucocorticoids from the 
adrenal cortex. The systemic release of glucocorticoids function essentially to 
alter metabolism required for the higher energy demand during the stress 
response. However, and crucially in terms of pathology, glucocorticoids also act 
within the CNS on glucocorticoid receptors to initiate the negative feedback loop 
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and thus the cessation of the stress response. A large body of evidence 
indicates that aberrations in glucocorticoid-mediated negative feedback 
mechanisms within the CNS contribute to maladaptive or disease-inducing 
stress responses due to the inadequate cessation of the stress response, even 
in the absence of any overt stressors. Indeed, some of the hallmark traits of 
major depressive disorder such as hyper arousal, reduced libido and loss of 
appetite have been linked with the prolonged activation of the HPA axis. (Board 
et al., 1956, Raadsheer et al., 1994). This suggests that an individual’s 
perception of a stressful situation is central to determining the degree of stress 
one is subjected to. As such, understanding the stress response at the cognitive 
level is essential.  
At the CNS or behavioural level, the engagement of the stress response 
manifests in heightened arousal and vigilance. Central to such behaviours is the 
collective activity of the noradrenergic LC nucleus and serotonergic DRN. 
Stressors influence the excitability of LC and DRN neurons, particularly in 
response to CRH (Curtis, 1999, Swinny et al., 2010, Kirby et al., 2000, Kirby et 
al., 2007). As such, the activity of the neurons embedded within the networks of 
the LC and DRN is shaped by prior stress exposure. In turn, stress-induced 
alterations in LC and DRN neuronal excitability impacts upon noradrenaline and 
serotonin release throughout the brain (Rossetti et al., 1990, Tanaka et al., 
1991, Finlay et al., 1995, Kirby et al., 1995, Kirby et al., 1997, Adell et al., 1997). 
Current thinking is that noradrenaline and serotonin modulate the activity of 
brain regions which underlie the behavioural strategies adopted to contend with 
such challenges (Valentino and Van Bockstaele, 2008). Therefore, it is 
important to characterise the neural substrates which could underlie stress 
174 
 
induced alterations in LC and DRN neuronal excitability. Broadly, stressors 
could either affect afferent drive or result in alterations in the expression of 
neurotransmitter receptor subtypes. Thus, characterising the expression profiles 
of neurotransmitter receptor subtypes within the LC and DRN provides a basis 
for examining stress induced plasticity in receptor expression. To begin to 
explore the possibility that stress-induced changes in neurotransmitter function 
within the LC and DRN might underlie stress-induced changes in the activity of 
these brain regions, we exposed animals to acute and repeated bouts of stress 
and determined the expression of GABAAR subunits within such brain regions. 
We also used a number of behavioural assays to assess any stress-induced 
plasticity in the expression of GABAAR subunits in the context of behavioural 
phenotype. 
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4.3. Materials and methods 
 
All procedures involving experimental animals were performed in accordance 
with the Animals (Scientific Procedures) Act, 1986 (UK) and associated 
procedures. Every effort was made to minimise any pain or discomfort to the 
animals. 
4.3.1. Animals 
 
Male C57BL/6J mice were bred in-house in a temperature and humidity 
controlled environment under a 12-hr light/dark cycle, with free access to 
standard chow and water. Mice lacking the GABAAR alpha3 subunit (alpha3-
KO) were derived on a C57BL/6J background from alpha3 subunit 
heterozygous female and alpha3 subunit hemizygous male breeding pairs 
obtained from Uwe Rudolph at Harvard University and were reared under the 
conditions described above. The generation of the alpha3-KO mice is described 
in (Yee et al., 2005). In brief, Gabra3 KO mice were generated by homologous 
recombination, insertion vectors containing a duplication of exon 4 of the 
Gabra3 gene were electroporated into the embryonic stem cells. This 
duplication is predicted to shift the reading frame and prevent the formation of 
the GABAAR alpha3 subunit protein. Following verification of targeting events by 
Southern blotting, stem cell clones were injected into C57BL/6J blastocysts 
which were transplanted into pseudopregnant foster dams. This knockout strain 
has been characterized by RT-PCR which revealed that no normal mRNA was 
produced from either WT or mutant alleles, which could be due to nonsense-
mediated RNA decay. In accordance, no protein product was identified with the 
GABAAR alpha3 subunit antibody used by Yee et al., (2005). 
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4.3.2. Genotyping 
DNA was extracted from ear punches of the offspring using the Sigma 
mammalian genomic DNA GeneElute® Kit (#G1N70-1KT).  PCR was 
performed using 1μl genomic DNA, 1μl each of 25 pM Gabra3 forward 
(GACAGACATGGCATGATGAAAGACTGAAAT) and Gabra3 reverse primers 
(ACAAAATGTAAGAACAAGAACCAAGAAAAT), 12.5 μl of Promega GoTaq® 
mastermix (#M712) and 9.5 μl of nuclease free water to yield a total reaction 
volume of 25 μl. The PCR was run under the following cycling conditions: 96°C 
for 1 min and 40 cycles of 96°C for 15 sec, 50°C 10 sec and 70°C for 1 min 
followed by 68°C for 5 min. PCR products were run on a 3% agarose gel at 
100V. A single PCR product at 480 bp denotes a Gabra3 WT animal, whereas 
two PCR products, one at 480 bp and one at 520 bp, representing the WT and 
mutant alleles, respectively, denotes a Gabra3 KO animal (see Appendix II for 
an illustrative aragrose gel). Since the Gabra3 gene is located on the X 
chromosome it is not possible to distinguish between heterozygous and 
homozygous alpha3-KO females, therefore only male alpha3-KO animals were 
used. 
4.3.3. Choice of stress models 
 
We sought to determine whether various stressors induce changes in the levels 
of expression of GABAAR subunits in the brain regions of interest and whether 
these changes were correlated with the adoption of an altered behavioural 
phenotype in response to novelty.  
4.3.4. Repeated stress: eight days of variable, repeated restraint stress 
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We have chosen the paradigm of restraint stress (Buynitsky and Mostofsky, 
2009) since this procedure is highly reproducible as all restrainers are 
essentially identical. Thus, any variations in the outcomes or experiences 
between animals are due to inherent differences between animals. Therefore, if 
using in-bred strains, as is the case with this study, these inter-individual 
differences should be minimal. This is not the case with other repeated stress 
models such as the social defeat or resident intruder models (Koolhaas et al., 
2013). For these models, the stressor is the aggression displayed by the 
resident mouse to the intruder. However, variations in the levels of aggression 
between animals confound the degree of stress levels within the intruder 
subjects. Furthermore, the restraint stress model does not result in any physical 
trauma to the subjects. This is not the case with the social defeat or resident 
intruder models in which a physical confrontation ensues between the resident 
and the intruder which might results in physical wounds.  
There are variations in the duration of restraint with some investigators 
choosing extreme parameters such as 6 hours of restraint per day for 21 days 
(McEwen, 2001). Individuals very rarely encounter such extreme, repeated 
episodes of stress during their lifetime. While identifying any changes in 
GABAAR subunit expression as a result of such extreme stressors would be 
informative, we adopted a sub-chronic, uncontrollable repeated restraint stress 
paradigm in order to model the consequences of being exposed to variable 
stressors which individuals are more likely to have to contend with on a daily 
basis. From the outset, there were no expectations as to whether this protocol 
would result in an adaptive or maladaptive outcome. One week prior to the start 
of the stress experiment the animals were divided into stress and control 
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experimental groups, to allow adaptation to the new cage environment before 
commencing the stress. To deliver restraint, mice aged postnatal day (PND) 40 
were inserted tail first into a Broome rodent restrainer (Harvard Apparatus # 52-
0470) for 30 minutes per day. Mice were restrained within the tube, but not fully 
immobilised. They thus were able to move slightly backwards and forwards in 
the device. During restraint stress, mice were kept individually in standard 
housing cages containing a thin layer of corn cob. After the restraint stress, 
animals were removed to their home cages. The restraint stress was delivered 
at set times during the day for eight consecutive days. To mitigate against any 
habituation to the stressor which may occur over the course of the experiment, 
the type of restraint stress applied was subtly varied, as detailed in Table 4.1. 
To apply escapable restraint, the animal was inserted into the tube and 
restrained for 1 minute, after which the stopper was removed and the animal 
was able to emerge from the restrainer and explore the novel environment of 
the cage. Control mice remained in their original cages and were left 
undisturbed in this home environment. 
Table 4.1  
Eight day repeated restraint stress schedule 
 
 
Day 1 2pm: restraint 
Day 2 10am: restraint 
Day 3 2pm: animal placed in cage with restrainer but not restrained 
Day 4 10am: ‘escapable’ restraint  
Day 5 2 pm: restraint 
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Day 6 10am: ‘escapable’ restraint 
Day 7 10am: restraint 
Day 8 2pm: restraint 
 
4.3.5. Assessment of the effects of stress on GABAAR subunit 
expression at the mRNA level 
 
Quantitative reverse transcription polymerase chain reaction (qRT-PCR)  
Tissue preparation, RNA extraction and reverse transcription 
One day after the final stress episode (day 9), mice were killed by cervical 
dislocation and their brains rapidly removed. One and two millimetre thick tissue 
sections containing the LC and DRN respectively were obtained using a brain 
matrix (Harvard apparatus; #726233). From these sections, a tissue punch of 2 
mm diameter was used to extract the LC or DR nuclei which were then placed 
in RNAlater® for post hoc RNA extraction. Each tissue punch was removed 
from the RNAlater® and placed in RLT lysis buffer (Qiagen) and was disrupted 
with a rotor homogeniser. Total RNA was extracted from the tissue lysate using 
RNeasy® RNA Purification kit (Qiagen) according to the manufacturer’s 
instructions. Subsequently, purified RNA was reverse transcribed to cDNA 
using M-MuLV and Oligo(dT)18 primers. For each sample, 4 µl of 100 ng/µl 
RNA was mixed with 11 µl nuclease free water, 2 µl 20x M-MuLV mastermix, 1 
µl oligo(dT)18 (Fermentas #SO131), 1 µl dNTPs (2.5 mM), 0.5 µl Ribolock 
(Fermentas #E00181) and 0.5 µl M-MuLV (New England Biolabs #M0253S) to 
yield a total reaction volume of 20 µl. For the reverse transcription, each sample 
was incubated at 37 °C for 1 hour. 
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Multiplex qPCR 
Multiplex qPCR was used to simultaneously analyse the expression of both 
housekeeping gene (Gapdh) and a second gene of interest. Genes investigated 
are shown in Table 4.2. qPCR was performed a according to Carter et al. 
(2013), for each sample 2 µl cDNA was mixed with nuclease free water, 
mastermix (Roche) and the primers and probes of housekeeping gene and 
gene of interest, tagged with VIC (primer limited) and FAM respectively, to yield 
a 10 µl total reaction volume. The qPCR was performed under the following 
cycling conditions: 95°C for 10 mins and 55 cycles of 95°C for 10 sec and 60°C 
for 30 sec. 
 
 
Table 4.2 
Genes of interest and product codes for the corresponding primers and probes 
used in this chapter 
Gene of interest  Corresponding protein Primers and Probes 
(Life Technologies™) 
Tph2 Tryptophan hydroxylase 2 Mm00557715_m1 
Th Tyrosine hydroxylase Mm00447557_m1 
Slc6a4 Serotonin transporter Mm00439391_m1 
Gabra1 GABAAR alpha1 subunit Mm00439046_m1 
Gabra2 GABAAR alpha2 subunit Mm00433435_m1 
Gabra3 GABAAR alpha3 subunit Mm01294271_m1 
Gabrg2 GABAAR gamma2 subunit Mm00433489_m1 
Gapdh Glyceraldehyde 3-phosphate 
dehydrogenase 
Mm99999915_g1 
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 Analysis of RNA expression levels 
The relative standard curve method was used for quantitative determination of 
the amount of gene of interest in relation to the amount of housekeeping gene 
(Gapdh). Standard curves were generated for Gabra1, Gabra2, Gabra3, and 
Gabrg2 using serial dilutions of cDNA from whole mouse brain. Standard curves 
for Tph2, Slc6a4 were generated using serial dilutions of cDNA from DRN 
punches and Th from LC punches, owing to the low levels of mRNA expression 
of these genes in whole brain. Each measurement was performed in triplicate 
and each Ct value was then converted into ng RNA using linear regression 
analysis of the standard curve (Microsoft Excel). Each ng RNA value was 
normalised against the ng housekeeping gene level within the same sample. 
Mean ng RNA levels were computed from the normalised measurements and 
compared across stress and control experimental groups. qRT-PCR data is 
presented as relative change in gene expression above or below control. 
4.3.6. Assessment of the effects of repeated restraint stress on GABAAR 
subunit expression at the protein level 
 
Immunohistochemistry 
Tissue preparation 
Although lack of significant changes in GABAAR subunit mRNA does not 
preclude changes at the protein level, we chose to quantify GABAAR alpha3 
subunit expression within DRN and baso-lateral amygdala (BLA) only. One day 
after the final repeated restraint session or one hour after the tail suspension 
test, brain tissue was prepared for immunohistochemistry as follows. 
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Anaesthesia was induced with isofluorane and maintained with pentobarbitone 
(1 mg/kg of bodyweight; i.p.). The animals were perfused transcardially with 0.9 
% saline solution for 1 minute, followed by 15 minutes fixation with a fixative 
consisting of 1% paraformaldehyde, 15% v/v saturated picric acid, in 0.1 M 
phosphate buffer (PB), pH 7.4. The brains were kept in the same fixative 
solution overnight at 4°C. Coronal sections of the DRN and baso-lateral 
amygdala (BLA) 60 µm thick, were prepared on a Vibratome and stored in 0.1 
M PB containing 0.05% sodium azide. 
Immunohistochemical reactions 
With the antibodies used in this study, we obtained the highest signal to noise 
ratio using the proteolytic antigen unmasking method, therefore this method 
was adopted as follows. Briefly, the tissue sections were incubated at 37°C for 
10 minutes in 0.1 M PB followed by 15 minutes in 0.2 M HCl containing 1 mg/ml 
pepsin (Sigma, UK) after which they were washed thoroughly in Tris-buffered 
saline containing 0.3% Triton-X100 (TBS-Tx) for 30 minutes. Non specific 
binding of secondary antibodies was blocked by incubating sections with 20% 
normal horse serum for 2 hours at room temperature (~ 22°C). The tissue 
sections were incubated with cocktails of primary antibodies diluted in TBS-Tx, 
overnight at 4°C. After washing with TBS-Tx, sections were incubated in a 
mixture of appropriate secondary antibodies conjugated with either Alexa Fluor 
488 (Invitrogen, Eugene, OR), indocarbocyanine (Cy3; Jackson 
ImmunoResearch), and indodicarbocyanine (Cy5; Jackson ImmunoResearch) 
for 2 hours at 21°C. Sections were washed in TBS-Tx and mounted in 
Vectashield (Vector Laboratories, Burlingame, CA). 
Antibody specificity 
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The antisera against the GABAAR alpha3 subunit has been used and reported 
on extensively in other publications (Fritschy and Mohler, 1995, Marowsky et 
al., 2012). We have in addition used tissue from alpha3-KO mice to verify the 
specificity in brain regions which we have not previously reported on under our 
reaction conditions such as the BLA.  
Image acquisition 
Sections were examined with a confocal laser-scanning microscope (LSM710; 
Zeiss, Oberkochen, Germany) using either a Plan Apochromatic 63x DIC oil 
objective, pixel size 0.13 µm (NA1.4) or a Plan Apochromatic 100x DIC oil 
objective, pixel size 0.08 µm (NA1.46). Z-stacks were used for routine 
evaluation of the labelling. All images presented represent a single optical 
section. These images were acquired using sequential acquisition of the 
different channels to avoid cross-talk between fluorophores, with the pinholes 
first adjusted to one airy unit and then optimised to ensure equal optical section 
thicknesses for all channels. Images were processed with the software Zen2008 
Light Edition (Zeiss, Oberkochen, Germany) and exported into Adobe 
Photoshop. Only brightness and contrast were adjusted for the whole frame, 
and no part of a frame was enhanced or modified in any way.  
4.3.7. Quantification of the relative proportion of GABAAR alpha3 subunit 
and gephyrin immunoreactive puncta on TPH immunopositive 
somata and dendrites in tissue from repeated restraint stress and 
control mice 
 
The quantitative method used is according to (Lorenzo et al., 2007). Tissue 
from six animals, three stress and three control, was used to quantify the 
relative proportion and degree of co-localisation of GABAAR alpha3 subunit and 
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gephyrin immunoreactive puncta on TPH-immunopositive dendrites and 
somata. Tissue sections at the rostra-caudal midline level of the DRN 
(approximately -4.60 bregma) from each animal were selected for the following 
immunohistochemical reaction: TPH-GABAAR alpha3 subunit-gephyrin. Two 
fields of view (FOV) were randomly selected within the ventromedial sub-region 
of each tissue section, the ventromedial sub-region was selected because we 
have previously shown that inhibitory innervation is enriched on the dendritic 
domains of TPH-immunopositive neurons and TPH dendrites are densest within 
the ventromedial sub-region. A z-stack consisting of three optical sections was 
acquired for each FOV with a Plan Apochromat x100 (NA1.4) DIC oil immersion 
objective. The dimensions of the optical sections were 84.94µm x 84.94µm in 
the X & Y planes and 1µm thick in the Z plane. Optical sections were spaced 2 
µm apart. Triple immunofluorescence was acquired using sequential acquisition 
of the different channels. The number of GABAAR alpha3 puncta, gephyrin 
puncta and GABAAR alpha3 co-localisations within an optical section 
associated with TPH immunoreactivity was manually counted using ImageJ 
(NIH) software. The numbers of puncta for each optical section within a field of 
view were combined and the means ± SD for all FOV within and between 
sections were compared for statistical differences using Kruskal–Wallis one-way 
analysis of variance. These values were then pooled since there were no 
statistical differences between FOV and between animals. The proportion of 
GABAAR alpha3 puncta which co-localised with gephyrin puncta was computed 
from the pooled data and presented as a density per 1000 um2 DR.  
4.3.8. Quantification of GABAAR alpha3 subunit immunofluorescence 
intensity in the BLA of repeated restraint stress and control mice 
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Tissue from eight animals, 4 repeated restraint stress and 4 control, were used 
to quantify the relative change in GABAAR alpha3 immunofluorescence 
intensity. Tissue sections at the rostra-caudal midline of the BLA (approximately 
-1.46 bregma) were selected for GABAAR alpha3 subunit-gephyrin 
immunolabelling. Two fields of view were randomly selected within 
magnocellular and parvocellular sub-divisions of the basomedial nucleus of the 
amygdala. A z-stack consisting of 4 optical sections was acquired for each FOV 
with a Plan Apochromat x100 (NA1.4) DIC oil immersion objective, as described 
above. Immunofluorescence intensity was quantified using the z-stack profile 
function of ImageJ. All immunofluorescence intensity data is presented as mean 
fluorescence intensity and relative change above/below control is displayed as 
a percentage.  
 
4.3.9. Assessment of the effects of stress on the behaviour of the animal 
 
We subjected control and stress exposed animals to a number of behavioural 
assays in order to correlate the stress-induced gene and protein changes with 
those of behaviour 
The elevated plus maze 
Three cohorts of animals totalling 12 control and 11 stress animals were used to 
investigate stress induced behaviour in the elevated plus maze. The elevated 
plus maze exploits the inherent conflict experienced by rodents between a 
desire to explore a novel but exposed environment versus a desire to remain in 
the relative safety of a more sheltered area. Classical anti-anxiety 
pharmacological agents such as the benzodiazepines increase the time spent in 
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the open arms of the elevated plus maze. Thus, the elevated plus maze is used 
as a surrogate marker of anxiety-like behaviour in rodents. One day after the 
final stress exposure (day 9), the behaviour of the control and experimental 
(stress) groups was assessed in the elevated plus maze. The elevated plus 
maze used is according to published guidelines (Walf and Frye, 2007). It 
consisted of two enclosed arms (50 cm long x 10 cm wide x 40 cm high, 50 LUX 
at farthest point from centre) and two open arms (50 cm long x 10 cm wide, 500 
LUX at farthest point from centre) forming a cross, with a square centre (10 cm  
x 10 cm, 350 LUX). The maze was made of wood painted black and was raised 
50 cm off the ground. At the beginning of the test, each animal was placed at 
the centre of the plus maze such that the animal had a choice between entering 
the sheltered closed arm or the exposed open arm. The experimenter was not 
present in the room for the duration of the test. Between each test, the plus 
maze was cleaned thoroughly with 70% ethanol. Activity in the elevated plus 
maze was recorded for 5 minutes by video camera and analysed offline. Time 
spent in seconds in the open and closed arms was recorded manually; a full 
open or closed arm entry was only scored when all four paws of the animal 
were within the arm. 
Light dark box 
Three cohorts of animals totalling 14 control and 11 stress animals were used to 
investigate the influence of stress on behaviour in the light dark box. The light 
dark box is used to assess anxiety-like behaviours in rodents in response to a 
novel environment. The light dark box exploits the inherent conflict experienced 
by rodents between a desire to explore a novel environment, versus a desire to 
remain in the relative safety of a darker, more sheltered space. Anxiety-like 
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behaviour in the light dark box is characterised by an increased tendency to 
remain in the dark, enclosed zone and a decreased tendency to venture into the 
more exposed and brightly lit zone. The light compartment of the light dark box 
was constructed from transparent plexiglass, 40 cm long x 20 cm wide x 35 cm 
high (540 LUX) and the dark compartment was constructed from black opaque 
plexiglass, 40 cm long x 20 cm wide x 35 cm high (1 LUX) with a tight fitting 
black plexiglass lid (40 cm long x 20 cm wide). At all times throughout the test 
each compartment is freely accessible through an opening in the dark 
compartment (6.5 cm high x 7 cm wide). For assessing behaviour in the light 
dark box, a video camera was mounted centrally 140 cm above the apparatus; 
this video camera was connected to a laptop which ran ANY-maze® video 
tracking software. Each animal was placed in the bottom left hand corner of the 
light compartment and allowed to explore the light-dark box for 5 minutes. The 
apparatus was thoroughly cleaned with 70% ethanol between each animal 
tested. ANY-maze® automated video tracking system was used to trace the 
trajectory of the animal in the light zone during the 5 minute test period. The 
time spent in the light and dark compartments of the light-dark box was 
assessed manually by subtracting the time in light compartment from the total 
time for the test. An entry into the light or dark zone was only considered if all 
four limbs of the animal were in a single zone. A relative decrease in the time 
spent in the light compartment and a relative increase of the time spend in the 
dark compartment was used as a measure of anxiety-like behaviour. The 
latency to enter the dark compartment was used as a surrogate marker of fear 
response when confronted with a novel environment, as it represented the 
ability of an animal to identify and enter a relatively safer compartment. 
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The open field test 
Four cohorts of animals totalling 16 control and 14 stress animals were used to 
assess the influence of stress on behaviour in open field. The open field test is 
used to assess locomotor activity, exploratory and anxiety-like behaviours in 
rodents in response to a novel environment. Anxiety-like behaviour in the open 
field is characterised by an increased propensity to remain close to the more 
sheltered parameters of the open field such as the walls of the open field, and a 
decreased propensity to venture into the central and more exposed areas of the 
open field. The open field apparatus was constructed from grey, non-reflective 
opaque plexiglass 40 cm long x 40 cm wide x 35 cm high (Stoelting #60101), 
light intensity was equal in all areas of the open field (380 LUX). For assessing 
motor and anxiety-like activity, a video camera was mounted centrally 140cm 
above the apparatus. The video camera output was connected to a laptop 
which ran ANY-maze® video tracking system, ANY-maze® was used to overlay 
grid lines that defined separate zones within the open field (Fig. 4.5,6). Each 
animal was placed in the bottom left hand corner of the field and allowed to 
explore for 5 minutes. The apparatus was thoroughly cleaned with 70% ethanol 
between each animal. ANY-maze® automated video tracking system was used 
to trace the trajectory of the animal in the open field, monitor total distance 
travelled and assess the time spent and number of entries made into the 
periphery, middle and centre zones. Duration and number of entries made into 
the periphery, middle and centre zones was used to investigate anxiety-like 
behaviours. Total distance travelled and average speed was used to investigate 
overall motor activity in the open field. Total number of entries into the different 
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zones of the open field was used to assess exploratory like behaviour in the 
open field. 
Tail suspension test 
Three cohorts of animals totalling 12 control and 13 stress animals were used to 
assess the influence of repeated stress on escape-directed behaviour in the tail 
suspension test. The tail suspension test was originally designed as a model to 
test the efficacy of new antidepressants (Steru et al., 1985). The test was 
designed based on the observation that when a mouse is suspended by the tail, 
it will display periods of agitation, termed ‘escape-directed’ behaviours and 
periods of immobility termed ‘behavioural depression or despair’. Classically 
used antidepressants increase the duration of escape-directed behaviours and 
reduce periods of immobility. In this study, the tail suspension test was used to 
investigate the influence of the stress paradigm on the behavioural strategies 
adopted in response to a novel behavioural challenge. Mice were attached by 
the tail onto a hook suspended 40cm above the table surface for 5 minutes. 
ANY-maze® video tracking software was used to record the behaviour of the 
animal. Time spent immobile within each 1 minute epoch was measured. 
Swaying generated by prior body movement was classed as periods of 
immobility.  
Novel object recognition test 
Three cohorts of animals totalling 12 control and 10 stress animals were used to 
investigate the influence of stress on recognition performance. The novel object 
recognition test was used to assess the influence of repeated stress on 
cognitive performance; the acquisition, consolidation and retrieval of 
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information. This test is based on the principle that a rodent will display greater 
exploration of a novel object over a familiar object, if they can remember that 
they have encountered the familiar object previously. The procedure for the 
novel object recognition test occurs in three stages i) habituation to the open 
field on day 1 ii) familiarisation of two identical objects on day 2 and iii) 
discrimination between the one familiar and one novel object on day 3. The 
novel object recognition test was performed in a square open field (40 cm wide 
x 40 cm long x 35 cm high) (Stoelting #60101), light intensity was equal in all 
areas of the open field (380 LUX). For the familiarisation stage, two objects 
were placed symmetrically, 9 cm away from the side of the open field (Fig. 4.1). 
The objects and the open field were thoroughly cleaned with 70% ethanol prior 
to and between each session to prevent the use of odour cues. The objects 
used in the exploration session were blue and white plastic containers (7cm 
high x 1.7 cm diameter), the novel object used in the discrimination session was 
an upturned 100ml plastic beaker (7.5 cm high x 3.4 cm diameter at base 2 cm 
diameter at top) with blue, black and green tape, mice were able to climb onto 
the objects without displacing them. Prior testing had confirmed that the 
percentage of time spent exploring each object was not statistically different, 
confirming that mice showed no inherent preference for either object. 
Exploration was defined as when the animal was directing the nose to the 
object within a distance of 1.5 cm and/or touching the object with the nose. 
Sitting on the object was not considered exploratory behaviour. For assessing 
behaviour in the novel object recognition test a video camera was mounted 140 
cm above the objects in the open field. In the first habituation phase, animals 
were placed in the bottom left hand corner of the open field and allowed to 
explore for 10 minutes. Twenty-four hours later, the animals were brought into 
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the experimental room in their home cages for 10 minutes prior to the beginning 
of the second phase (familiarisation) to allow habituation to the change in 
environment. Animals were placed in the bottom left hand corner of the open 
field and allowed to explore the field and the objects for 10 minutes. Exploratory 
activity was scored offline. The time spent exploring both identical objects was 
assessed in two 5 minute epochs in the event of altered patterns of exploratory 
behaviour over the course of the 10 minutes. Twenty-four hours later, the 
animals were again allowed to habituate to the experimental room and then 
returned to the open field for the discrimination phase. Animals were placed in 
the bottom left hand corner of the open field, this time containing one familiar 
and one novel object, and allowed to explore for 10 minutes. Exploratory activity 
was scored offline. The time spent exploring the familiar and the novel object 
was assessed in two 5 minute epochs, in case of altered exploratory behaviour 
over the course of the 10 minutes. To evaluate discrimination between the novel 
and familiar object in light of inter-animal variation in exploration time, the 
following formula was used according to Şık et al. (2003); d2 = (b-a)/e2, where 
d2 is the level of discrimination and is equal to time spent exploring the novel 
object minus the time spent exploring the familiar object, divided by the total 
time spent exploring both objects. 
 
Figure 4.1 
Positioning of objects in the open field for the novel object recognition test 
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4.3.10. The effect of an acute stressor on the immunoreactivity 
levels of GABAAR alpha3 subunit in the DRN and Basolateral 
Amygdala  
 
Data obtained from the repeated restraint stress protocol suggested that it 
induces robust changes in the levels of GABAAR alpha3 subunit in the DRN and 
BLA. At the end of these experiments, we investigated whether some of these 
changes also manifest following exposure to acute stress. The experiments 
were initiated towards the end of my PhD and are thus relatively exploratory. As 
such, I was not able to pose all the questions or adopt all the techniques used 
following the repeated stress paradigm. We chose the tail suspension test 
(TST) as a model of acute stressor since the behaviour it assays (immobility as 
a correlate of behavioural despair) has been shown to be mediated by 
noradrenergic and serotonergic pathways (Cryan et al., 2004). To administer 
this stressor, mice were removed from their home cages into a transport cage, 
individually suspended by their tails for 5 minutes, then removed to the transport 
cage and placed back in their home cages. Control mice were left undisturbed 
in their home cages. An hour after the TST, animals were processed for 
immunohistochemistry and the levels of GABAAR alpha3 subunit 
immunoreactivity in the DRN and BLA were quantified. 
4.3.11. Quantification of GABAAR alpha3 subunit 
immunofluorescence intensity in the DRN and BLA of mice exposed 
to acute tail suspension test and control  
 
DRN and BLA tissue from eight animals, 4 tail suspension and 4 control, were 
used to quantify the relative change in GABAAR alpha3 immunofluorescence 
intensity. Animals underwent perfusion fixation as described above (4.3.6), 1 
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hour after tail suspension. Tissue sections at the rostral-caudal midline of the 
DRN and BLA were selected and processed as described above (4.3.8). 
4.3.12. Statistical analyses 
 
For each test, the data was tested for normality using a Shapiro-Wilk test.  An 
Independent T-test or Mann-Whitney test was used for normally and non-
normally distributed data, respectively. In all cases, SPSS was used for 
statistical analyses. GraphPad was used for graphical representation of data. 
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4.4. Results 
 
Having previously characterised the expression profiles of the GABAAR alpha1, 
alpha2, alpha3 and gamma2 subunits on the neurochemically diverse cell types 
of the LC and the DRN, a central focus of this study was to determine whether 
stress influences the expression profile of diverse GABAAR subunits in these 
brain regions. 
4.4.1. Repeated stress alters GABAAR expression at the mRNA level in 
a brain region and subunit specific manner 
 
qRT-PCR was used to first investigate the influence of repeated stress on the 
GABAAR subunit molecular machinery at the transcriptomic level in the LC and 
DRN (Fig. 4.2). As the DRN modulates the stress response, and dysregulated 
serotonin signalling is one of the hallmarks of neuropsychiatric disorders such 
as major depressive disorder (Stockmeier et al., 1998, Underwood et al., 1999, 
Baumann et al., 2002, Boldrini et al., 2005, Bach-Mizrachi et al., 2005, Gos et 
al., 2008), we commenced by investigating the influence of stress on the 
expression of mRNA encoding the serotonin synthesising enzyme tryptophan 
hydroxylase 2 (Tph2) and the serotonin transporter (Slc6a4) within N = 14 
control, 13 stress mice (Fig. 4.2A). Repeated restraint stress did not significantly 
alter the expression of TPH encoding mRNA (p = 0.206). Despite there being a 
strong trend towards increased expression of Slc6a4 encoding mRNA, the 
effect did not reach statistical significance (p = 0.120). Thus, exposure to this 
stress paradigm does not significantly impact on the expression of serotonergic 
machinery at the mRNA level within the DRN. Subsequently, the influence of 
repeated stress on the expression of GABAAR subunit encoding mRNA was 
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investigated. In the DRN, repeated stress significantly increased the level of 
expression of the mRNA encoding for the GABAAR alpha2 subunit by 13% (p = 
0.007) and that of the GABAAR alpha3 subunit by 27% (p = 0.011). However, 
exposure to stress had no significant effect on the level of the mRNA encoding 
for the GABAAR alpha1 subunit (p = 0.365) and the GABAAR gamma2 subunit 
(p = 0.386). In Chapter 3, it was demonstrated that the GABAAR alpha2 and 
alpha3 subunits are preferentially localised to serotonergic neurons of the DRN 
whereas the GABAAR alpha1 and gamma2 subunits are predominantly 
expressed on non-serotonergic neurons. Since we detected stress-induced 
changes in the levels of only those mRNAs which encode for GABAAR subunits 
that are enriched on serotonergic neurons (alpha2/3 subunits), it is tempting to 
speculate that environmental stress signals within the DRN engage GABAAR-
mediated pathways which are preferentially associated with serotonergic 
neurons rather than non-serotonergic neurons.  
We then investigated whether these stress induced alterations in GABAAR 
subunit mRNA expression were restricted to the DRN, or whether they were 
also present in the LC within N = 9 mice per group. There were no significant 
differences in the expression of mRNA encoding for the noradrenaline 
synthesising enzyme, tyrosine hydroxylase (Th) (p = 0.20). There were also no 
significant influences of repeated stress on the expression of mRNAs encoding 
the following GABAAR subunits: alpha1 (p = 0.820), alpha2 (p = 0.241), alpha3 
(p = 0.824) and gamma2 (p = 0.802). Taken together, it appears that the impact 
of repeated restraint stress on the expression of diverse GABAAR subunits at 
the genomic level are dependent both on the subunit and brain region.  
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Figure 4.2 
Repeated restraint stress alters GABAAR subunit mRNA expression in a brain 
region and subunit specific manner 
Mean ± SEM levels of the relative expression of mRNA encoding GABAAR 
subunits (Gabra), tryptophan hydroxylase (Tph), serotonin transporter (Slc6a4) 
and tyrosine hydroxylase (Th) mRNA above or below control. (A) in the DRN, 
the influence of stress on mRNA expression of GABAAR subunits was subunit 
specific, with the alpha2 and alpha3 subunit encoding mRNA levels significantly 
increased above control. In contrast, no significant differences in alpha1 and 
gamma2 subunit encoding mRNA levels were observed. The levels of mRNA 
encoding serotonin synthesising enzyme tryptophan hydroxylase and the 
serotonin transporter were not significantly different from control (N = 15 control, 
14 stress animals). (B) conversely, there was no significant effect of stress on 
the levels of alpha1, 2, 3 or gamma2 subunit encoding mRNA in the LC (N = 9 
animals per control or stress group). 
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4.4.2. Repeated restraint stress increases GABAAR alpha3 subunit 
expression on the serotonergic neurons of the DRN  
 
Having identified a stress induced increase in GABAAR alpha3 subunit encoding 
mRNA, we then investigated whether this change at the gene level translated to 
a change in the GABAAR alpha3 subunit expression at the protein level (Fig. 
4.3). GABAAR alpha3 subunit immunofluorescence labelling was examined 
within the ventromedial sub-regions of sections situated within the midline of the 
rostral-caudal extent of the DRN (Fig. 4.3A). At this location TPH dendrites, on 
which inhibitory innervation preferentially occurs, are most abundant (see 
Chapter 3). Examination of the GABAAR alpha3 subunit immunofluorescence 
density (mean ± SD immunofluorescence intensity in arbitrary units, AU) 
revealed a 17% increase in GABAAR alpha3 fluorescence intensity within the 
ventromedial region of the DRN (control, 11.17 ± 1.6 AU versus stress, 14.15 ± 
1.14 AU; p <0.001, Mann Whitney, N = 3 control animals, 3 stress animals). 
Since qRT-PCR and immunofluorescence densitometry data does not provide 
information about expression levels on neurochemically distinct cell types within 
the DRN, we quantified the GABAAR alpha3 immunoreactive puncta selectively 
located on TPH immunopositive profiles of the DRN (Fig. 4.3). Exposure to 
stress significantly increased the mean ± SD density of GABAAR alpha3 subunit 
immunoreactive clusters located on TPH-immunopositive profiles (control, 32 ± 
7 clusters/1000um2 versus 57 ± 12 clusters/1000um2; p <0.001, Mann Whitney; 
N = 3 control animals, 3 stress animals.  Thus, stress increases the expression 
of the GABAAR alpha3 subunit within the DRN at both the mRNA and protein 
level.  
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It would thus be informative to determine whether this stress-induced increase 
in GABAAR alpha3 subunit expression on serotonergic neurons is trafficked to 
synaptic or extrasynaptic cell surfaces since this is likely to impact on either the 
fast phasic or slow, persistent tonic forms of GABAAR-mediated inhibitory 
currents. Since gephyrin is a protein that functions in the anchoring of GABAARs 
within inhibitory synapses and has been shown to directly interact with the 
GABAAR alpha3 subunit (Tretter et al., 2011), we determined whether stress 
altered the degree of co-localisation between GABAAR alpha3 subunit and 
gephyrin immunoreactive clusters, which would be indicative of increased 
GABAAR alpha3 subunit synaptic content. There was no difference in the mean 
± SD density of gephyrin immunoreactive puncta localised to TPH labelled 
profiles (control, 28 ± 9 puncta/1000um2 versus stress, 29 ± 6 puncta/1000um2; 
p <0.001, Mann Whitney; N = 3 control animals and 3 stress animals). However, 
stress increased the density of GABAAR alpha3 subunit immunoreactive 
clusters which were co-localised with those of gephyrin on TPH immunopositive 
profiles of the DRN (mean ± SD density, control 6 ± 3 puncta/1000um2  versus 
stress, 10 ± 6 puncta/1000um2; p = 0.019, Mann Whitney; N = 3 control and 3 
stress animals). In Chapter 3, it was also demonstrated that a proportion of 
GABAAR alpha3 subunit immunoreactive puncta are not associated with 
inhibitory synaptic marker proteins such as gephyrin or neuroligin2 on TPH 
labelled profiles. These puncta are likely to represent an extrasynaptic pool of 
alpha3 subunit containing GABAAR subtypes. We thus investigated the 
influence of stress on the expression of this putative extrasynaptic pool of 
GABAAR alpha3 subtypes by quantifying the density of GABAAR alpha3 subunit 
puncta on TPH immunopositive profiles which did not co-localise with gephyrin. 
Repeated stress significantly increased the density of GABAAR alpha3 subunit 
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immunoreactive puncta which did not co-localise with gephyrin (mean ± SD 
control, 27 ± 7puncta/1000um2 versus stress, 46 ± 12 puncta/1000um2; p < 
0.001, Mann Whitney). Taken together, these data suggest that stress 
increases both synaptic and extrasynaptic pools of alpha3 subunit containing 
GABAAR subtypes on the serotonin neurons of the DRN.  
 
Figure 4.3 
Repeated restraint stress increases GABAAR alpha3 subunit puncta density on 
the serotonergic neurons of the DR 
(A) anatomical location of the region used for quantification of GABAAR alpha3 
puncta density within the midline of the rostral-caudal extent of the DRN and in 
the ventral sub-region of the nucleus. (B) repeated restraint stress significantly 
increased the level of GABAAR alpha3 immunoreactivity on TPH 
immunopositive profiles within the DRN. (C) quantification of GABAAR alpha3 
subunit and gephyrin immunoreactivity on TPH immunopositive profiles within 
the DRN. N = 3 animals per group, *p <0.05, ***p <0.001; Mann Whitney. Scale 
bar 5 μm. 
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4.4.3. Repeated restraint stress increases GABAAR alpha3 subunit 
expression in the Basolateral Amygdala 
 
As the GABAAR alpha3 subunit seems particularly sensitive to modulation by 
stressors, we investigated whether similar expression plasticity is evident within 
other brain regions which are enriched with this subunit such as the basolateral 
nucleus of the amygdala (BLA) and the lateral septum. (Pirker, 2000, Hortnagl 
et al., 2013, Marowsky et al., 2012). We first focussed on the BLA since this 
brain region is heavily involved in the processing of stress-related information. 
Since there is no reliable immunohistochemical marker to visualise BLA 
principal cells in their entirety (somatic and dendritic compartments) and thus 
ascribe GABAAR alpha3 subunit expression to a particular cell-type, such as 
TPH in the DRN, we used immunofluorescence densitometry analysis to 
explore whether stress alters the global expression levels of this subunit within 
this brain region. Representative sections from the midline of the rostral-caudal 
extent of the BLA (Fig. 4.4A) from control and stress animals were reacted and 
processed for immunohistochemical reactions under identical conditions. The 
pattern of GABAAR alpha3 subunit immunoreactivity within the BLA was 
consistent with what has been reported previously (Marowsky et al., 2012). A 
sub-population of GABAAR alpha3 subunit immunoreactive puncta co-localised 
with gephyrin (Fig. 4.4B arrows) but the majority of GABAAR alpha3 puncta did 
not co-localise with gephyrin (Fig. 4.4B arrowheads), in agreement with a 
previous report that reflected the central role of alpha3 subunit containing 
GABAARs in mediating tonic GABAergic inhibition within the BLA (Marowsky et 
al., 2012). Relative to control BLA, stress increased the mean ± SD, 
fluorescence intensity (arbitrary units, AU) of the GABAAR alpha3 subunit by 
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19% (control, 14.8 ± 2.8 AU versus stress, 17 ± 3.6 AU; p <0.001, Mann 
Whitney, N = 4 control and 4 stress animals). As alpha3 containing GABAARs 
mediate tonic inhibition within the BLA, this increased expression is likely to 
lead to enhanced dampening of neuronal excitability.  
We did not detect any differences in the levels of expression of the GABAAR 
alpha3 subunit in the lateral septum (LS) of control and stress animals. Even 
though the LS provides GABAergic input to the PVN surround and LS activity is 
negatively correlated with corticosteroid release (Singewald et al., 2010). Thus, 
this stress paradigm preferentially impacted upon expression of the GABAAR 
alpha3 subunit within only a sub-group of brain regions involved in the stress 
response, namely the DRN and the BLA. This selective engagement of distinct 
brain regions by stressors could be informative as to the circuitry underlying 
adaptive and maladaptive stress responses.  
Given the central role of the DRN and BLA in mediating diverse behaviours in 
response to stressors (Kirby et al., 1995, Kirby et al., 1997, Adell et al., 1997, 
Goldstein et al., 1996, Manzanares et al., 2005, Chhatwal et al., 2005, Sanders 
and Shekhar, 1995), we then  investigated whether these stress induced 
changes in the expression of the GABAAR alpha3 subunit within the DRN and 
BLA occur in parallel to any adaptive behavioural strategies when the animal is 
confronted with a novel stressor. 
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Figure 4.4 
Repeated restraint stress increases GABAAR alpha3 subunit immunoreactivity 
in the basolateral amygdala (BLA) 
(A) anatomical location of the region used for quantification of GABAAR alpha3 
puncta density located within the midline of the rostral-caudal extent of the BLA. 
(B1) and (B2) show the comparative levels of GABAAR alpha3 subunit 
immunoreactivity within the BLA in tissue from control and stress animals 
respectively, reacted and imaged under identical conditions. A sub-population of 
GABAAR alpha3 puncta co-localised with inhibitory synaptic marker gephyrin 
(arrows). However, the majority of GABAAR alpha3 subunit immunoreactive 
puncta were not associated with those of the inhibitory synaptic marker, 
gephyrin (arrowheads).  N = 4 animals per group. Scale bar 5 μm. 
 
4.4.4. Repeated stress did not induce an anxiety-like behaviour as 
measured in the elevated plus maze, open field test or light dark box 
 
As animal stress paradigms are frequently used to induce an anxiogenic 
behavioural profile, the effect of this repeated stress paradigm on anxiety-like 
behaviour was characterised in three tests, namely the elevated plus maze 
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(EPM), the light dark box and the open field test (Fig. 4.5 A1-2). In the EPM, no 
effect of stress was observed on the time spent in the more aversive open arms 
(control, 48.7 ± 30.1 seconds versus stress, 38.4 ± 12.5 seconds; Student’s 
independent T test p = 0.3; N = 12 control and 11 stress animals), or the more 
sheltered closed arms (control, 194.8 ± 39.7 seconds versus stress, 189.2 ± 9.3 
seconds; p = 0.645, Student’s independent T test). It was notable how stress 
reduced the inter-animal variability in the behavioural measures of the elevated 
plus maze indicating that while not inducing anxiogenic behaviour, stress was 
impacting on their responses to novelty. To ensure this lack of anxiety-like 
behaviour in the elevated plus maze was not due to the use of this particular 
behavioural test, we confirmed this behaviour in another widely used test of 
anxiety-like behaviour, the light dark box (Fig. 4.5B1). Similarly, no effect of 
stress was observed in the time spent in the more aversive light compartment 
(control, 134.0 ± 48 seconds versus stress, 125.1 ± 27.9 seconds; p = 0.590, 
Student’s independent T test) or the more sheltered dark compartment (control, 
162.5 ± 38.3 versus stress, 163.7 ± 30.6; p = 0.767, Student’s independent T 
test, N = 14 control, 11 stress). However, there was a strong trend towards 
stress decreasing the latency to enter the dark compartment of the light dark 
box (Fig. 4.5B2-3). On average, animals exposed to repeated stress spent less 
time exploring the more aversive light compartment before entering the relative 
safety of the dark compartment, compared with the control animals (control, 
40.5 ± 42 seconds to enter the dark compartment upon first exposure to the 
apparatus versus stress, 9 ± 6 seconds; p = 0.059, Mann Whitney test). To 
further validate the observation that this repeated stress paradigm did not 
induce an anxiety-like phenotype, the time spent exploring the centre, middle 
and peripheral zones of an open field was analysed (Fig. 4.5C1-2). Rodents 
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inherently prefer to remain in more enclosed and sheltered areas. Thus, a 
relative increase in time spent in the peripheral zones of the open field and a 
decrease in the time spent in the centre provides a surrogate marker for 
anxiety-like behaviours in rodents. No effect of stress was observed on the time 
spent in the centre (control, 12.5 ± 7.0 seconds versus stress, 11.5 ± 5.5 
seconds; p = 0.533, Mann Whitney test; N = 16 control and 14 stress animals), 
middle (control, 56.6 ± 15.5 seconds versus stress, 55.1 ± 14 seconds; p = 
0.835, Mann Whitney test) or peripheral zones (control, 230.8 ± 21 seconds 
versus stress, 235.2 ± 22 seconds; p = 0.771, Mann Whitney test) of the open 
field.  
Collectively, these behavioural data indicate that while the repeated stress 
paradigm used in this study induced a robust increase in the expression of the 
GABAAR alpha3 subunit in brain regions associated with anxiogenic behaviour, 
such behaviour did not manifest in animals exposed to this stress paradigm. A 
simplistic conclusion from these studies would be that the stress-induced 
increase in GABAAR alpha3 subunit expression within the DRN and BLA is not 
important for anxiogenic-like behaviour in response to novelty.  
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Figure 4.5  
Eight days of repeated restraint stress does not result in anxiogenic-like 
behaviour, as measured in the elevated plus maze, light dark box and open field 
test  
(A1-A2) behaviour in the elevated plus maze was not influenced by repeated 
stress; the time spent exploring the open and closed arms of the elevated plus 
maze did not differ significantly across control and stress groups. Of note, 
stress appeared to reduce the inter-animal variability in time spent in both open 
and closed arms of the elevated plus maze. (B1) prior exposure to repeated 
restraint stress does not affect exploration of the more averse light compartment 
in the light dark box; the time spent in the dark and light compartments of the 
box did not differ significantly across stress and control groups. (B2) exemplar 
traces from control and stress groups depicting the trajectory of the animal upon 
its initial exposure to the light dark box.  (B3) following eight days repeated 
restraint, there was a strong trend towards a decreased latency to enter the 
dark compartment of the light dark box. (C1-2) anxiogenic-like behaviour in the 
open field test was not influenced by prior exposure to repeated stress. (C1) 
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depicts the different zones of the open field. (C2) as expected, animals spent 
less time in the inner zone compared with the middle and outer zones and spent 
the majority of time in the outer zone. However, the time spent in the outer, 
middle and inner zones of the open field did not differ significantly across stress 
and control groups. (C1)  (EPM N = 12 control, 11 stress, OFT N = 16 control, 
14 stress, LDB N = 14 control, 11 stress). 
 
4.4.5. Prior repeated stress enhances exploratory and locomotor activity 
when confronted with a novel environment 
 
We next explored how prior repeated stress impacts on exploratory and 
locomotor behaviour when exposed to a novel environment, namely the open 
field (Fig. 4.6). Stress did not alter the amount of time the animals spent in the 
centre, middle or peripheral zones of the open field. However, qualitative 
observations of the trajectory of the animal in the open field suggested that 
stress does impact upon some aspects of behaviour (Fig. 4.6). The total 
distance travelled in the open field within the 5 minutes of the test was used as 
a measure of locomotor activity (Fig. 4.6B). Repeated stress significantly 
increased the total distance travelled within the open field (mean ± SD; control, 
15.2 ± 4 metres versus stress, 19.8 ± 3.4 metres; p = 0.002, Student’s 
independent T test; N = 16 control and 14 stress animals).  The total number of 
entries into each pre-defined zone was used as a surrogate marker of 
exploratory activity (Fig. 4.6C). Stress significantly increased the total mean ± 
SD number of entries made into the centre, middle and peripheral zones of the 
open field (control,  81 ± 25 entries versus stress,  100 ± 19 entries; p = 0.029, 
Student’s independent T test). 
Thus, the stress-induced increased in locomotion and exploration together with 
the absence of any overt anxiogenic effect, could point towards a behavioural 
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phenotype geared to adaptive or survival promoting responses when confronted 
with novelty.   
 
Figure 4.6  
Eight days repeated restraint stress increases locomotor activity and exploration 
of a novel environment 
(A) exemplar traces of a control and stress animal depicting their trajectories in 
the open field. (B) exposure to prior stress increased the total distance travelled 
and the average speed within the open field. Points represent distances 
travelled and average speeds for individual animals during the 5 minutes of the 
open field test with the long horizontal bars representing the group mean and 
the short horizontal bars representing the group ± SEM. (C) prior exposure to 
repeated stress increases the total number of entries made into the inner, 
middle and outer zones of the open field. Points represent the total number of 
entries into the different zones for individual animals during the 5 minutes of the 
open field test with the long horizontal bars representing the group mean and 
the short horizontal bars representing the group ± SEM.  *P < 0.05, **P < 0.01, 
Student’s independent T test; N = 16 control and 14 stress animals) 
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4.4.6. Repeated restraint stress enhances active coping in response to 
the challenge of the tail suspension test 
 
To further enhance the argument that these stress-induced behaviours might be 
adaptive or survival-promoting mechanisms which contribute to active coping 
strategies when confronted with future adversity, we used the tail suspension 
test to assay behaviour when confronted with an acute challenge. The tail 
suspension test was initially developed as a way of assessing the efficacy of 
antidepressants and it is believed to provide information about the ability of an 
animal to cope with a behavioural challenge (Steru et al., 1985).  Animals 
treated with antidepressants engage in escape-directed behaviours for longer 
periods i.e. spend less time immobile, when compared with untreated animals. 
In this study, the tail suspension test was used to assess depressive-like 
behaviour in response to prior repeated stress. Consistent with the theory 
underlying the tail suspension test, both stress and control groups became 
more immobile as the test progressed. However, animals exposed to prior 
stress exhibited lower mean ± SD periods of immobility overall (control, 59.1 ± 
33.3 seconds versus stress, 28.4 ± 21.3 seconds; p = 0.011, Student’s 
independent T test; N = 12 control and 13 stress animals).  
Thus, animals exposed to stress exhibited more escape-like behaviour when 
confronted with a novel, acute stress further enhancing the supposition that the 
stress paradigm used results in adaptive behavioural response to future 
stressors.   
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Figure 4.7 
Eight days repeated stress reduces immobility in the tail suspension test 
(A) represents the mean ± SEM of the time in seconds the control and stress 
animals spent immobile within each 1 min epoch of the test. (B) represents the 
mean ± SEM time in seconds which the control and stress groups spent 
immobile over the whole period of the 5 minute test. *P <0.05, Student’s 
independent T test; N = control 12 and 13 stress animals. 
 
4.4.7. Repeated restraint stress improves performance in the novel 
object recognition test 
 
Cognition is central to navigating and contending effectively with daily 
challenges. As such, enhanced cognitive ability is likely to parallel any 
behavioural adaptations to prior stress. To further characterise the behavioural 
phenotypes arising from repeated restraint stress, behavioural correlates of the 
animal’s cognitive abilities were determined using the novel object recognition 
test which assays recognition memory and is reliant on an intact hippocampus 
(Buckmaster et al., 2004) (Fig. 4.8). 
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The test is comprised of three stages; i) an habituation stage on day 1 in which 
the animal is merely allowed to explore the test arena for 10 minutes in the 
absence of any objects; ii) a familiarisation stage on day 2 during which time the 
animal is re-exposed for 10 minutes to the test arena which now has two 
identical objects and; iii) a discrimination stage on day 3, during which time the 
animal is re-exposed for 10 minutes to the test arena. However, one of the 
previous objects is maintained (the familiar object) and the other is replaced by 
a new object (the novel object). A striking difference was revealed in the time 
spent exploring two identical objects in the familiarisation phase (Fig. 4.8A-B). 
Within the first 5 minute epoch, repeated stress animals did not affect the mean 
± SD total time spent exploring both identical objects (control, 16.8 ± 6.2 
seconds versus stress, 18.9 ± 6.2 seconds; p = 0.454, Student’s independent T 
test; N = 12 control and 10 stress animals). However, within the second five 
minute epoch, there was a marked decrease in the mean ± SD time stress 
animals spent exploring both identical objects (control, 17.5 ± 6.2 seconds 
versus stress, 7.5 ± 2 seconds; p  <0.001, Student’s independent T test). Thus, 
compared with control animals, stress animals spend less time concentrating on 
the individual objects and choose to explore the rest of the arena once 
familiarity has been gained with the objects. To evaluate whether the different 
cohorts were able to discriminate between the novel and familiar object and 
thus obtain an index of their recognition memory of their previous experience 
with the objects, the following formula for the discrimination index was used; d2 
= (b-a)/e2, where d2 is the discrimination index and is equal to the time spent 
exploring the novel object (b) minus the time spent exploring the familiar object 
(a), divided by the total time spent exploring both objects (e2). Thus, a 
discrimination index score of > 0 indicates the ability of the animal to 
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successfully discriminate between a novel and familiar object since they spend 
more time with the novel object relative to the familiar object. Despite stress 
animals displaying reduced exploration of two identical objects in the 
familiarisation phase, they exhibited a higher discrimination index (control, 0.23 
± 0.15 versus stress, 0.46 ± 0.16; p = 0.002, Student’s independent T test). This 
enhanced discrimination displayed by the stress group was only evident within 
the first 5 minute epoch since during the second 5 minute epoch, no effect of 
stress was observed on the discrimination between a novel and familiar object 
(control, 0.21 ± 0.23 versus stress, 0.14 ± 0.38; p = 0.60, Student’s independent 
T test). Thus, upon initial exposure to a novel object, animals exposed to prior 
stress showed higher indices of recognition memory by spending comparatively 
more time exploring the novel object. However, once explored, they engaged in 
exploratory behaviour of the rest of their surroundings which does not involve 
the objects. Once again, at a simplistic level, this suggests that prior stress 
results in a behavioural phenotype that is primed to efficiently take stock of any 
novel environment or experience which is essential for thriving in a constantly 
changing milieu.  
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Figure 4.8  
Eight days repeated stress improves performance in the novel object 
recognition test  
(A) shows the time individual animals spend exploring the two identical objects 
in the familiarisation stage of the test. Control animals explore the objects 
equally during the two 5 minute epochs of the test. Stress animals, while they 
explore the objects within the first 5 minute epoch to the same degree as 
controls, their exploration of the objects decreases significantly during the 
second 5 minute epoch compared with control.  (B) represents the data from (A) 
presented as mean ± SEM of the time in which animals from the control and 
stress groups spend exploring the familiar objects during the two 5 minute 
epochs of the test. There was no statistically significant effect of stress on the 
time in which animals spent exploring the two identical objects within the first 5 
minute epoch of the test. However, stress significantly decreases the time spent 
exploring the objects during the second 5 minute epoch of the test. (C) animals 
exposed to stress exhibited a significantly higher index of discrimination 
between the familiar and the novel object compared to control animals, but this 
difference was only evident during the exploratory behaviour during the first 5 
minute epoch of the trial. *P <0.05, **P <0.01, ***P <0.001, Student’s 
independent T test; N = 12 control and 10 stress animals).  
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4.4.8. Brain wide deletion of the GABAAR alpha3 subunit encoding gene, 
Gabra3, may alter the behavioural response to repeated restraint 
stress 
 
The molecular and behavioural data presented above suggest that exposure to 
a repeated mild stressor results in an increase in the expression of the GABAAR 
alpha3 subunit which parallels a behavioural phenotype that is suggestive of an 
enhanced adaptability to future stressors. The most definitive way of testing the 
interdependence of DRN-BLA-alpha3 expression levels and adaptability to 
future stressors would be to use mouse models in which the Gabra3 subunit 
gene is selective ablated within these particular brain regions using Cre-LoxP 
technology (Kos, 2004). This is currently not possible since no floxed alpha3 
subunit mouse models are available (Uwe Rudolph, personal communications). 
The next best strategy is the use of constitutive Gabra3 subunit gene-deleted 
mice which are available (Yee et al., 2005).  
We therefore acquired this mouse strain and attempted to establish the colony 
at the University of Portsmouth. It has proven extremely difficult to obtain 
sufficient numbers of animals within the limited time that remained within this 
PhD project. Within this time frame, we managed to raise only 5 alpha3-KO 
mice which were at comparable ages and thus suitable for behavioural 
experiments. Together with a further 5 wild-type (WT) littermates, we had a total 
study cohort of 10 animals. The ideal design of the study would be to have the 
following experimental groups: 1) N = 5 WT-control; 2) N = 5 alpha3-KO-control; 
3) N = 5 WT-stress and; 4) N = 5 alpha3-KO-stress. Since we did not have 
sufficient animal numbers for all the ideal groups, we chose to pursue only 
groups #3 and #4 as a purely exploratory exercise. Even though we are aware 
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that this strategy does not provide us with baseline data on the starting 
behavioural phenotype of the alpha3-KO animals prior to exposure to stress 
(group 2 would provide those data), we feel that investigating whether KO 
animals exposed to this stress paradigm respond differently to WT littermates 
exposed to the same stress protocol at the behavioural level would at least 
provide the rationale for future studies. Despite the lack of alpha3-KO baseline 
behaviour under our conditions, it should be noted that a prior study reported no 
significant difference in baseline anxiety-like behaviour in alpha3-KO mice 
compared with WT animals. However a modest increase in the locomotor 
activity of alpha3-KO animals in the open field compared was observed (Yee et 
al., 2005). 
We therefore exposed both the WT and alpha3-KO animals to the repeated 
stress paradigm and assayed their behaviour using the models previously 
described (Fig. 4.9). There was no effect of genotype on the time the animals 
spent in the centre (WT, 14.1 ± 6 seconds versus KO, 11.6 ± 7 seconds; p = 
0.548, Mann Whitney test), or peripheral zones (WT, 214.2 ± 12.4 seconds 
versus KO, 227.7.2 ± 16.4 seconds; p = 0.222, Mann Whitney test) of the open 
field in response to stress. Although there was no statistically significant effect 
of the GABAAR alpha3 subunit deletion on the mean ± SD time spent in the light 
and dark compartments of the light dark box,  there was a trend towards the 
alpha3-KO mice spending less time within the light compartment (WT, 120.76 ± 
41 seconds versus WT, 89.06 ± 22 seconds; p = 0.076. Mann Whitney test). 
This could suggest a trend towards an anxiety-like phenotype, as measured in 
the light dark box. In terms of locomotor activity in the open field, the absence of 
the GABAAR alpha3 subunit resulted in a statistically significant decrease in the 
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speed of locomotion (WT, 0.09 ± 0.02 m/sec versus KO, 0.06 ± 0.014 m/sec; p 
= 0.019, Mann Whitney test).  A strong trend towards decreased exploration 
was also observed since alpha3-KO mice made fewer total entries into each 
zone of the open field (WT, 157 ± 31 entries versus KO, 113 ± 39 entries; p = 
0.056, Mann Whitney test). There was no significant difference in the 
recognition memory performance between genotypes when assessed in the 
novel recognition test (discrimination index: WT, 0.41 ± 0.24 versus KO, 0.24 ± 
0.17; p = 0.421, Mann Whitney test). There was also no differences in 
depressive-like behaviour between genotypes when total immobility time was 
assess in the tail suspension test (WT, 60.7 ± 44.8 seconds versus KO, 110.7 ± 
70.14 seconds; p= 310, Mann Whitney test). An overview of the raw 
behavioural data pertaining to the WT-KO stress cohorts as well as the control-
stress cohorts is provided in Table 4.3. This data suggest that certain stress-
induced behaviours are dependent on plasticity of the GABAAR alpha3 subunit. 
Future experiments remain to determine whether the behavioural phenotype of 
WT and alpha3-KO animals differ without prior exposure to stressors, and with 
a greater sample size, whether other behavioural measures emerge to be 
statistically significantly different. 
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Table 4.3 
Quantitative data of the influence of stress on the behavioural parameters of 
C57BL/6J, gabra3WT and gabra3KO mice (data are presented as mean ± SD, 
P* <0.05, P** <0.01). 
 
 
CONTROL STRESS STRESS 
 
C57BL/6J Gabra3 WT Gabra3 KO 
Open field test 
    locomotor activity 
(m/sec) 0.051 ± 0.01 0.066 ± 0.01** 0.096 ± 0.02 
0.064 ± 
0.01* 
time in centre 12.6 ± 7 11.5 ± 1 14.1 ± 6 11.6 ± 7 
time in periphery 230.8 ± 21 235.5 ± 22 214.2 ± 12 227.7 ± 16 
no. of entries 81 ± 26* 100 ± 19 156.8 ± 31 112.6 ± 39 
Light dark box     
  time in light 134 ± 48 125 ± 118 120.8 ± 41 89.1 ± 22 
latency to enter 
dark 40.5 ± 42 9 ± 7 5.6 ± 6 4.72 ± 3 
Novel object 
recognition     
  discrimination 
index 0.23 ± 0.1 0.46 ± 0.2** 0.41 ± 0.2 0.24 ± 0.2 
Tail suspension 
test     
  time spent 
immobile 59.1 ± 33 28.4 ± 21* 60.7 ± 45 110.7 ± 70 
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Figure 4.9 
Brain wide deletion of the gene encoding for the GABAAR alpha3 subunit alters 
some aspects of the behavioural response to repeated restraint stress 
(A1, B1) when the eight day repeated stress paradigm was applied to Gabra3 
knockouts (KO) and their wild type (WT) littermates, no anxiety-like phenotype 
was detected in the open field test or the light dark box. (A2, A3) however, 
deletion of the Gabra3 gene reduced the locomotor activity in the open field in 
response to stress. This is in contrast with prior data on the influence of 
repeated stress on C57BL/6J mice relative to non-stressed controls, in which 
locomotor activity was significantly increased by prior stress exposure. (C) the 
influence of stress on discrimination between a novel and familiar object in the 
novel object recognition test was unaltered by the absence of the GABAAR 
alpha3 subunit. (D) depressive-like behaviour was assessed by immobility in the 
tail suspension test. The absence of the GABAAR alpha3 subunit did not 
produce a significant difference in time spent immobile following prior stress 
exposure (N = 5 animals per group). *P < 0.05, **P < 0.01.  
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4.4.9. A severe acute stressor in the form of the tail suspension test 
increases GABAAR alpha3 subunit expression in the DRN but not in 
the BLA 
 
The expression of the GABAAR alpha3 subunit appears sensitive to repeated 
restraint stress. We then investigated whether the acute stress also impacts on 
GABAAR alpha3 subunit expression. The tail suspension was used as an 
uncontrollable acute stressor and the fluorescence intensity of GABAAR alpha3 
subunit immunoreactivity in the DRN and BLA was examined by 
immunohistochemistry. Note that for earlier studies, we quantified GABAAR 
alpha3 subunit immunoreactivity within the DRN by counting individual puncta. 
In this series of experiments, we quantified the densitometry of the global 
GABAAR alpha3 subunit immunofluorescence signal within the DRN and BLA. 
Our unpublished data show that both methods faithfully relay any significant 
changes in expression levels. However, this higher throughput method allowed 
for the inclusion of these remaining data in this thesis. Only 5 minutes of tail 
suspension was sufficient to induce a statistically significant 17% increase in the 
mean ± SD fluorescence intensity (arbitrary units, AU) for the GABAAR alpha3 
subunit within the DRN (for (control, 9.1 ± 3.6 AU versus stress, 10.6 ± 4 AU; p 
= 0.007, Mann Whitney test, N = 4 control and 4 stress animals). In contrast, no 
change in the mean ± SD fluorescence intensity for the GABAAR alpha3 subunit 
within the BLA following tail suspension test (control, 12.9 ± 2.4 AU versus 
stress, 13.6 ± 3.2 AU; p = 0.489, Mann Whitney test, N = 4 control and 4 stress 
animals). The implication is that distinct neural circuits mediate the effect of 
acute and repeated stress.  
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Figure 4.10 
Exposure to an isolated acute stressor in the form of 5 minutes of tail 
suspension increases GABAAR alpha3 expression in the DRN but not in the 
BLA 
(A1, A2) GABAAR alpha3 subunit immunoreactive puncta were localised to the 
somata and dendrites of TPH immunopositive profiles. (B1, B2) acute stress 
increased the intensity of GABAAR alpha3 subunit puncta within the DRN, on 
both TPH immunopositive dendrites and somata. Scale bar 5 μm. 
 
Finally, in order to provide the anatomical substrates by which stress could 
impact on DRN GABAAR expression, we examined the immunohistochemical 
association of GABAAR-associated machinery with that of the stress-related 
peptide, CRH. The DRN is extensively innervated by CRH containing fibres 
(Valentino et al., 2001, Waselus et al., 2005) and it is CRH which mediates the 
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effects of stress on DRN activity and impacts upon stress-related serotonin 
release in DRN target fields (Price et al., 1998, Kirby et al., 2000, Price and 
Lucki, 2001). CRH immunoreactive profiles were closely opposed to gephyrin 
immunoreactive puncta located on TPH profiles (Fig. 4.11A), as well as 
appearing closely opposed to GABAAR alpha1 subunit immunoreactivity which 
outlined the membrane of a non-TPH neuron (Fig. 4.11B). This suggests that 
CRH is directly released onto GABAAR-expressing synapses. Future studies 
are in place to expose animals to the same stress protocol with and without the 
administration of CRH receptor antagonists in order to determine whether CRH 
receptor activation is linked to stress-induced GABAAR plasticity.  
 
Figure 4.11 
CRH immunoreactive puncta oppose gephyrin and GABAAR alpha1 subunit 
immunoreactivities on TPH and non-TPH profiles within the DRN 
(A) discrete CRH immunoreactive puncta were closely opposed to TPH 
immunopositive profiles within the DRN (arrowheads). (B) non-TPH positive 
neurons displayed CRH immunoreactive signal closely opposed to GABAAR 
alpha1 subunit immunoreactivity which outlines the membrane of a non-TPH 
cell within the DRN (arrowheads). Scale bar 5 μm 
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4.5. Discussion 
 
The current study provides evidence for the stress induced plasticity of the 
GABAAR system at both the mRNA and protein level in a brain region and 
subunit specific manner. In addition, this stress-induced GABAAR expression 
plasticity presented concurrently with a behavioural phenotype which appeared 
to be geared towards adaptability to future stressors. The implication is that the 
level of expression of GABAARs is dynamic and varies according to life 
experience and behavioural state. 
4.5.1. Stressors alter GABAAR expression in a brain region, GABAAR 
subunit and stressor specific manner 
 
Most studies have focused on changes in composite GABAAR function rather 
than receptor subtype, in these brain regions in response to acute stress, in 
rats. Acute swim stress in rats reportedly resulted in an increase in the 
frequency of miniature inhibitory postsynaptic currents on serotonergic neurons 
(Lamy and Beck, 2010). A recent study from the Beck group has reported 
attenuated inhibitory synaptic input onto serotonergic neurons following 5 days 
of social defeat (Crawford et al., 2013). In addition, this group has also reported 
that the application of the stress neuropeptide CRH has both direct and indirect 
effects on GABAergic currents on serotonergic neurons (Kirby et al., 2008). A 
caveat to all these findings is the recording configuration adopted in these 
studies. They state that they are measuring GABAergic currents since they 
block all glutamatergic events. However, the DRN serotonergic neurons receive 
strong glycinergic input (Jeremy Lambert, Delia Belelli, personal 
communications). Thus, some of the changes in inhibitory events could be 
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glycinergic. Finally, early life environment has been shown to influence the 
expression of GABAAR subunit encoding mRNA in the amygdala and LC of rats; 
the DRN was not reported on (Caldji et al., 2003). Thus, this is the first study to 
provide a high resolution analysis of the changes in the expression of individual 
GABAAR subunits within the cellular networks of the DRN and amygdala in 
response to repeated or acute stress. The implication is one’s individual 
complement of GABAARs within such brain regions is a manifestation of the 
one’s life experience in terms of the challenges contended with on a day to day 
basis.  
It is intriguing that the trajectory of the stress-induced change in GABAAR 
alpha3 subunit was towards an increase in expression, suggesting enhanced 
alpha3 subunit containing GABAAR synaptic transmission. Generally, stress-
related mental illnesses such as anxiety are treated with agents, such as 
benzodiazepines, which enhance GABAAR-mediated synaptic transmission. 
This suggests that such stress-induced disorders arise from decreased native 
GABAAR function which might infer decreased GABAAR expression in such 
conditions. Indeed, evidence has been provided for reduced GABAAR 
expression in the pathophysiology of stress related psychiatric disorders 
(Bremner et al., 2000, Merali et al., 2004, Sanacora et al., 2004, Poulter et al., 
2008). Thus, since this repeated stress paradigm apparently resulted in a 
GABAAR expression profile that might be diametrically opposite to that expected 
in stress related disorders, it is tempting to speculate that such transient 
exposure to stressful situations/experiences is beneficial for future adversity and 
that GABAARs are integral to such processes. Additional fodder for this 
speculation is the stress-induced behavioural profile of the animals in response 
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to novelty such as the absence of anxiogenic-like behaviour, increased 
locomotor and exploratory behaviour as well as enhanced memory retention. 
While it is far-fetched to try to find correlations between the behaviour of a 
rodent with that of human mental function, it could be extremely beneficial to 
uncover the underlying mechanisms which are involved in the trafficking of such 
receptors. If so, the manipulation of such mechanism could be used as 
surrogates of the repeated stress protocol and thus exploited for therapeutic 
potential if such GABAAR expression profiles prove to be beneficial in terms of 
mental health. 
4.5.2. Potential mechanisms underlying stress-induced plasticity in 
GABAAR subunit expression 
 
Multiple and distinct mechanisms are likely in place to modulate stress-induced 
GABAAR alpha3 subunit expression. Glucocorticoids, as a result of the HPA 
axis activation, are central molecular players of the stress response and signal 
both peripherally and centrally to engage metabolic and neural process required 
for dealing with adversity. As such, the signal transduction cascades initiated by 
such steroid hormones and their derivatives are well placed to dynamically 
regulate gene transcription in response to an external stimulus. Chronic 
exposure to glucocorticoids has been shown to elevate GABAAR subunit mRNA 
expression within the hippocampus (Orchinik et al., 1995). As the DRN 
expresses high levels of glucocorticoid receptor (Aronsson et al., 1988), 
glucocorticoid mediated regulation of transcription may mediate the stress 
induced increases in GABAAR subunit mRNA in the DRN shown here. 
Interestingly, GABAAR subunit mRNA expression within the LC, a region of 
enriched glucocorticoid receptor expression, was not affected by repeated 
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stress. The obvious caveat is that stress might affect GABAAR subunit 
expression within the LC at the protein level. Nevertheless, this suggests that 
multiple mechanisms are in place to regulate GABAAR mRNA expression in a 
brain region specific manner. Other potential mechanisms may include 
epigenetic influences such as dinucleotide methylation of cytosine-
phosphodiester bond-guanine (CpG) islands (Weaver et al., 2006) and histone 
modification (Renthal et al., 2007, Uchida et al., 2011). Both mechanisms have 
received considerable attention recently in mediating the effects of 
environmental factors on brain function, behaviours and psychiatric diseases 
(Tsankova et al., 2007). Bioinformatic analysis of the Gabra3 gene revealed the 
absence of a CpG island within or near the Gabra3 promotor sequence; this 
suggests that if epigenetic mechanisms do contribute to the regulation of 
Gabra3 gene transcription, it is unlikely to be mediated by changes in the 
methylation status of CpG dinucleotides. Several different types of post 
translational histone modifications exist. However, acetylation and methylation 
are the most widely studied. Histone deacetylase inhibitors have been shown to 
influence GABAAR subunit mRNA expression in the nucleus accumbens 
(Kennedy et al., 2013). Therefore, it is possible that post translational histone 
modifications may also contribute to stress induced alterations in GABAAR 
subunit mRNA plasticity within the DRN. Evaluation of epigenetic changes in 
GABAAR subunit expression could represent new avenues for investigating how 
environmental factors such as stress, shape brain function and behaviour. 
In addition to increased GABAAR alpha3 mRNA levels, we also show that stress 
increases the expression of the GABAAR alpha3 subunit at the protein level. 
Through extensive intracellular signalling cascades, encompassing a vast array 
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of proteins, trafficking pathways dynamically regulate the distribution and 
number of diverse GABAAR subtypes within the cell membrane (Luscher et al., 
2011). Due to the complexity of GABAAR trafficking, multiple points along the 
secretory or endocytotic pathway may be targeted to influence GABAAR 
expression and in turn neuronal activity. Clathrin-mediated endocytosis is an 
important factor in regulating GABAAR expression (Kittler et al., 2000). The 
phosphorylation status of beta subunits of GABAARs has a major role in 
regulating the clathrin mediated endocytosis of such receptors. When specific 
residues of the GABAAR beta subunits are phosphorylated, the affinity between 
the GABAAR beta subunit and clathrin adaptor protein (AP2) is reduced thereby 
attenuating receptor endocytosis (Kittler et al., 2005). A number of proteins can 
phosphorylate GABAAR beta subunits including protein kinase A, C and B 
(PKA, PKC, PKB) as well as calmodulin dependent kinase II (CaMKII). A 
potential trigger of such secondary messenger cascades is likely to be the 
endogenous stress hormone CRH. Receptors for CRH are coupled to diverse 
intracellular signalling pathways which activate kinase pathways including PKA 
and PKC (Hauger et al., 2009). Since CRH together with both receptors for 
CRH, CRH-R1 and R2, are expressed and mediate the effects of stress on 
DRN neuronal activity (Kirby et al., 2000), CRH is the likely candidate through 
which stress can dynamically regulate the expression of GABAAR subtypes via 
PKA or PKC mediated phosphorylation of GABAAR beta subunits. 
One particularly intriguing finding of this study was that repeated stress impacts 
upon GABAAR alpha3 subunit expression at both mRNA and protein levels. 
This is surprising as the constitutive activity of endoplasmic reticulum (ER) 
degradation enzyme results in it being more efficient to recycle endocytosed 
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GABAARs, as opposed to transporting newly assembled receptors from the ER 
to the cell membrane. Thus, the influence of environmental stimuli at both the 
gene and protein levels suggests that this stress exposure exerted a high 
demand on the cell’s alpha3 subunit containing GABAAR machinery. Therefore, 
despite the variety of intracellular signalling cascades available for dynamic 
regulation of GABAAR trafficking, the cell also needs to resort to utilising less 
energy efficient processes. These processes are likely to serve the cell well 
during short-term bouts of stress. However, it could be speculated that during 
severe chronic periods of stress, especially episodes which trigger mental 
disorders, such molecular pathways are exhausted. To explore this, 
experiments are in the process of being undertaken by exposing animals to 
periods of restraint stress beyond the 8 days used in this study. The expectation 
is that longer periods of stress will eventually manifest in lower levels of 
GABAAR expression within the DRN. If so, this could lead to the anxiogenic 
profile which requires benzodiazepines to augment the activity of the remaining, 
diminished levels of GABAARs. Such data could provide a wholly novel avenue 
on the biological mechanisms which underpin adaptive or maladaptive stress 
pathways which may contribute to the identification of newer and more effective 
drug targets for the treatment of stress-related psychiatric disorders. 
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5. General discussion 
5.1 Methodological considerations 
Immunohistochemistry with confocal microscopy can provide a visually 
appealing way of localising specific proteins within different brain regions. 
Moreover, double, triple and quadruple immunolabelling described within this 
thesis, provides important information about the context i.e. which brain region, 
which of the cells within that brain region and which cellular compartment 
expresses a certain protein? Immunohistochemistry coupled with confocal 
microscopy can also provide some information about the sub-cellular location of 
proteins of interest, such as whether they are synaptic or extrasynaptic. 
However, this is limited by lack of resolution which is about 1 µm, as such 
confocal microscopy cannot reveal the components of individual synapses, 
which are only around 100 nm. Thus in this study, immunoreactive puncta 
represent clusters of a particular protein and it cannot be definitively stated 
whether a protein is located synaptically or non-synaptically. Immunogold 
labelling of freeze fractured replicas (FRIL) (Kasugai et al., 2010) is the ultimate 
method for the quantification of integral membrane proteins within sub-cellular 
compartments.  or a comparison between confocal microscopy and  RIL see 
 igure 5.1.  or this method tissue sections are fractured at 120  C, the fractured 
tissue is then coated with carbon and platinum and the remaining tissue is 
digested away with SDS. What remains is the exposed cytoplasmic face of the 
cell membrane, including any integral membrane proteins. Combining electron 
microscopy with FRIL provides the resolution to detect receptors present at low 
density such as those in extrasynaptic compartments. In this study, FRIL would 
not only provide important information about the location and density of different 
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GABAAR subunits on the cells which comprise the LC and DRN, but would be 
the most sensitive method for quantifying stress induced plasticity in GABAAR 
subunit expression and localisation. 
 
Figure 5.1 A comparison between confocal microscopy and Freeze Fracture 
Immunogold Labelling. (A) Shows a confocal image of clusters of GABAAR 
alpha2 subunit immunoreactivity decorating TPH immunopositive profiles in the 
DRN. Each immunoreactive puncta represents clusters of receptors. In contrast, 
(B) shows an electron microscopy image following FRIL of GABAAR beta3 
subunit immunolabelling on a pyramidal cell body of the hippocampus, note the 
scale bars between panels A and B. The higher resolution of electron 
microscopy allows visualisation of individual synapses (1 and 2). Here, each 
gold particle represents a single receptor. (Panel (B) is modified from Kasugai 
et al., 2010). 
 
Although I have shown the application of GABAAR ligands influences the 
excitability of noradrenergic neurons in whole cell patch clamp experiments, 
these experiments could be further refined by altering the configuration of the 
patch clamp. In whole cell configuration the intracellular solution within the 
electrode dilutes the cytoplasmic contents of the recorded neuron, and is 
therefore not the most physiological preparation. Using a cell attached 
configuration would allow the membrane potential to be recorded without 
dialysis of the cytoplasm. Alternatively, using sharp microelectodes, the 
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membrane potential of a cell can be recorded with minimal disruption to the 
ionic constituents of the cytoplasm. 
 
In this study, qRT-PCR has provided an insight into stress induced plasticity in 
GABAAR subunit expression at the transcriptomic level. However, the DRN and 
LC are very small brain regions at around ~ 2mm wide, within a 2 mm diameter 
tissue punch other non-DRN and non-LC brain regions are likely to be included. 
Moreover, with the technique used in this study it is not possible to look at the 
mRNA expression in topographically or neurochemically distinct neurons. Single 
cell qRT-PCR would allow the investigation of neurons within distinct sub-
divisions of the LC and DRN. This could be performed by using a patch 
electrode in an acute slice of LC or DRN to asparate the contents of the 
cytoplasm for subsequent reverse transcription and qPCR. However, 
contaminants from the electrode entering and leaving the slice could confound 
any potential findings. The most effective way to investigate mRNA levels in 
neurochemically diverse cell types could be to sort out the 
serotonergic/noradrenergic neurons from the non-serotonergic/noradrenergic 
neurons by fluorescence-activated cell sorting, which could be performed by 
using a mice expressing a fluorescent reporter under the promotor of the 
serotonergic or noradrenergic synthesising enzymes, or more recently a 
Figure 5.2 Comparison between whole 
cell and cell attached patch clamp 
configurations. 
In whole cell mode, the intracellular 
solution (in blue) becomes continuous 
with the cell’s cytoplasm, disrupting the 
ionic composition within the cell. In cell 
attached mode, the intracellular solution 
does not come into contact with the 
cytoplasm and the ionic constituents of 
the cell are unperturbed. 
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technique has been developed to sort neurochemically diverse neurons in wild 
type brains using commercially available antibodies (Barber et al., 2012).  
 5.2 The importance of my findings 
With the behavioural techniques used in this thesis I have been able to 
demonstrate that repeated stress favours a more adaptive behavioural coping 
style in response to novelty. However, the tail suspension test of depressive-like 
behaviour has been replaced more recently in the literature with the social 
interaction test, whereby a mouse is placed in an open field which has a second 
mouse contained within a small compartment, thus former animal is thus able to 
explore the open field and the amount of time spent exploring the interaction 
zone which contained the second mouse is quantified. This test attempts to 
model the social withdrawal displayed by depressed patients. This social 
interaction test also displays greater face validity than the tail suspension test 
because only after chronic, not acute antidepressant treatment does the animal 
spend more time within the interaction zone, thus modelling the clinical onset of 
current antidepressant treatments (Tsankova et al., 2006). Therefore this study 
may be improved by using a greater variety of tests for depressive-like 
behaviour including the social interaction test. 
 
For this PhD project, I set out to determine which GABAAR subunits are 
expressed throughout the neurochemically diverse cell types which comprise 
the neuronal networks of the LC and DRN, what effect exposure to 
environmental stress has on such expression patterns, and how these altered 
expression patterns may correlate with the ensuing behavioural phenotype of 
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the animal. These aims have been met resulting in a unique contribution to our 
understanding of the GABAAR system and its likely contribution to the regulation 
of neuronal activity within brain regions which are central to the processing of 
emotional stimuli and thus at the nexus of associated mental illnesses. Since I 
have Discussion sub-sections within the individual chapters which analyse in 
detail the results from each Chapter, below, I target the discussion to the 
functional implications of the composite expression data arising from the PhD 
project as a whole. I also take the liberty to venture bold predictions on the 
future direction of this research.  
5.3. GABAAR expression in the LC and DRN; why so similar yet so different? 
 
A skill I have learnt to appreciate as my PhD progressed is the need to pose 
questions which, on the surface, might seem overly simplistic. For example; 
why on earth would a brain need so many different GABAAR subunits, and why 
are they conserved throughout various different species? The obvious answer is 
that diversity and versatility in GABAergic signalling poses a significant 
evolutionary advantage which is essential for the survival of the species. If this 
supposition is correct, the aggregation of particular GABAAR sub-types to 
particular brain regions and cell types is functionally significant in terms of 
adaptability and survival. From this, further questions are drawn, such as why is 
expression of alpha3 subunit containing GABAARs in the LC and DRN, but not 
in cortical pyramidal cells required for optimal brain function? It is not a 
coincidence that the diffuse monoaminergic modulatory systems are enriched in 
alpha3 containing GABAAR subtypes. This brain region specific expression 
profile represents the fruits of a genetic blueprint designed to enable a species 
to thrive in its particular environment. Thus, evolution decided that in order to 
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promote survival, monoaminergic transmission must be under the regulation of 
the slower activation and deactivation kinetics of the alpha3 containing GABAAR 
subtypes, as opposed to the faster kinetics of alpha1 containing GABAAR 
subtypes. Since the impact on brain noradrenaline and serotonin levels 
following the deletion of these GABAAR subtypes enriched in monoaminergic 
brain regions has yet to be determined, one is left to theorise based on 
anatomical data within such regions (this thesis) and functional data from other 
brain regions (the published literature).  
As the expression of diverse GABAAR subtypes exerts exquisite temporal and 
spatial control over the release of cellular contents. If we consider not only the 
functional roles of the different substances being released from monoaminergic 
neurons compared with pyramidal cells, but also when they need to be released 
in order to bring about different brain states and behaviour. It will be possible to 
theorise how the GABAAR expression profiles described in this thesis contribute 
to the development of such complex brain states.  
Monoamines do not participate as primary neurotransmitters such as glutamate, 
but rather modulate on-going neuronal activity and support the encoding of 
information related to diverse stimuli. Thus the patterns of monoaminergic 
neuronal activity resulting from GABAAR alpha3 subunit mediated cellular 
control may be important determinants of brain function. If so, what is the 
correlation between GABAAR kinetics, neurotransmitter/modulator release and 
brain-behaviour state? If one takes the case of mood, a focus of this 
programme of work, it is influenced by brain serotonin and noradrenergic levels. 
As such, mood stability in the face of a constantly changing environment is 
essential for well-being. At the other end of the spectrum, erratic mood swings 
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represent an inability to cope with changing environments and in extreme cases 
manifest as bi-polar disorders. Thus, the complement of GABAAR expression 
within mood related brain circuits needs to ensure the pattern of neuronal 
activity of the principal cells provides optimal fluctuations in noradrenaline and 
serotonin release required to correctly encode information related to diverse 
stimuli. One would thus not expect a stop-start approach to neuronal activity 
within brain regions tasked with such responsibilities; rather, one would expect 
a rhythmically flexible pattern that seamlessly transitions across changes in on-
going neuronal activity. How then, theoretically, could, the GABAAR expression 
patterns within the LC and DRN contribute to such patterns of cellular 
excitability? The GABAAR alpha2 and alpha3 subunit were the main subunits 
expressed on the principal cells of the LC and DRN on both synaptic and 
extrasynaptic cell surfaces. This partitioning onto synaptic and extrasynaptic cell 
surfaces determines the magnitude of either the fast, though short-lived phasic 
inhibition of neuronal activity, or the longer, sustained tonic inhibition. It is the 
balance between these two forms of GABAAR-mediated inhibition that will, in 
part, determine the pattern of release of noradrenaline and serotonin. While 
most neurons which express GABAARs exhibit the phasic forms of inhibition, 
tonic currents are only expressed in a select population of neurons (Semyanov 
et al., 2003). Furthermore, different GABAAR subtypes appear to determine cell-
specific tonic currents. For example, alpha4-delta subunit containing GABAARs 
underlie tonic inhibitory currents in the thalamus and dentate gyrus (Chandra et 
al., 2006) whereas alpha3 subunit containing GABAARs underlie tonic inhibitory 
currents in the amygdala (Marowsky et al., 2012), a region integral to the 
processing of stress or emotion associated information that is routed through 
LC and DRN pathways. Thus, the deliberate expression of both tonic and 
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phasic forms of inhibition on the DRN and LC is likely to be predictive of the 
importance of the balance of such forms of neuronal control during associated 
brain functions. At a systems level, one can understand the importance of a cell, 
involved in modulating brain or behaviour in an on-line or real-time manner, 
having fast, but short lived phasic inhibitory currents in its armoury with slower, 
sustained inhibitory currents in the background. I feel it’s analogous to steering 
a car down a winding descent. Consider having to approach such a task with a 
car that has a breaking system which allows for rapid deceleration only for a 
short period, but is ineffective upon continuous application (analogous to 
GABAARs which underlie fast phasic inhibitory currents but rapidly desensitise 
in the presence of sustained GABA presence). In contrast, the navigation 
through such a twisting descent would be far smoother if the car was also 
equipped with an additional breaking system that allowed for the sustained 
control of speed, analogous to GABAARs which underlie slow, persistent tonic 
currents which do not desensitise in the presence of sustained GABA presence. 
So to, one might expect for cell-types which drive emotions across the twists 
and turns of life. I therefore feel that the importance of tonic inhibition in 
particular is under-recognised in terms of the neurobiology of mood or emotion. 
This is because I think that any changes in the GABAAR synaptic extrasynaptic 
expression ratios will change the balance of phasic and tonic currents which will 
deprive the neuron of the flexibility to respond to the challenges faced in 
everyday life at the level of the LC and DRN and thus contribute to the 
pathophysiology of mood disorders. This assertion is supported by the array of 
clinical evidence for altered noradrenaline and serotonin release in the context 
of psychiatric disorders (Stockmeier et al., 1998, Underwood et al., 1999, 
Baumann et al., 2002, Boldrini et al., 2005, Bach-Mizrachi et al., 2005, Gos et 
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al., 2008). Yet, the role of changed GABAAR synaptic extrasynaptic expression 
ratios has simply not been considered in such disorders. I therefore predict that 
the elucidation of changes within the patterns of phasic and tonic inhibition in 
associated brain regions will be a focus of research in mental health conditions.  
Within this argument, I would, however, not like to create the impression that 
the GABAAR expression pattern is identical in neurons of the LC and DRN. 
Indeed, the degree of synaptic and extrasynaptic located alpha2 and alpha3 
containing GABAARs differed between the LC and the DRN. Alpha3 containing 
GABAARs were the predominantly synaptically localised receptor within the LC, 
but the alpha2 containing GABAARs were the predominant synaptically 
localised receptor within the DRN. However, in both LC and DRN, alpha3 
containing GABAARs were localised to non-synaptic specialisations of the 
principal noradrenergic/serotonergic neurons. This suggests that distinct 
subunits mediate different forms of GABAergic inhibition within the LC 
compared with the DRN.  
 
5.3. The levels of GABAAR expression determine behavioural responses to 
future challenges 
 
The sub-chronic, repeated stress paradigm used here increased the GABAAR 
alpha3 subunit mRNA within the DRN, but not the LC, and increased alpha3 
protein expression in the DRN and BLA. This suggests that mechanisms are in 
place to transduce an external signal, the stressor, into a cellular response are 
divergent across brain regions. This GABAAR alpha3 plasticity was 
accompanied by the development of more adaptive like responses to novelty, 
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although it is difficult to categorically state that any behaviour is adaptive in the 
context of the laboratory rodent. When you consider the mouse, an animal 
which inherently fears predator attack, enhanced exploration and locomotion, 
recognition memory and a greater desire to respond in an active manner to 
challenging situations could be construed as survival promoting behaviour. 
These data suggest that this stress paradigm increases synaptic and 
extrasynaptic alpha3 containing GABAARs within the DRN serotonin neurons. 
The functional implication of such plasticity could be to limit DRN serotonin 
output, as an enhanced excitatory drive would be required to overcome the 
potentiated GABAergic tone. In line with this finding, decreased brain serotonin 
has been found to favour the adoption of more adaptive like behaviours in 
response to a stressful stimuli (Howard et al., 2008). It is intriguing that such 
stress-induced increases in GABAAR subunit expression did not manifest in the 
LC. This lends further weight to the argument above that such stress-induced 
changes are adaptive. Indeed, a hallmark of the LC-stress response, and thus 
adaptive response to future stressors, is increased tonic LC neuronal activity. 
Thus, any stress-induced increase in alpha3 subunit expression on LC 
noradrenergic neurons would likely dampen LC neuronal activity, the complete 
opposite of what is needed.  Thus, this brain-region specific effect of stress on 
GABAAR expression is highly choreographed.  
The amount of GABAAR which reaches the cell membrane is dependent on two 
mechanisms, the more efficient recycling of endocytosed receptors back to the 
extracellular space, or the less efficient exocytosis of newly formed receptors 
from the ER. The repeated stress paradigm used here appeared to engage both 
mechanisms to increase alpha3 containing GABAAR expression. Suggesting a 
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high demand on the cell to elevate GABAAR mediated inhibition. Thus dynamic 
regulation of GABAAR expression is important for defining behavioural response 
to stressors. 
5.4. The GABAAR alpha1 subunit underlies local circuit control of LC and 
DRN principal neurons 
 
The neurochemically diverse cell types which comprised the cellular networks of 
the LC and DRN express distinct GABAAR subunits. In this study, the GABAAR 
alpha1 subunit was localised exclusively to the non-principal, non-noradrenergic 
cell types of the LC and predominantly on GABAergic neurons of the DRN. At 
least 4 different types of LC GABAAR alpha1 expressing neuron were identified 
based on their divergent neurochemistry. The diversity displayed by the 
GABAAR alpha1 expressing neurons of the LC is reminiscent of the other 
defined and well classified interneuron networks of the cortex and hippocampus 
(Freund, 2003). Despite some additional published anatomical evidence for the 
existence of a pool of local circuit interneurons within LC (Aston-Jones et al., 
2004) there has been no functional characterisation of such cells. LC 
noradrenergic neurons display diversity in terms of their morphology, 
neurochemical content and efferent targets (Holets, 1988). As such, this 
putative pool of interneurons may serve to organise LC noradrenergic neurons 
into functionally distinct sub-populations. The significance for such an 
interneuron network could be to further integrate information conveyed to the 
LC through diverse afferents and allow LC noradrenergic activity to be 
exquisitely regulated within strict temporal windows to permit optimal processing 
of external stimuli. I therefore expect this to become an area of intense focus 
within this field. In contrast, the presence of GABAergic interneurons within the 
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DRN is well accepted (Qing-Ping et al., 1992, Gervasoni et al., 2000, Challis et 
al., 2013). If these alpha1 subunit expressing cells universally function as 
conventional local circuit GABAergic neurons which, when activated attenuate 
the release of noradrenaline and serotonin, then administered alpha1 subunit 
ligands should result in raised brain levels of these monoamines. This is rather 
counter-intuitive given the use of alpha1 subunit ligands as sedative or 
hypnotics while raised brain levels of noradrenaline correlates with higher levels 
of arousal. This highlights the profound pitfalls in theorising functional 
implications based on expression patterns. While it would have been extremely 
informative to include in vivo and in vitro functional analyses alongside these 
expression studies, such combinatorial studies would extend beyond the 
relatively narrower technical confines of the PhD period. Nevertheless, these 
expression studies provide an anatomical framework for future functional 
dissections of these pathways.  
 
 
5.5. The importance of these findings in terms of stress related mental 
illnesses 
 
Mental illnesses arise because the impact of prior experiences leaves the 
individual ill-equipped to deal with subsequent behavioural challenges. I build a 
case for life experience having the ability to shape GABAAR mediated 
neurotransmission. Strong evidence has been provided for augmented 
GABAergic neurotransmission in psychiatric disorders such as post-traumatic 
stress disorder (Bremner et al., 2000), depression (Sanacora et al., 1999, 
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Sanacora et al., 2004, Hasler et al., 2007) and in suicide victims (Merali et al., 
2004, Poulter et al., 2008). Based on this clinical evidence, and in light of the 
findings of others (Crestani et al., 1999, Crawford et al., 2013, Vithlani et al., 
2013) and this thesis, I propose enhanced  GABAAR mediated 
neurotransmission correlates with an adaptive response to behavioural 
challenge, and that exhaustion of the pathways which enhance GABAAR 
expression may contribute to the manifestation of stress-related psychiatric 
disorders. 
5.6. Future challenges in GABA-GABAAR systems and LC, DRN biology 
 
This work provides the first demonstration of which GABAAR subunits are 
expressed in individual cell-types of the LC and DRN. From this, we can only 
infer how this collection of subunits assembles to compose the different 
GABAAR subtypes within such brain circuits. A recent study has shown that the 
targeting of diverse GABAAR alpha subunits to overlapping synaptic populations 
defines the time course of inhibitory post synaptic potentials. In this thesis, I 
demonstrate that within the non-principal cells of the LC and DRN, the GABAAR 
alpha1 and alpha3 subunits are targeted to overlapping synaptic populations. 
This suggests that although the kinetic profile of inhibitory currents on the non-
principal cells of the LC and DRN are predominantly fast, as indicated by the 
enriched GABAAR alpha1 subunit expression, GABAAR mediated 
neurotransmission is further diversified by the presence of alpha3 containing 
GABAAR subtypes within a sub-population of inhibitory synapses. This diversity 
is likely to be integral for defining the precise spatial and temporal release of the 
neurotransmitters expressed within LC and DRN non-principal neurons. This 
same study also demonstrates how important knowledge of the expression and 
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function of the composite receptor subtype is, in terms of receptor function and 
pharmacology. Unfortunately, available tools do not allow a direct determination 
of the diversity of receptor subtype expressed within individual cell-types; this is 
inferred by the subunits expressed within such cells since the antibodies are 
generated to recognise individual subunits, rather than the composite GABAAR 
subtypes. Furthermore, available GABAAR specific pharmacological agents lack 
the subunit specificity (Rudolph and Mohler, 2006). Mouse mutant models 
involving the global deletion of individual GABAAR subunits often results in 
compensatory responses in the remaining subunits. The advent Cre-LoxP 
technology which allows for gene manipulation in individual cell-types holds 
some promise.  Further pharmaco-genetic strategies which render mutant mice 
insensitive to certain drugs such as benzodiazepines (Wulff et al., 2007, 
Wieland et al., 1992) require that the brain region of interest expresses the 
subunit target, in this case the gamma2 subunit. This is not the case with the 
LC. The field thus requires a new generation of tools to probe the function of 
individual GABAAR subtypes in identified cell-types in situ. One way to attempt 
to characterise the subunit composition of native GABAAR subtypes within the 
LC and DRN would be to combine freeze fracture immunogold labelling to first 
identify which subunits are expressed within the same synapse (Kasugai et al., 
2011), then conduct co-immunoprecipitation to identify whether two subunits 
which are expressed in the same synapse have a physical interaction which 
might infer co-assembly to form GABAAR receptor subtypes. 
The natural progression of this research could be to investigate the input 
specific GABAAR mediated regulation of LC and DRN function, in the context of 
the behaving animal. This could provide information about how the neuronal 
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ensembles which comprise the networks LC and DRN contribute to 
noradrenaline and serotonin release. One recent paper has used an 
optogenetic approach to reveal the behavioural correlates of silencing the 
GABAergic neurons of the DRN. The authors make the claim that silencing 
GABAergic input onto DRN serotonergic neurons prevents the adoption of a 
depressive-like phenotype following resident-intruder stress (Challis et al., 
2013). However, in this study, the light sensitive channel, archaerhodopsin was 
targeted to all GAD65 expressing neurons within this brain region. Expression is 
likely to occur in not only local circuit, non-serotonergic GABAergic neurons of 
the DRN but also a population of GABA projection neurons within the DRN and 
possibly the neurons of periaqueductal gray which is situated dorsal to the 
DRN. Furthermore, GABA has been reported to be expressed by some 
serotonergic neurons as well (Fu et al., 2010, Shikanai et al., 2012). Thus, the 
ensuing behavioural effects from optical stimulation cannot be unequivocally 
confirmed as arising solely from one population of neurons since they and no 
attempt was made to characterise the contribution of different sub-populations 
of GABAergic neuron to behavioural phenotype. This relatively inelegant study 
illustrates the importance of combining anatomy with physiology, optogenetics 
and behaviour in order to gain a more comprehensive view of the contribution of 
specific circuits to different brain states and behaviours. The question I would 
like to ask is do diverse GABAergic inputs innervate populations of inhibitory 
synapses which contain distinct GABAAR subunits, and how might GABAAR 
alpha3 subunit mediated regulation of LC and DRN neuronal excitability 
correlate with diverse behavioural phenotypes?  
To address this question I would first use paired recordings between putative 
interneurons and principal cells within the LC and DRN to identify the function 
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and neurochemical identity of the diverse local circuit input onto LC and DRN 
principal neurons. Subsequently, after neurochemically characterising the 
interneurons and determining whether different classes exist, I would use 
optogenetics to control the activity of such distinct sub-populations of 
GABAergic neuron and ascertain their influence on the activity of the LC and 
DRN principal neurons in defining different brain states and behaviour. Next, I 
would investigate the role of the GABAAR alpha3 subunit in mediating the 
effects of these diverse inputs by combining optogenetic stimulation of distinct 
sub-populations of local GABAergic neuron and inducible Cre-LoxP technology 
to selectively delete the GABAAR alpha3 subunit in the principal neurons of the 
LC and DRN. I thus believe that the anatomical data provided in this thesis 
provide the foundations for addressing the fundamental functional questions 
relating to the role of GABAARs in determining coordinated activity in the 
neuronal circuits of the LC and DRN.   
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Appendix I 
 
Immunoreactivity for choleycystokinin (CCK), calcitonin gene related peptide 
(CGRP) and parvalbumin (PV) was not detected in the non-noradrenergic, 
alpha1 immunopositive cells of the LC. (A) CCK immunoreactivity was punctate 
and was not evident on the neurochemically diverse cell types of the LC. CGRP 
and PV immunolabelling was diffuse and cytoplasmic and exclusively localised 
to TH immunopositive neurons within the LC. Scale bar 10 µm. 
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Appendix II 
  
An illustrative agarose gel for genotyping. The double band, one at ~520 bp and 
one at ~480 bp denotes the presence of both the WT and mutant Gabra3 
alleles. A single band denotes the presence of only the WT allele.  
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